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3 SUMMARY 
The plasma membrane (PM) of animal cells represents a dynamic lipid bilayer which is 
constantly remodeled and adapted to cellular demands e.g. by formation of protrusions such as 
lamellipodia, filopodia or membrane ruffles. Spherical PM blebs are another type of protrusions 
and are generated after exposure to specific triggers in distinct circumstances including e.g. 
apoptosis, secretion and cell motility. They are thought to be controlled by a common blebbing 
machinery which orchestrates bleb expansion, retention and retraction by influencing 
cytoskeletal organization and integrity as well as its interaction with the PM. A key factor in PM 
blebbing is the Rho kinase ROCK which activity is required for PM blebbing. 
First, SH4-domains were identified as novel trigger for non-apoptotic PM blebbing. These 
anchoring domains of peripheric PM proteins such as the proto-oncogenic Src kinases or the cell 
surface protein HASPB of Leishmania parasites are attached to the PM via acetylated and 
saturated hydrocarbon chains, in some cases in combination with basic clusters. PM association 
was required for induction of PM blebbing which showed kinetics similar to other described PM 
blebbing phenotypes. Consistently, this dynamic process was controlled by Rho but not Rac or 
Cdc42 GTPase signaling pathways, was regulated by the activities of ROCK kinase and myosin 
II ATPase and was dependent on the integrity of F-actin as well as microtubules. In addition, Src 
kinases were identified as novel determinants in regulation of PM blebbing. Endogenous Src 
kinase activity was essential for PM blebbing in SH4-domain expressing cells. Active c-Src as 
well as active ROCK were enriched in PM blebs.  
As a functional consequence, SH4-domain mediated PM blebbing correlated with enhancement 
of fluid-phase uptake as well as cell invasion in 3D matrices which is connected to the amoeboid 
mode of cell migration in metastasizing tumor cells. In fact, CHO cells expressing SH4-domains 
also showed PM blebbing in 3D environments and their invasiveness closely matched that of 
MDA-MB-435 breast cancer cells indicating a novel function of these anchoring domains. 
Second, the diaphanous related formin FHOD1 was identified in RNAi based knockdown 
experiments to be involved in SH4-domain induced PM blebbing. Consistently, co-expressed 
with ROCK1, FHOD1 participated in non-apoptotic PM blebbing dependent on its formin 
specific ability to nucleate F-actin and possibly related to its binding to ROCK1. Induction of 
PM blebbing as well as binding required Src kinase activity, suggesting a direct interplay 
between these factors. In a here postulated hypothetical model, c-Src and ROCK1 are 
responsible for PM association and regulation of the blebbing machinery. In this scenario 
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FHOD1 mediated F-actin polymerization is required for cytoskeletal rearrangements during PM 
blebbing possibly in combination with other formins. 
Finally, by application of a novel FHOD1 specific antibody it was demonstrated that endogenous 
FHOD1 localized in a perinuclear and Golgi related region. In knockdown experiments, 
however, additional functions beyond its contribution to PM blebbing were not detected, neither 
in relation to its Golgi association nor to its supposed capability of F-actin reorganization. 
Collectively, Src kinases as well as FHOD1 were identified as compounds of a cellular 
machinery that involves Rho-ROCK activity and regulates SH4-domain triggered PM blebbing. 
These results suggest a novel interplay between SH4-domains, Src activity, ROCK signaling and 
FHOD1 mediated cytoskeletal rearrangements. Since PM blebbing was correlated with enhanced 
fluid-phase uptake and 3D motility, SH4-domain mediated PM dynamization might be a 
mechanism that influences invasiveness of cells transformed by SH4-domain containing 
oncoproteins. 
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4 ZUSAMMENFASSUNG 
Die Plasmamembran (PM) tierischer Zellen besteht aus einer dynamischen, lipidhaltigen 
Doppelschicht, die beispielsweise bei der Bildung von Zellausläufern wie Lamellipodien, 
Filopodien oder Membranfalten abhängig von zellulären Bedürfnissen konstant umgestaltet 
wird. Die ballonartigen PM "blebs" stellen ebenfalls einen solchen Typ Zellausläufer dar und 
können zum Beispiel während Apoptose, Sekretion und Zellbeweglichkeit auftreten. Dabei 
werden Ausdehnung, Stabilisierung und Rückbildung der "blebs" vermutlich durch eine 
gemeinsame zelluläre Maschinerie kontrolliert, die sowohl die Organisation und Integrität des 
Zytoskeletts als auch dessen Interaktion mit der PM beeinflusst. Eine wichtige Rolle spielt dabei 
die Rho Kinase ROCK, deren Aktivität notwendig für PM "blebbing" ist. 
In dieser Studie wurden SH4-Domänen als neuartiger Auslöser für PM "blebbing" identifiziert. 
SH4-Domänen sind die Ankerdomänen bestimmter peripherer PM Proteine wie der 
protoonkogenen Src Kinasen und des Oberflächenproteins HASPB des Leishmania Parasiten. 
Sie werden durch acetylierte und gesättigte Kohlenwasserstoffketten, teils unterstützt durch 
basische Bereiche in der Aminosäuresequenz an die PM gebunden. Es stellte sich heraus, dass 
diese Assoziation an die PM notwendig für die Induktion von SH4-Domänen vermitteltem PM 
"blebbing" war, welches Kinetiken aufwies, die vergleichbar mit beschriebenen PM "blebbing" 
Phänotypen waren. Darüber hinaus stand dieser dynamische Prozess allein unter der Kontrolle 
eines auf Rho, jedoch nicht auf Rac oder Cdc42 basierenden GTPase Signalweges, wurde durch 
ROCK Aktivität und Myosin II ATPase reguliert und benötigte sowohl F-Aktin- als auch 
Mikrotubuli-Integrität. Als neuer regulierender Faktor wurden Src Kinasen bestimmt, da 
endogene Src Kinase Aktivität essentiell für SH4-Domänen induziertes PM "blebbing" war. 
Darüber hinaus waren SH4-Domänen induzierte PM "blebs" sowohl mit aktivem c-Src als auch 
mit aktivem ROCK angereichert. 
Es bestand eine funktionelle Korrelation von SH4-Domänen induziertem PM "blebbing" sowohl 
mit einer erhöhten zellulären Aufnahme flüssiger Bestandteile als auch mit einer erhöhten 
Zellinvasion in 3D Matrizen, welche in direktem Zusammenhang mit der amöboiden Form der 
Zellwanderung metastasierender Tumorzellen steht. Tatsächlich zeigten SH4-Domänen 
exprimierende CHO Zellen auch in 3D Umgebungen eine ähnliche "bleb" Morphologie und ihre 
Invasivität war vergleichbar mit der von MDA-MB-435 Brustkrebszellen, was auf eine neue 
zelluläre Funktion dieser Ankerdomänen hinweist. 
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Auch das "diaphanous related formin" FHOD1 konnte, basierend auf RNAi vermittelter 
Herunterregulierung, als Faktor für SH4-Domänen induziertes PM "blebbing" identifiziert 
werden. In Koexpression mit ROCK1 war FHOD1 in Abhängigkeit von seiner Fähigkeit zur  
F-Aktin-Nukleierung und möglicherweise durch direkte Interaktion mit ROCK1 an der 
Induktion von nicht-apoptotischem PM "blebbing" beteiligt. Dabei war Src Kinase Aktivität 
sowohl für die Induktion von PM "blebs" als auch für Interaktion von FHOD1 mit ROCK1 
notwendig, was auf ein direktes Zusammenspiel dieser Faktoren hinweist. In einem in dieser 
Studie aufgestellten hypothetischen Modell sind c-Src und ROCK1 verantwortlich für PM 
Assoziation und Regulation der "blebbing" Maschinerie. FHOD1 vermittelte F-Aktin 
Polymerisierung ist hingegen notwendig für die Organisation des Zytoskeletts während des 
"blebbing" Vorganges, möglicherweise mit Unterstützung anderer Formine. 
Schließlich konnte unter Verwendung eines neuen FHOD1 spezifischen Antikörpers gezeigt 
werden, dass endogenes FHOD1 in tierischen Zellen in perinukleären, Golgi ähnlichen 
Bereichen lokalisierte. Zusätzlich zu seiner Rolle in SH4-Domänen vermitteltem PM "blebbing" 
war es jedoch durch RNAi vermittelte Herunterregulierung nicht möglich, weitere Funktionen 
für FHOD1 zu ermitteln, weder in Bezug auf seine Golgi Assoziation noch auf seine postulierten 
Funktion für F-Aktin-Organisation. 
Zusammenfassend wurden sowohl Src Kinasen als auch FHOD1 als neue Bestandteile einer 
zellulären Maschinerie identifiziert, die von Rho-ROCK Aktivität abhängig war und von SH4-
Domänen gesteuert wurde. Ferner weisen die hier beschriebenen Ergebnisse auf ein neuartiges 
Zusammenspiel von SH4-Domänen, Src Aktivität, ROCK Signalwirkung und FHOD1 
vermittelte Zytoskelett Umgestaltung hin. Da PM "blebbing" mit erhöhter zellulärer Aufnahme 
flüssiger Bestandteile und erhöhter Zellwanderung in 3D Umgebungen korrelierte, könnte SH4-
Domänen vermittelte PM Dynamik einen Mechanismus darstellen, der die Invasivität von Zellen 
beeinflusst, die durch SH4-Domänen-haltige Onkoproteine transformiert wurden. 
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5 INTRODUCTION 
Dynamic processes are found at each level of organization and determine the life cycle of all 
organisms. In vertebrates, the blood circulates in vessels, a process driven by the muscular 
activity of the heart. During infections, the immune system specifically reacts to germs affecting 
the organism. Therefore, specialized immune cells actively migrate through tissues, an ability 
that is also ascribed to metastasizing tumor cells. For delivery of cellular determinants, vesicles 
are actively carried through the whole cell. Most of the secretory proteins, for instance, are 
transported and processed by the Golgi apparatus. Compositions of cellular structures like 
plasma membranes are constantly reconstructed and altered similarly to the shape of the whole 
cell. Cells form several kinds of protrusions like filopodia, lamellipodia, membrane ruffles or 
plasma membrane blebs on their surface that are needed for active locomotion and are 
specifically formed even in the process of dying. Required for all these actions is the dynamic 
cytoskeleton consisting of three different types of protein-polymers: The F-actin filaments that 
made of G-actin monomers representing the microfilament system, the intermediate filaments 
consisting of heterologous monomers, and the microtubules composed of tubulin monomers 
forming a tubular structure. Polymerization of the cytoskeletal components itself is very 
organized and depends on active signaling events of regulatory proteins like Rho-GTPases or Src 
kinases as well as on proteins that directly facilitate the assembly process. Nucleation of F-actin 
filament polymerization in particular is catalyzed by molecular machineries such as the Arp2/3 
complex, the spire proteins as well as by diaphanous related formins (Drfs). 
This work deals with the influence of Src kinases and of the Drf FHOD1 on several dynamic 
cellular processes. A particular focus is put on cellular motility and PM blebbing, two processes 
that have been shown to correlate in certain situations. 
5.1 The Microfilament System 
The cytoskeleton of eukaryotic cells is the basis for various dynamic cellular processes. It is also 
involved in cellular adhesion, migration, polarity, development and cytokinesis and mediates 
stability of the cell as well as intracellular transportation. The three main components of the 
cytoskeleton have in common that they consist of monomers with the capacity for non-covalent 
polymerization and formation of filaments. The biggest filamentous structures found within a 
cell are the microtubules. These polarized filaments of about 25 nm in diameter and consist of 
polymerized heterodimers of α-tubulin and β-tubulin. Usually, they originate from the 
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microtubule organizing center (MTOC) which is associated with the nucleus and is divided 
during cytokinesis, thus playing a pivotal role in chromatin separation. By binding of motor 
proteins, microtubules are important structures for delivery of cellular determinants. They are 
therefore directly involved in organization of intracellular traffic that is related e.g. to the Golgi 
apparatus (Brinkley, 1997, Pellegrini and Budman, 2005, Wade et al., 1998). The next smaller 
polymers are the very stable intermediate filaments with a size of approximately 10-12 nm in 
diameter. Intermediate filaments are built up of homo- or heterodimers that are successively 
organized to proto-filaments and non polarized filaments. They have been suggested to play a 
tissue specific role in which their principal function is a structural one: By providing mechanical 
support they are thought to play a pivotal role in reinforcement of the cell and organization of 
cells into tissues (Kim and Coulombe, 2007). Keratins for example are typically expressed in 
epithelial cells and therefore give rise to hairs or nails. Vimentin on the other hand can be found 
in leukocytes, fibroblasts and other cells types where it supports cellular membranes and 
contributes to the localization of cellular organelles (Lodish et al., 2000). The smallest 
polymerized compounds of the cytoskeleton are the microfilaments which consist of F-actin. 
These filaments with a diameter of 5-7 nm are homopolymers of single globular G-actin 
proteins. Their cellular role, structure, organization and dynamics are the topics of the following 
chapters. 
5.1.1 The Actin Protein and Microfilaments 
The actin cytoskeleton or microfilament system is the main component of most eukaryotic cells 
and contributes to many processes including polarization, protrusion, contraction, nuclear 
segregation, cytokinesis, gene transcription and vesicle trafficking (Evangelista et al., 2003, 
Pederson and Aebi, 2005, Pollard and Borisy, 2003). Six isoforms of the globular actin monomer 
with a size of 42-45 kDa encoded by separate genes have been described in mammals and are 
divided into three classes: α-actins are mainly present in muscle cells (α-skeletal, α-aortic 
smooth, α-cardiac and γ2-enteric smooth), whereas β- and γ-actins are primarily found in non-
muscle cells (β- and γ1-cytoplasmic) (Vandekerckhove and Weber, 1978). Despite small 
differences in sequence and properties between the isoforms, all actins polymerize non-
covalently into microfilaments. Thereby, G-actin monomers that are bound to adenosine-
triphosphate (ATP) assemble under physiological conditions to F-actin filaments (Laki et al., 
1950). Following irreversible hydrolysis of ATP to adenosine-diphosphate (ADP) in the middle 
section of a newly formed linear and unbranched microfilament, the resulting structure develops 
certain stability. Detected by electron microscopy, F-actin filaments show a clear polarity 
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following treatment with myosin heads that specifically decorate these filaments: They have a 
fast growing barbed or plus end and a slow growing pointed or minus end (fig. 1). This diversity 
in kinetics results from a higher affinity of ATP-bound G-actin to the barbed end leading in vitro 
to a less critical concentration for assembly at this site (Kd = 0.12 µM) compared to the pointed 
end (Kd = 0.6 µM, fig. 1) (Pollard and Borisy, 2003).  
Figure 1: Elongation of F-actin filaments. 
An electron micrograph (EM) of an F-actin seed that is decorated 
with myosin heads to indicate the barbed and the pointed end of 
the filament. The non decorated parts are newly added G-actin 
monomers indicating a slow assembly rate at the pointed end, but a 
fast polymerization at the barbed end. The dissociation equilibrium 
constants Kd [µM] for these elongation reactions are depicted in 
the schematic presentation of a microfilament on the right. 
Addition of ADP bound G-actin (= D) to any end as well as 
addition of ATP bound G-actin (= T) to the pointed end are 
energetically not favorable reactions. In contrast, its addition to the 
barbed end is energetically preferred (adapted from Pollard and 
Borisy, 2003). 
 
 
 
 
 
In non-muscle cells the concentrations of ATP bound G-actin has been shown to exceed 100 µM 
(Pollard et al., 2000). To prevent spontaneous polymerization, the concentration of free G-actin 
is highly adjusted by binding to regulatory proteins like thymosin-β4 or members of the profilin 
family. These G-actin binding proteins reduce the amount of free cytosolic ATP bound G-actin, 
thereby inhibiting uncontrolled self assembly to filaments (Pollard et al., 2000). Furthermore, 
profilins are able to stimulate the nucleotide exchange of ADP to ATP which is available in 
excess, resulting in a regeneration of the ATP bound G-actin pool. The G-actin binding capacity 
of profilins is regulated by its binding to membrane bound phosphatidylinositol-4,5-bisphosphate 
(PIP2) (Lassing and Lindberg, 1985). Additionally, profilins have a high affinity and directly 
bind to proline rich regions of several proteins that control F-actin nucleation such as the 
Wiskott-Aldrich-syndrome protein (WASp) (Lu and Pollard, 2001) or formins (see  
chapter 5.1.2.2) (Frazier and Field, 1997, Tojo et al., 2003, Wasserman, 1998, Watanabe et al., 
1997). Besides G-actin binding proteins there are additional classes of regulated proteins that 
maintain, modify or organize existing microfilament structures (fig. 2): Capping proteins either 
bind to the barbed (capping protein, AIP1) or to the pointed end (tropomodulin) of F-actin 
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filaments, thereby blocking further filament growth or shrinkage of the polymer. Severing 
proteins like gelsolin, villin or ADF/cofilin induce destruction of existing F-actin filaments 
resulting in their depolymerization but also in formation of new F-actin filaments. 
 
Figure 2: The cellular appearance of actin and the role of associated proteins. 
In the cytosol, the appearance of actin is organized by highly regulated actin associated proteins: Spontaneous 
assembly to F-actin filaments is prevented by binding of the monomers to G-actin binding proteins. Nucleation and 
polymerization is controlled by nucleating compounds like formins, the Arp2/3 complex and spire, but is also 
initialized by severing proteins that are involved in destruction of existing microfilaments. F-actin filaments are 
protected for depolymerization by capping proteins and are linked to each other by crosslinking and bundling 
proteins (Pollard and Earnshaw, 2004). 
Crosslinking proteins like α-actinin or filamins connect and organize single F-actin filaments. 
Similarly, motor proteins like myosins contribute to bundling of microfilaments to stress fibers 
as well as provide contractility (Ruegg et al., 2002, Siripala and Welch, 2007, Siripala and 
Welch, 2007, Stossel et al., 2001, Wang et al., 2007, Weeds and Maciver, 1993). Finally, there 
are specific proteins and protein complexes that facilitate nucleation of F-actin polymerization. 
These proteins, their regulation and their specific mechanisms of polymerization will be 
described in the following chapters. 
5.1.2 The Dynamics of the Microfilament System 
The limiting step in actin polymerization is the nucleation of new filaments. Since spontaneous 
association of G-actin monomers is a very unlikely process, there are at least three types of 
nucleators that function with distinct mechanisms: The Arp2/3-complex, the spire protein and the 
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family of formins (fig. 3) (Mullins et al., 1998, Pruyne et al., 2002, Quinlan et al., 2005, Welch 
and Mullins, 2002). 
5.1.2.1 Nucleation of F-Actin Polymerization 
The Arp2/3-complex is composed of seven strongly associated proteins: The two actin related 
proteins (Arp) Arp2 and Arp3 and the five unique proteins ARPC1, ARPC2, ARPC 3, ARPC4 
and ARPC5 form a complex with a stoichiometry of 1:1 (Millard et al., 2004). The Arp2/3-
complex itself represents the nucleus that binds to the pointed end of a newly formed 
microfilament (fig. 3). Following this initial assembly step the filament growth proceeds at the 
barbed end independent of Arp2/3. However, to induce nucleation, Arp2/3 binds to an existing 
microfilament at an angle of 70° leading to a meshwork of short and branched filaments 
(Blanchoin et al., 2000, Mullins et al., 1998, Pollard et al., 2000). The activity of the Arp2/3-
compex is controlled by the family of WASp adaptor proteins with WASp, its brain isoform  
N-WASP, WAVE (WASp-verprolin homologous protein) and Scar (suppressor of cAMP 
receptor) (Machesky and Insall, 1998, Machesky et al., 1999). The structural components that 
are needed for their activity are combined in the VCA-module that is located at the C-terminal 
end: The WH2 (WASp homology 2) or verprolin (V) domain is required for binding of G-actin 
monomers, the acidic (A) domain binds to the Arp2/3-complex and the central (C) domain 
induces conformational changes that are required for nucleation (Higgs and Pollard, 2001). The 
WASp/N-WASP proteins are activated by binding of GTP bound Cdc42 and PIP2 that release an 
intramolecular autoinhibition (Millard et al., 2004). In contrast, the WAVE/Scar proteins 
function in a complex that includes Sra1 and further proteins. By binding of the Rho-GTPase 
Rac1 to Sra1 the complex is activated and regulates the activity of the Arp2/3-complex (Kunda 
et al., 2003). WAVE proteins are also activated by binding of IRSp53, another effector of Rac 
that plays a role in Arp2/3-complex activation (Miki et al., 2000). Since the Arp2/3-complex is 
directly involved in F-actin polymerization at the leading edge of migrating cells, it plays a 
pivotal role in cell motility by formation of the branched microfilament network in lamellipodia 
(Higgs and Pollard, 2001, Pollard and Borisy, 2003).  
The second class of F-actin nucleators is represented by the spire protein. Its functional unit 
consists of four G-actin binding WH2-domains, which are also present in the family of WASp 
related proteins as described above. Spire presumably nucleates unbranched F-actin filaments at 
the pointed end by recruitment and organization of G-actin monomers into a prenucleation 
complex that templates filament formation from the side (fig. 3) (Baum and Kunda, 2005, 
Kerkhoff, 2006). 
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Figure 3: Nucleation of F-actin polymerization. 
The limiting step in polymerization of F-actin filaments is the nucleation process. Therefore, at least three ATP 
bound G-actin monomers have to assemble in order to form the very unstable initiating seed or nucleus. In vivo, this 
spontaneous nucleation is extremely unlikely. In cellular systems, certain different mechanisms exist to mediate 
nucleation. Formins are "leaky cappers" that bind to the barbed end of growing F-actin filaments by their FH2-
domains. They are thought to stabilize intermediates like short actin dimers. The Arp2/3-complex binds to an 
existing microfilament and also requires adaptor proteins like WASp that are also bound to G-actin monomers. 
Therefore, the Arp2/3-complex is associated to the pointed end of newly formed F-actin filaments that stick out of 
the mother filament at an angle of 70°. The elongation, however, proceeds at the barbed end without a contribution 
of the Arp2/3-complex, resulting in the formation of meshwork of short and branched microfilaments. Similarly, 
spire also binds to the pointed end of newly formed microfilaments by its array of WH2-domains, thus stabilizing 
the nucleus by a prenucleation complex (Goode and Eck, 2007).  
The capacity of spire to nucleate F-actin polymerization has only been discovered recently 
(Quinlan et al., 2005), even though the spire-gene has been identified in 1989 (Manseau and 
Schupbach, 1989). The cellular functions of spire are related to intracellular vesicle transport and 
Golgi organization as well as to organization of the cortical actin network (Kerkhoff, 2006, 
Kerkhoff et al., 2001). 
Similar to spire, formins form unbranched F-actin filaments. However, the mechanism is 
completely different and will be described in the following. 
5.1.2.2 Formins 
Formins are a large family of ubiquitous and highly conserved multidomain proteins generally 
consisting of over 1000 amino acid residues (Faix and Grosse, 2006, Higgs, 2005). The term 
"formin" originates from transgene insertion into the limb deformity gene resulting in limb 
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formation defects in mice (Mass et al., 1990, Woychik et al., 1990). However, it was shown 
recently that the adjacent gremlin gene rather than formins is required for limb bud patterning 
(Zuniga et al., 2004). Formins are involved in a variety of actin-based processes in eukaryotic 
cells. Their common characteristic is the unique and highly conserved C-terminal formin 
homology 2 (FH2)-domain of about 400 amino acid residues that is preceded by an N-terminally 
proline-rich FH1-domain (fig. 8A) (Faix and Grosse, 2006). Typically, the FH2 core-domain and 
the intervening linker region between the FH1- and the FH2-domain are necessary and sufficient 
to nucleate F-actin polymerization from G-actin monomers in vitro (Kovar et al., 2003, Pruyne et 
al., 2002, Sagot et al., 2002). During filament elongation, the formin remains at its barbed end 
resulting in long unbranched F-actin filaments. The central motif of the FH2-domain is a 
conserved stretch of amino acids with the consensus sequence G-N-X-M-N (where G is 
glutamine, N is asparagine, M is methionine and X is any amino acid) (Wasserman, 1998). The 
FH1-domain binds to SH3-domains (see chapter 5.3.1.2) and WW-domains (W for tryptophan) 
as well as in a low micromolar range to the G-actin binding protein profilin (see chapter 5.1.1), 
recruiting G-actin monomers in close proximity to the FH2-domain and to the barbed end of  
F-actin filaments (Bedford et al., 1997, Chang et al., 1997). Profilin has the capacity to increase 
the elongation rate of several FH1-FH2-domains in vitro, but it is not required for all formins 
(Kovar and Pollard, 2004, Romero et al., 2004). The nucleation of new microfilaments is thought 
to be facilitated by stabilization of an F-actin dimer (fig. 3) (Pring et al., 2003). During 
polymerization, formins remain at the barbed end of the newly generated F-actin filament and 
are directly involved in the elongation process (Higashida et al., 2004, Kovar and Pollard, 2004, 
Pruyne et al., 2002). In line with this, they can inhibit and replace capping proteins that stay at 
the barbed end. Therefore, formins are also termed as "leaky cappers" (Harris and Higgs, 2004, 
Kovar et al., 2003, Zigmond et al., 2003) and the mechanism they provide for nucleation and 
elongation is referred to as "processive capping" (Goode and Eck, 2007). According to this 
model, a dimer of the FH2-domain is required (Harris et al., 2004, Harris et al., 2006, Li and 
Higgs, 2005, Moseley et al., 2004). Structural analysis of the FH2-domain of the yeast formin 
Bni1p also revealed a dimer that is flexibly linked by a lasso-domain and forms a doughnut-like 
structure (Otomo et al., 2005, Xu et al., 2004). Disruption of this lasso-domain inhibits 
dimerization and thus F-actin polymerization (Moseley et al., 2004). During nucleation, this 
structure presumably forms a scaffold for assembly of the first actin subunits (fig. 3). During 
elongation, the two halves of an FH2-domain dimer localize at the barbed end and are proposed 
to alternately assume one of two states, which are referred to as the "bound" state and the 
"migrating" state (fig. 4).  
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Figure 4: Model for elongation of microfilaments by processive capping of formins. 
The FH2-domain (blue) which is tightly bound to the two terminal actin subunits (light grey 2 and 3) is linked by a 
lasso structure to the second FH2-domain (green) of the dimer (left panel). Addition of a new actin subunit (1) to 
the barbed end leads to conformational changes in the FH2-domain dimer resulting in a release of actin binding of 
the first FH2-domain (blue) that becomes the "migrating" unit, and a strengthening of the second one (green). The 
migrating unit is now capable of binding new G-actin monomers (0) resulting in polymerization (middle panel). In 
this state, the actin subunit can also be released leading to depolymerization (right panel). This process is also 
known as stair-stepping mode of elongation (Otomo et al., 2005). 
The bound FH2-domain tightly interacts with the two terminal actin subunits at the barbed end, 
whereas the migrating unit interacts only weakly and therefore facilitates addition of new G-actin 
monomers. This migrating FH2-domain is also supposed to be in a dynamic equilibrium between 
an open or accessible and a closed or blocked conformation, in which actin subunits can also 
dissociate under certain conditions. Addition of a new subunit to the filament in the open 
conformation of the migrating FH2-domain causes a conformational switch in the FH2-domain 
dimer, consequently their roles reverse. This model allows that one subunit of the FH2-dimer is 
always bound to the microfilament and proposes a stair-stepping mode of elongation (Goode and 
Eck, 2007). However, this mechanism implies that the formin circles around the filament, which 
has been shown to be not the case (Kovar and Pollard, 2004). Until now, this rotation paradox is 
not understood. 
According to a phylogenetic analysis of the FH2-domain, seven subgroups of formins in 
metazoans have been classified: Dia (diaphanous), DAAM (dishevelled-associated activator of 
morphogenesis), FRL (formin-related gene in lymphocytes), FHOD (formin homology 2 domain 
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containing protein), INF (inverted formin), FMN (formin) and delphilin (Higgs and Peterson, 
2004). 
5.1.2.3 Regulation of the Cytoskeleton by Rho-GTPases 
Rho-GTPases are major regulators of cytoskeletal organization and comprise a family of 
eukaryotic highly conserved regulatory proteins that are members of the superfamily of Ras 
related Rho-GTPases. In mammals, 22 Rho-GTPases have been identified, whereupon the most 
prominent and investigated members are Rho (Ras homolog protein), Rac (Ras-related  
C3 clostridium botulinum toxin substrate) and Cdc42 (cell division cycle 42 homolog protein). 
Three isoforms of Rho have been described (RhoA, RhoB and RhoC) and four isoforms of Rac 
(Rac1, Rac2, Rac3 and RhoG) (Aspenstrom et al., 2004, Jaffe and Hall, 2005). Most of the Rho-
GTPases are modified by prenylation and carboxymethylation of a conserved cysteine at the  
C-terminal end. Rho, Rac and Cdc42 are prenylated by a geranylgeranylgroup that contributes to 
their localization at membrane structures (Adamson et al., 1992, Marshall, 1993). Furthermore, 
Rho and Rac have been shown to be targeted to lipid-rafts in the plasma membrane through 
interaction with integrins (del Pozo et al., 2004, Palazzo et al., 2004). 
Figure 5: The GTPase cycle. 
Rho-GTPases cycle between an inactive GDP-bound 
form and an active GTP-bound form. This activity is 
regulated by associated proteins that stimulate GDP to 
GTP exchange (GEF = guanine nucleotide exchange 
factor) and activate the Rho-GTPase, stimulate 
hydrolysis of bound GTP to GDP (GAP = GTPase 
activating protein) and inactivate the Rho-GTPase or 
block spontaneous activation (GDI = guanine 
nucleotide dissociation inhibitor). Active Rho-GTPases 
interact with effector proteins to mediate a response 
(adapted from Jaffe and Hall, 2005). 
 
 
 
 
The activity of Rho-GTPases is determined by their binding to guanine-nucleotides. Thus they 
act as molecular switches cycling between an active form that is bound to guanosine-
triphosphate (GTP) and an inactive state in which the protein is bound to guanosine-diphosphate 
(GDP). This activity is controlled by three types of associated proteins (fig. 5): GTPase 
activating proteins (GAPs) stimulate the intrinsic GTPase activity to facilitate the hydrolysis of 
GTP to GDP and lead to its deactivation. Guanine nucleotide dissociation inhibitors (GDIs) 
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block spontaneous activation of the GTPase, whereas guanine nucleotide exchange factors 
(GEFs) catalyze the exchange of GDP to GTP, thus leading to an activation of the GTPase (Jaffe 
and Hall, 2005). Mutation of certain amino acid residues alters the intrinsic GAP stimulated 
activation of Rho-GTPases and leads to their deregulation. As discovered first for Ras, Rho-
GTPases often carry a proto-oncogenic capacity (Campbell and Der, 2004). According to Rac 
numbering, constitutively active forms of Rho-GTPases are usually mutated at amino acid 
residue 12, where glycine is substituted with valine (G12V), or at residue 61, where glutamine is 
substituted with leucine (Q61L), whereas dominant negative forms are mutated at residue 17, by 
substitution of threonine with asparagine (T17N) (Bishop and Hall, 2000). Rho-GTPases have 
been suggested to facilitate most of their interaction to effector proteins by their effector regions 
switch I and switch II which facilitate GDP and GTP binding (Bishop and Hall, 2000). Through 
activation of a large array of effector proteins, Rho-GTPases indirectly regulate the organization 
of the cytoskeleton and therefore play a role in various cellular processes. Addition of the pro-
inflammatory peptide Bradykinin stimulates the activation of Cdc42 and therefore the formation 
of microspikes and filopodia (fig. 6) (Allen et al., 1997, Hall, 1998). These cellular protrusions 
are thought to be involved in exploration of the environment and therefore play an important role 
during cell motility and neurite outgrowth (Kater and Rehder, 1995, Ridley, 2006). Cdc42 
activates diaphanous related formins and the Arp2/3-complex through WASp/N-WASP (see 
chapter 5.1.2.1 and 5.1.3), and is mainly localized at the Golgi apparatus indicating a role in 
vesicle transport (Qualmann and Mellor, 2003). 
Treatment of cells with the platelet derived growth factor (PDGF) activates Rac and leads to the 
formation of lamellipodia and membrane ruffles by WAVE/Scar mediated activation of the 
Arp2/3-complex (fig. 6; see chapter 5.1.2.1) (Allen et al., 1997, Norbury, 2006, Ridley, 2006). 
Furthermore, through p21 activated kinase (PAK) signaling, Rac induces the activation of 
myosin II and of LIM-kinases (LIMK) that regulate the activity of the F-actin severing protein 
ADF/cofilin. Rac also interacts with diaphanous related formins like FHOD1 and FRL, 
indicating that formins could play a role in formation of lamellipodia and cell migration 
(Gasteier et al., 2003, Westendorf, 2001, Yayoshi-Yamamoto et al., 2000). 
Addition of growth factors like lysophosphatic acid (LPA) to animal cell cultures results in an 
activation of Rho and therefore in the formation of stress fibers, which are contractile bundles of 
F-actin filaments that are linked by myosins and other proteins (fig. 6) (Allen et al., 1997, Hall, 
1998). This stress fiber formation depends on the activity of the Rho effector proteins mDia for 
F-actin nucleation (see chapter 5.1.3) and ROCK for induction of filament bundling. 
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Figure 6: Signaling of Rho-GTPases. 
Depicted are the Rho-GTPase signaling cascades that are involved in formation of cell protrusions:  
LPA = lysophosphatic acid, PDGF = platelet derived growth factor; blue rectangles = Rho-GTPases; light green 
ellipses = central serine/threosine kinases; dark green boxes = adaptor proteins; red diamonds = effector proteins; 
grey boxes = MLC phosphatase and MLC kinase; P = phosphorylation; black arrows = activation; black blocked 
lines = deactivation. 
5.1.2.4 The family of ROCK proteins 
The Rho associated coiled-coil containing protein kinases ROCK1 and ROCK2 form a family of 
serine/threonine kinases. They are Rho effector proteins required for induction of F-actin 
bundling and contractility at the rear of a motile cell (Bishop and Hall, 2000). The two isoforms 
show 65 % identity in their overall amino acid sequence and 92 % in their kinase domains at the 
N-terminal end (Riento and Ridley, 2003) (fig. 7). Inside their coiled-coil region between the 
kinase region and the C-terminal Pleckstrin Homology (PH) domain with its cysteine-rich region 
lays the Rho binding domain (RBD) that plays a role in ROCK activation. ROCK kinase activity 
is intramolecularly autoinhibited by independent binding of the RBD and the PH-domain to the 
Introduction 
 
  
 
16
kinase domain (fig. 7) (Chen et al., 2002). Therefore, ROCK proteins are thought to be activated 
by direct binding to active Rho-GTP and to lipids like arachidonic acid to the PH-domain 
(Dvorsky et al., 2004, Riento and Ridley, 2003). In line with this, ROCK1 is constitutively 
activated by caspase-3 mediated and ROCK2 by granzyme B mediated cleavage of its carboxyl-
terminus. This naturally occurs in apoptotic cells and causes extensive PM blebbing (Coleman et 
al., 2001, Sebbagh et al., 2005). 
 
Figure 7: Organization and regulation of ROCK Rho kinases.  
(A) Schematic presentation of ROCK proteins. The two isoforms ROCK1 and ROCK2 show 65 % overall amino 
acid sequence identity and 92 % in their kinase domains at the N-terminal end. The Rho binding domain (RBD) is 
situated within a predicted coiled-coil region that is followed by a Pleckstrin homology (PH) domain with a cysteine 
rich region (CRD) at the carboxyl terminus. (B) Regulation of ROCK kinases. The kinase domain of ROCK 
independently binds to its PH domain and RBD resulting in an intracellular autoinhibition. The kinase domain is 
released by binding of active Rho-GTP to the RBD, lipids like arachidonic acid to the PH domain or apoptotic 
cleavage by caspase-3 (ROCK1: residue 1113, DETD) or granzyme B (ROCK2: residue 1131, IGLD; not shown) 
(Riento and Ridley, 2003). 
To understand how ROCK proteins mediate their activities to the microfilament system one has 
to have a closer look at their kinase activity and effector proteins. ROCK proteins are 
serine/threonine kinases with two consensus sequences for phosphorylation that are R/K-X-S/T 
and R/K-X-X-S/T (where R is arginine, K is lysine, S is serine, T is threonine and X is any 
amino acid). They can be auto-phosphorylated which is thought to contribute to their activation 
state as well, but their main target is the myosin II motor protein in non-muscle cells. The 
myosin II regulatory part myosin light chain (MLC) is phosphorylated directly by ROCK 
proteins at Ser19 and thereby activated (fig. 6). The phosphorylation state is furthermore 
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regulated by MLC kinase (MLCK) that stands in balance with MLC phosphatase (MLCP) 
leading to dephosphorylation and inactivation of MLC. ROCK proteins phosphorylate MLCP 
and thereby induce its release from MLC resulting in an indirect activation of MLC (Bishop and 
Hall, 2000, Matsumura, 2005). Active myosin II decorates F-actin fibers, aligns them to bundles 
and stress fibers and facilitates contraction in an ATP consuming process. Similar to the 
sacromeric structure of muscle cells, but not as organized, myosin II mediates the antagonistic 
gliding of F-actin filaments (Geeves and Holmes, 1999, Ruegg et al., 2002).  
5.1.3 Diaphanous Related Formins 
A subfamily of formins, the diaphanous related formins (Drfs) interact with Rho-GTPases and 
are therefore thought to represent effectors of these regulatory proteins (see chapter 5.1.2.3). Drfs 
share a typical domain structure that mediates an intramolecular autoinhibition which initially 
had been identified in the Drosophila formin diaphanous (Wasserman, 1998). The autoinhibition 
is mediated by the C-terminal diaphanous autoregulatory domain (DAD) and the N-terminal 
regulatory domain (fig. 8A) (Wasserman, 1998, Watanabe et al., 1997).  
 
 
Figure 8: Diaphanous related formins and their activation. 
(A) Formins consist of a proline rich FH1-domain that is capable to associate the G-actin binding protein profilin. 
The FH2-domain is located in an adjacent position facilitating the nucleation process. The FH3-domain is only 
poorly defined and in some formins it is involved in their cellular localization. Drfs are autoinhibited by an 
intramolecular binding of the C-terminal diaphanous autoregulatory domain (DAD) to the N-terminal regulatory 
domain consisting of a Rho-GTPase binding domain (GBD), a diaphanous inhibitory domain (DID) with an 
armadillo repeat region (ARR), a dimerization domain (DD) and a coiled-coil region (CC). (B) By binding of a GTP 
bound Rho-GTPase to the GBD the autoinhibition is partially released. Additional signals are required for full 
activation (Faix and Grosse, 2006). 
Introduction 
 
  
 
18
The DAD represents a relatively small stretch of amino acids and is characterized by a highly 
conserved regulatory motif with the consensus sequence M-D-X-L-L (where D is aspartic acid, 
L is leucine, M is methionine and X is any amino acid) and a conserved regulatory region of 
basic amino acid residues (Alberts, 2001, Schonichen et al., 2006). In contrast, the N-terminal 
regulatory domain is much bigger in size and includes a GTPase binding domain (GBD), a 
diaphanous inhibitory domain (DID) with an armadillo repeat region (ARR) and a dimerization 
domain (DD) (Alberts, 2001, Li and Higgs, 2005, Rose et al., 2005). The DID and DD together 
loosely define the less characterized FH3-domain that contributes to the subcellular localization 
of some formins (Brandt et al., 2007, Kato et al., 2001, Kitayama and Uyeda, 2003). In its 
dormant state, the Drfs DAD is bound to the N-terminal regulatory domain and remains in a 
closed conformation (fig. 8B). 
Upon binding of a Rho-GTPase to the GBD the autoinhibition is released (Alberts, 2001, Li and 
Higgs, 2003, Watanabe et al., 1999). In mDia1, the Rho-GTPase interacts via its switch I and 
switch II effector regions with the GBD and the DID (Otomo et al., 2005, Rose et al., 2005). 
However, the DAD binding to the N-terminal region is not fully released, additional 
conformational changes of the DID are thought to be required (Lammers et al., 2005). Therefore 
further factors are suggested to be required to fully activate Drfs (Li and Higgs, 2005).  
5.1.3.1 Cellular Functions of Formins 
Formins are involved in a variety of cellular processes that are related to the cytoskeleton. 
During cytokinesis, formins contribute to the formation of the contractile ring in mammalian and 
yeast cells (Castrillon and Wasserman, 1994, Evangelista et al., 2002, Noguchi and Mabuchi, 
2001). In line with this, formins like Bni1p play a pivotal role in polarization of yeast cells 
during cytokinesis and budding (Evangelista et al., 1997). The Drf DAAM1 is involved in 
formation of the planar cell polarity in Xenopus laevis, a highly regulated process of 
morphogenesis and cell coordination during gastrulation (Habas et al., 2001). 
Additionally, endocytosis also depends on cytoskeletal interactions. A splice variant of hDia2 
has been identified to regulate the motility of early endosomes along microfilaments in a Src 
dependent manner (see chapter 5.3.1.1) (Gasman et al., 2003). Furthermore, other Drfs like 
mDia1 and mDia2 localize to endosomes as well (Tominaga et al., 2000). 
A possible role for Drfs in the formation of cellular protrusions like filopodia has also been 
proposed. Therefore, a combined activity of the vasodilator stimulated phosphoprotein (VASP) 
and the Drf mDia2 at the filopodia tip complex is suggested (Faix and Rottner, 2006). In line 
with this, dynamic rearrangement of the microfilament system is essential for cellular shape as 
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well as for cell-substrate and cell-cell adhesion. It has been shown for mDia1 that its expression 
is sufficient to induce focal adhesions in fibroblasts (Riveline et al., 2001). This Drf as well as 
formin-1 also mediate the accumulation of integral adhesion proteins, suggesting a capacity for 
reshaping the PM (Kobielak et al., 2004, Sahai and Marshall, 2002). 
Furthermore, de novo synthesis of new microfilaments is required during cell motility as well. 
Various formins are thought to be involved in this process. The Drf mDia1 for instance is 
necessary for migration of fibroblasts in wound healing assays (Goulimari et al., 2005), and the 
Drf FHOD1 has been shown to contribute to chemotaxis of fibroblasts (Koka et al., 2003). 
The ability of formins to reorganize the actin cytoskeleton also has transcriptional consequences 
on various cytoskeletal target genes. Many of them are upregulated by binding of the actin 
binding coactivator megakaryocytic acute leukemia (MAL) to the serum response factor (SRF) 
that recognizes a promoter region termed as serum response element (SRE) (Faix and Grosse, 
2006). The SRF appears to be essential for cell adhesion, spreading and stress fiber formation. 
Drfs like mDia1, mDia2, FHOD1 and diaphanous have been shown to induce SRE activity 
(Boehm et al., 2005, Gasteier et al., 2003, Miralles et al., 2003, Tominaga et al., 2000, 
Westendorf, 2001).  
Interestingly, not only the microfilament system is organized by formins. They assist in 
orientation and formation of stable microtubules presumably by binding to their tip (Gasteier et 
al., 2005, Goulimari et al., 2005, Palazzo et al., 2001). Nevertheless, this function is actin-
dependent as well (Wen et al., 2004). Therefore, formins are thought to mediate the crosslink 
between microtubules and microfilaments (Gundersen et al., 2004). 
Many formins have been identified since the discovery of the limp deformity gene and most of 
their individual functions are supposed to be specific instead of redundant. It is thought that this 
individuality is directly linked to various factors such as cell-cycle steps, their expression pattern 
in tissues, their interaction partners and regulation mechanisms, their cellular localization as well 
as their specific mechanism for F-actin nucleation.  
5.1.3.2 FHOD1 
The mammalian FHOD1 (formin homology 2 domain containing 1) protein is a member of the 
Drf family. It has been identified in a Yeast-two-hybrid screen as an interaction partner of the 
transcription factor AML-1B (acute myelogenous leukemia protein-1B) and has initially been 
termed as FHOS (Formin Homologue Overexpressed in Spleen) (Koka et al., 2003, Westendorf 
et al., 1999, Westendorf et al., 1998). The open reading frame with a size of 3945 basepairs is 
located on the human chromosome 16q22 resulting in a protein consisting of 1164 amino acid 
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residues (Westendorf et al., 1999). The gene of its homolog FHOD2 is located on chromosome 
18q12 and encodes 1422 amino acids (Kanaya et al., 2005). FHOD1 is ubiquitously expressed, 
but is found in greatest abundance in spleen (Westendorf et al., 1999). Its structural organization 
is similar to that of other formins, but also shows specific characteristics: The proline rich FH1-
domain is located in the middle of the protein adjacent to the FH2-domain that follows in C-
terminal direction and has the capability for oligomerization (fig. 9) (Madrid et al., 2005).  
 
Figure 9: Schematic presentation of the Drf FHOD1. 
Like other Drfs FHOD1 consists of a central FH1-domain adjacent to the FH2-domain. At the C-terminal end the 
diaphanous autoregulatory domain (DAD) that binds to the N-terminally located regulatory domain is located here 
depicted as FH3-domain. The poorly defined GTPase binding domain (GBD) binds the Rho-GTPase Rac1 (GDP 
and GTP bound) and is situated in between the FH1- and FH3-domain (Schonichen et al., 2006). 
The DAD is situated at the C-terminal end. In contrast to other Drfs, FHOD1 possesses two 
leucine rich consensus sequences (Schonichen et al., 2006, Wallar and Alberts, 2003). At least 
the more C-terminally located one in combination with a basic stretch of amino acids contributes 
to the intramolecular autoinhibition by binding to the DID or FH3-domain that is located at the 
N-terminal end (Schonichen et al., 2006). In contrast to other formins like mDia1 or Bni1, the 
poorly defined GBD was suggested to be located between the FH3- and the FH2-domain and 
shows no sequence homology to that of other Drfs (Westendorf, 2001). The Rho-GTPase Rac1 
has been identified to bind to this GBD, however, in its GDP- as well as in its GTP-bound form 
(Gasteier et al., 2003, Westendorf, 2001). Nevertheless, co-expression of constitutively active 
Rac1 with FHOD1 recruits the Drf to membrane ruffles, whereas over-expressed FHOD1 alone 
shows an unspecific cytoplasmic distribution (Gasteier et al., 2003). Interestingly, expression of 
a C-terminally truncated FHOD1 mutant lacking its DAD results in formation of F-actin stress 
fibers (Gasteier et al., 2003, Koka et al., 2003, Takeya and Sumimoto, 2003). These fibers are 
bundled to thick cables and depend on the activity of the Rho-ROCK pathway. FHOD1 also 
decorates F-actin fibers generated by co-expression of constitutively active ROCK1 (Gasteier et 
al., 2003). By induction of these stress fibers, FHOD1 organizes microtubules along these cables 
and thereby mediates cell elongation (Gasteier et al., 2005). Motility is stimulated in cells stably 
expressing FHOD1 via acto-myosin contractility but is independent of integrin mediated cell 
adhesion (Koka et al., 2003). Furthermore, the constitutively active FHOD1 mutant also induces 
SRE activity (Gasteier et al., 2003, Westendorf, 2001). It has been shown that this activation 
depends on the activity of the ERK/MAP-kinase pathway (extracellular signal regulated 
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kinase/mitogen activated protein kinase) and that FHOD1 has the capacity to bind to ERK and 
Raf1, a further component of this pathway (Boehm et al., 2005). Interestingly, the capacity of 
FHOD1 for SRE induction also requires the activity of Src kinases (see chapter 5.3), whereas 
depletion of Src activity has no influence on FHOD1 mediated stress fiber formation (Koka et 
al., 2005). Additionally, Src kinases also interfere with FHOD1 gene expression (Koka et al., 
2005). FHOD1 interacts with F-actin and the FH1-domain of FHOD1 binds to profilin IIa, 
suggesting profilin to be the recruiting protein for G-actin (Takeya and Sumimoto, 2003, Tojo et 
al., 2003). FHOD1 is phosphorylated at amino acid residue Ser1131 in vascular smooth muscle 
cells by cyclic GMP dependent protein kinase 1 (PGK1) which directly interacts with FHOD1 in 
the absence of cyclic guanosine monophosphate (cGMP) (Wang et al., 2004). Furthermore, the 
C-terminus of FHOD1 co-localizes and binds to the cytoplasmic domain of the multifunctional 
receptor CD21 that interact with Epstein-Barr virus (EBV) particles (Gill et al., 2004). Finally, 
FHOD2 had been suggested to represent a link between the microfilament system and the nestin 
intermediate filaments (Kanaya et al., 2005).  
5.1.4 The Regulation of the Microfilament System During Cell Motility 
Directional motility is a fundamental cellular process essential for embryonic development, 
wound healing, immune response, development of tissues and metastization of tumors cells. The 
basic mechanism is directly connected to the cytoskeleton and requires a constant and dynamic 
reorganization of cytoskeletal components as well as stimulation by extracellular signals. 
5.1.4.1 Cell Migration on Planar Surfaces 
Crawling cell motility on planar surfaces involves a cycle of four steps: protrusion of the leading 
edge, adhesion to the substratum, retraction of the rear and de-adhesion (Pollard and Borisy, 
2003). This process is highly regulated by Rho-GTPases and is mediated by the microfilament 
system. Therefore, Rac and Cdc42 are required at the front of a polarized cell: By regulation of 
formins and of Arp2/3-complex activity through WASp/N-WASP, Cdc42 induces the formation 
of filopodia which are thought to be involved in exploration of the cellular environment (see 
chapter 5.1.2.3) (Faix and Rottner, 2006). Activity of Rac mediates the protrusive force and 
controls the formation of lamellipodia which expand forward as the cell moves and forms the 
leading edge. This cortical actin structure reveals a characteristic dense meshwork of short, but 
branched microfilaments mainly formed by the activity of the Arp2/3-complex which is 
regulated by Rac through WAVE/Scar signaling (see chapter 5.1.2.1). Both Rac and Cdc42 are 
furthermore supposed to control formation and release of integrin-dependent matrix adhesion of 
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the cell to the surface (Raftopoulou and Hall, 2004). Activity of Rho at the rear of the cell is 
needed for retraction of the cell body. It induces formation of long F-actin filaments bundled to 
stress fibers, tethered to focal adhesions and reaching through the cytoplasm. The microfilaments 
are polymerized with the help of formins, whereas regulation of myosin activity through its 
effector kinase ROCK resulted in filament bundling and contractility (Pollard and Borisy, 2003, 
Raftopoulou and Hall, 2004). 
5.1.4.2 Cell Migration in 3D-Environments – Cancer Cell Invasion 
Compared to planar surfaces, three dimensional environments are characterized by completely 
different conditions: The extracellular matrix (ECM) for instance is a three dimensional network 
of polysaccharides, fibrous and adhesive proteins, secreted by animal cells and providing 
structural support in tissues. In order to cross this network, single tumor cells use at least two 
distinct strategies to invade this environment. The mesenchymal or elongated mode of motility is 
similar to migration on planar surfaces (fig. 10A):  
 
 
Figure 10: Different modes of cancer cell invasion. 
Invasion of single metastasizing tumor cells in 3D-environments like tissues can be performed by two distinct 
mechanisms: (A) The mesenchymal or elongated mode of motility is characterized by an elongated morphology and 
is dependent on activities of metalloproteases (MMPs). (B) The amoeboid or rounded mode of motility is 
characterized by an amorphous cell shape or PM blebbing (Sahai, 2005). 
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Activated by external signals like chemokines and regulated by the already described signaling 
pathways, the cells form protrusions in the direction of the stimulus. These protrusions, referred 
to as invadopodia or pseudopodia, are related to lamellipodia and display an enrichment of cell 
substrate connections. Src kinases have been shown to play an important role in their formation 
(Linder and Aepfelbacher, 2003). For invasion, however, these cells locally destroy the ECM by 
secretion of proteases such as metalloproteases that are enriched in podosomes (Sahai, 2005, 
Yamazaki et al., 2005). This mode of motility is highly regulated by Rac and Cdc42, whereas 
Rho and ROCK activity is dispensable (Sahai, 2005). This is in contrast to the second mode of 
motility termed amoeboid or rounded mode (fig. 10B). Here, the activity of Rho and ROCK is 
essential, whereas a degradation of the ECM does not occur (Wyckoff et al., 2006). Instead, 
when imaged in the 3D environment, these cells show extensive PM blebbing at their surface 
which is directed to the stimulus (Sahai and Marshall, 2003). By this mechanism, cells are 
thought to be able to squeeze through small gaps of the ECM. In these cells, cell-substratum 
interactions are weak and dispersed over the whole PM. Under certain conditions, various tumor 
cell lines are able to switch between the elongated and blebbing mode of invasion (Sahai, 2005, 
Yamazaki et al., 2005). 
5.2 Plasma Membrane Blebbing 
The generic term PM blebbing defines a dynamic process that alters the appearance of the PM 
surface of animal cells. It results in the formation of large spherical structures referred to as PM 
blebs. Depending on the reason for blebbing, PM blebs are either constantly formed and 
retracted (zeiotic blebs) or occasionally shed from the cellular surface (budding vesicles). 
Versatile physiological situations have been described in which PM blebbing occurs: The most 
noted one can be observed during programmed cell death or apoptosis. Initially it had been 
thought that PM blebbing contributes to cellular destruction and DNA fragmentation as well as 
to attraction of phagocytotic immune cells (Fadeel, 2004, Martinez et al., 2005). However, 
opposing observations had been made that clearly uncouple PM blebbing and fragmentation 
events (Schulze-Osthoff et al., 1994, Shiratsuchi et al., 2002). Nevertheless, in late apoptotic 
stages these blebs bud from cells as apoptotic bodies finally leading to cellular disruption (Mills 
et al., 1999, Zhang et al., 1998). Second, secretion of certain proteins like galectins or IL-1β are 
directly linked to PM blebbing since vesicles containing these proteins bud from the cellular 
surface (MacKenzie et al., 2001, Mehul and Hughes, 1997). However, contradictory 
observations have been made indicating two separate events that are not related (Verhoef et al., 
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2003). Although viral budding has a similar appearance, it is not directly linked to PM blebbing 
since the vesicle scaffold is formed by viral proteins. However, Vaccinia viruses have been 
observed to induce PM blebbing during the entry process into host cells (A. Helenius and J. 
Mercer: 58. Mosbacher Kolloquium 2007), suggesting a connection to endocytosis. Other 
viruses cause PM blebbing simply by induction of apoptosis (Mosquera et al., 2005). PM 
blebbing also occurs during mitosis of tissue cultured cells (Boss, 1955, Laster and Mackenzie, 
1996) and following seeding in culture dishes before spreading (Bereiter-Hahn et al., 1990, 
Erickson and Trinkaus, 1976). Finally, PM blebbing can be observed during cellular movement 
in embryonic development and at the leading edge of cellular sheets (Dipasquale, 1975, 
Trinkaus, 1973). PM blebs that are generated during migration in 3D environments and tissues, 
e.g. of certain amoebas or metastasizing tumor cells have been well investigated. This amoeboid 
or rounded mode of motility is distinct from the mesenchymal or elongated mode which in 
contrast is dependent on secretion of metalloproteases and formation of podosomes or 
invadopodia (see chapter 5.1.4.2) (Linder and Aepfelbacher, 2003, Sahai, 2005, Yamazaki et al., 
2005, Yoshida and Soldati, 2006). 
PM blebbing has also been observed in several non-physiological situations as during  
2D migration and can be specifically induced. M2 melanoma cells lacking the F-actin cross-
linking protein filamin a (FLNa) bleb extensively and continuously because of defects in their 
cortical actin integrity (Byers et al., 1991, Charras et al., 2005, Cunningham, 1995, Cunningham 
et al., 1992). Similarly, MEF (mouse embryonal fibroblast) knockout cells that are depleted in 
the cell cycle regulatory protein p53 have recently been shown to bleb constantly in a mode that 
is linked to cell invasion (Gadea et al., 2007). Furthermore, over-expression of the Rho kinases 
ROCK1 or ROCK2 induce PM blebbing especially in a constitutively active form lacking the 
respective regulatory C-terminal end (Coleman et al., 2001, Sebbagh et al., 2005, Sebbagh et al., 
2001, Song et al., 2002). PM blebbing has also been shown to be inducible by expression of a 
constitutively active mutant of the Rho-GTPase Rac1 (Rac1-L61A37) (Schwartz et al., 1998). 
Disassembly of microtubules by colchicine leads to PM blebbing in Walker carcinosarcoma cells 
(Keller and Eggli, 1998). Stabilization of F-actin filaments by inhibition of the actin severing 
factor ADF/cofilin has been shown to induce PM blebbing as well (Amano et al., 2001, 
Tomiyoshi et al., 2004). Finally artificial detachment of the PM from the cortical actin layer by 
suction pressure also induces local PM blebbing (Rentsch and Keller, 2000, Sheetz et al., 2006). 
Although the specific function of any kind of PM blebbing is not clear and the circumstances in 
which PM occurs are different, the general machinery that is required for their dynamics is 
thought to be similar and will be discussed in the following. 
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5.2.1 Formation of PM Blebs and the Contribution of the Cortical Actin 
The site of blebbing activity is the PM. This outer barrier of an animal cell is a lipid bilayer that 
separates the intracellular compartments from the external medium. Furthermore, the PM is the 
site where communication with the extracellular milieu takes place: For instance, intracellular 
proteins and signal peptides are secreted via the PM. The PM is enriched with membrane 
proteins that either traverse the PM by hydrophobic domains (integrated or transmembrane 
proteins) or are linked indirectly via lipid anchors. Some of them are part of receptor complexes 
that transmit external signals into the cell causing cellular responses. The PM also facilitates and 
regulates uptake of differently sized extracellular components by different mechanisms. 
However, the PM is also the place where blebbing occurs. At least for apoptotic cells, PM 
blebbing is thought to be a form of communication as well. Thereby the dying cell is opsonized 
to phagocytotic cells of the immune system (Fadeel, 2004). 
The PM of animal cells is directly connected to the cortical actin meshwork that lies in parallel 
beneath lipid bilayer and plays a pivotal role in cell motility, adhesion, endo- and phagocytosis, 
cytokinesis and organization of integral proteins (Weed and Parsons, 2001). Lacking the cell 
wall that is usually found in plant cells, it antagonizes extra- and intracellular pressure by 
maintaining an isotropic tension. Thereby it provides both elastic and viscous properties forming 
a robust framework for the membrane (Bray and White, 1988). This web like organized and 
about 50–2000 nm thick layer is enriched in F-actin filaments and actin associated proteins like 
myosin II that are needed for contractility and other proteins that are required for its organization 
(Bray and White, 1988). How the cortical actin meshwork is tethered to the PM is not fully 
understood and depends on the cell type as well as on the specific setting of the cell. A major 
role is suggested for the ezrin–radixin–moesin (ERM) family of proteins. These proteins are 
attached to microfilaments by a highly conserved C-terminal actin binding site and associated to 
the PM by direct binding of their N-terminal FERM domain to integral PM proteins like CD44, 
ICAM-1-3 and CD43 or by indirect binding, respectively (Bretscher et al., 2000, Bretscher et al., 
2002, Tsukita and Yonemura, 1999). In fact, in microinjection experiments, Charras and 
coworkers have shown a requirement for functional ezrin in tethering the PM to newly formed 
cortical actin (Charras et al., 2006). In addition, a role for cortical F-actin attachment to the PM 
has been suggested for a variety of other proteins as well. Similarly by binding to integral PM 
proteins, proteins like cortactin, talin, vinculin, zyxin, filamins, catenins, α-actinins, spectrins, 
and others contribute to F-actin PM tethering (Daly, 2004, Siripala and Welch, 2007, Stossel et 
al., 2006, Weed and Parsons, 2001). Peripheric PM proteins like the myristoylated  
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alanine-rich C kinase substrate (MARCKS) are also able to link F-actin filaments to the PM. 
Interestingly, a role for MARCKS in formation of podosomes that are different to PM blebs has 
been suggested recently (Sheetz et al., 2006). However, a role for the cortical actin meshwork in 
PM blebbing is very likely, since it is constantly reorganized to form distinct types of dynamic 
protrusions that are coated by the PM. Activation of Cdc42 induces filopodia, whereas Rac 
activity is required for formation of lamellipodia and PM ruffles (see chapter 5.1.2.3), whose 
functions are not clear although they are thought to be involved in macropinocytosis (Norbury, 
2006, Ridley, 2006). Nevertheless, the contribution of the cortical actin meshwork to PM 
blebbing is not fully understood. Some insights in its role have been obtained in the recent years 
and will be discussed here. 
5.2.1.1 The Model of Poroelastic PM Bleb Formation 
Zeiotic PM blebbing is defined by a cycle of processes that are described by certain 
characteristics: Following loss of tension of the cortical actin meshwork a PM bleb is formed 
which is subsequently stabilized by F-actin polymerization. Upon contractility of the 
microfilament system a bleb is retracted to PM levels. It is worth mentioning that a major 
contribution to our knowledge about PM blebbing originates from a cell line that has been 
isolated from a human cutaneous malignant melanoma (Byers et al., 1991). These M2 cells lack 
the F-actin cross-linking protein FLNa and bleb extensively and constantly (Cunningham, 1995, 
Cunningham et al., 1992). FLNa, also known as actin binding protein 280 (ABP280) is a  
280 kDa protein that efficiently organizes F-actin filaments in an orthogonal meshwork (Bennett 
et al., 1984, Brotschi et al., 1978), thus stabilizing the microfilament system. FLNa is 
phosphorylated by several serine/threonine kinases including protein kinase A (PKA), protein 
kinase C (PKC), Ca2+/calmodulin-dependent protein kinase II and p90 ribosomal S6 kinase 
(Stossel et al., 2001). Although the physiological relevance of these modifications is unclear, 
phosphorylation by the Src kinase Lck is thought to regulate its F-actin cross linking activity as 
well as its membrane association (Goldmann, 2002, Pal Sharma and Goldmann, 2004). 
Furthermore, FLNa specifically binds to the PH domain of the serine/threonine kinase ROCK 
(Ueda et al., 2003). Loss of FLNa in M2 cells is thought to cause defects in the integrity of the 
microfilament system pervading the whole cell and in particular in the cortical actin meshwork. 
In the model of poroelastic PM bleb formation (fig. 11) it is assumed that the cytoplasm is 
composed of a porous, actively contractile, elastic network (cytoskeletal filaments, organelles, 
ribosomes). Comparable to a sponge this network is infiltrated with an intestinal fluid (cytosol, 
water, ions, soluble proteins). 
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Figure 11: Poroelastic description of 
PM blebbing.  
(A) Local contraction of the actin 
cortex meshwork by myosin II leads to 
a shortening of the cortical periphery 
and therefore to a compression of the 
cytoskeletal network that fills the cell 
creating a hydrostatic pressure. In FLNa 
depleted cells fluid cytosol infiltrating 
this porous network with an average 
pore size (ζ) squeezes through the 
cortical actin (B), causing the 
protrusion of PM blebs (Charras et al., 
2005). 
 
 
 
Contraction of the acto-myosin cortex would create a local hydrostatic pressure to the cytosol 
causing the intestinal fluid to flow out through the porous network which leads to PM 
detachment and bleb formation (Charras et al., 2005). However, the initiating event is related to 
a weakening of the actin structure, since the blebs initially contain mainly monomeric actin 
(Cunningham, 1995). Subsequently, actin polymerization and actin cross-linking proteins limit 
bleb enlargement by production of a new cortical actin meshwork lining the inner leaflet of a 
bleb. This process is accompanied by incorporation of the PM tethering proteins of the ERM 
family. Finally, PM blebs are successively retracted in a myosin II dependent process, resulting 
in a stabilization and flattening of the PM (Charras et al., 2006, Cunningham, 1995, Paluch et al., 
2005, Stossel et al., 2001, Wyckoff et al., 2006). 
The loss of FLNa represents the trigger for bleb genesis in M2 cells leading to a weakening of 
the cortical actin meshwork. Although this FLNa deficiency creates an artificial situation, it 
provides a basic model for the cycle of PM blebbing which requires distinct signaling events. 
this has been shown by the involvement of regulatory proteins such as the Rho-GTPase Rho and 
its effector kinase ROCK.  
5.2.1.2 The Roles of Rho, ROCK and Myosin II in PM Blebbing 
During apoptosis, ROCK proteins are constitutively activated via cleavage of the carboxyl-
terminus either by caspase-3 (ROCK1) or by granzyme B (ROCK2) which causes extensive PM 
blebbing (Coleman et al., 2001, Sebbagh et al., 2005). This process is independent of Rho 
activity but requires the kinase activity of the ROCK proteins. Active ROCK proteins mediate 
contractility and F-actin filament bundling by direct or indirect elevation of MLC 
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phosphorylation, which activate this regulatory compartment of myosin II (see chapter 5.1.2.4). 
In fact, the need for myosin activity in PM blebbing has been shown in several studies for 
different situations in which PM blebbing occurs. Treatment of blebbing cells with the myosin II 
specific drug Blebbistatin (BS) interfering with its ATPase activity (Allingham et al., 2005, 
Ramamurthy et al., 2004) abolishes PM blebbing in dividing cells, apoptotic cells and 
additionally in amoebae movement in a physiological milieu (Orlando et al., 2006, Straight et 
al., 2003, Yoshida and Soldati, 2006). During induction of PM blebbing, MLC is phosphorylated 
(Coleman et al., 2001, Sebbagh et al., 2005). This active form also localizes at PM blebs 
(Charras et al., 2006, Keller et al., 2002, Torgerson and McNiven, 1998). In line with the model 
of poroelastic PM bleb formation described for M2 cells lacking FLNa, ROCK activity is 
increased in local areas of the actin cortex mediated by ROCKs constitutive activation or over-
expression. Subsequently, myosin II is activated resulting in limited but intensive contractility. 
This enhanced contractility might then lead to a loss of integrity of the cortical actin and would 
cause detachment of the PM resulting in bleb formation (Paluch et al., 2005, Sahai and Marshall, 
2003). 
5.2.1.3 The Role of Nucleation of F-actin Polymerization in PM Blebbing 
As introduced in the previous chapter, F-actin filaments are involved in PM blebbing. As the 
main component of the actin cortex, they are required to determine cell shape and form the 
scaffold for myosin II mediated contractility. F-actin has been shown to be newly polymerized in 
already formed PM blebs to stabilize the bleb structure and retract the PM bleb to its origin 
(Charras et al., 2006, Cunningham, 1995). In general, nucleation of F-actin polymerization is 
mediated by the Arp2/3 complex and spire proteins as well as by Drfs in distinct mechanisms 
(see chapter 5.1.2.1). However, the contribution of any of these proteins during PM blebbing is 
unclear and requires further investigation. 
5.3 Src Kinases and SH4-Domain Containing Proteins 
Many formins functionally and physically interact with Src kinases. These non-receptor protein-
tyrosine kinases bind to the formin FH1-domain and are suggested to contribute to their 
activation. This had been shown for DAAM1, FHOD1, mDia1 and mDia2 (Aspenstrom et al., 
2006, Koka et al., 2005, Matusek et al., 2006, Tominaga et al., 2000, Uetz et al., 1996, Yamana 
et al., 2006), but Src kinase activity is also regulated by Drfs (Gasman et al., 2003). Src kinases 
are a family of proto-oncogenic proteins playing a pivotal role in a variety of biological and 
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dynamic processes, such as cell morphology regulation, motility, proliferation and survival of 
animal cells. The first identified member of this group is the transforming protein v-Src (viral 
Src) of the oncogenic retrovirus Rous sarcoma virus, a chicken tumor virus discovered in 1911 
by Peyton Rous (Martin, 2001). Its cellular homolog c-Src (cellular Src) is ubiquitously 
expressed in animal cells and localizes at endosomes, perinuclear membranes, secretory vesicles 
and the cytoplasmic part of the PM where it interacts with certain growth factors and integrin 
receptors. Additionally to c-Src ten further members of Src kinases in humans are thought to be 
partially redundant in some cellular functions. Similarly to c-Src, the Src kinases Fyn and Yes 
are ubiquitously expressed, whereas the other ones have been shown to be tissue specific: Srm is 
found in keratinocytes, Frk and Brk in a variety of cell types, and Blk, Fgr, Hck, Lck as well as 
Lyn are found in hematopoietic cells. The functionality of Src kinases is directly linked to their 
localization to cellular membranes via their N-terminal Src homology 4-domain (SH4-domain) 
(Frame, 2004, Resh, 1993, Resh, 1994, Roskoski, 2004, Thomas and Brugge, 1997). 
5.3.1.1 Cellular Functions of Src Kinases 
In line with their proto-oncogenic capacity, Src kinases are involved in versatile regulatory 
processes of animal cells that are related to gene transcription as well as to cell cycle control, 
cell-cell and cell-matrix contacts and cytoskeletal rearrangements (Martin, 2001). They 
functionally and physically interact with various cellular enzymes, adaptors, regulatory and 
cytoskeletal proteins. Activated by integrins for instance, Src kinases are directly involved in cell 
adhesion and spreading (Resh, 1999, Roskoski, 2004). The Src kinases c-Src, Fyn and Yes are 
thought to phosphorylate several proteins like focal adhesion kinase (FAK), talin, vinculin, 
tensin and others necessary for maintenance of focal adhesions. These contact sites are required 
for attachment of the cell to the extracellular matrix and for attachment of the intracellular 
microfilament system, since they are enriched with PM crossing integrin proteins. Therefore, Src 
kinases play an important role in cell migration where focal adhesion turnover is highly 
regulated (Resh, 1999, Roskoski, 2004). During migration on planar surfaces, cells develop 
lamellipodia at their leading edge. These highly dynamic F-actin meshworks are constantly 
formed at the front and destructed at the rear. In both processes Src kinases have the capacity to 
be involved: At least v-Src takes part in depolymerization of the microfilament system by 
causing dephosphorylation and thereby activation of the severing protein ADF/cofilin (Pawlak 
and Helfman, 2002). In addition to Drfs, the Arp2/3-complex is negatively regulated by tyrosine 
phosphorylation of cellular proteins like cortactin (Daly, 2004, Weed and Parsons, 2001). 
Interestingly, Src kinases also have the capacity to regulate the activity of Rho-GTPases, thus 
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controlling central regulators of cytoskeleton dynamics (DerMardirossian et al., 2006, Meng et 
al., 2004). In line with this, active Rho has been found in podosomes of Src transformed 
fibroblasts (Berdeaux et al., 2004). Podosomes or invadopodia are developed during invasion of 
monocyte-derived cells and certain carcinoma cells during invasion (see chapter 5.1.4.2). Src 
kinases have been shown to play a crucial role in signaling events leading to formation of these 
protrusions (Linder and Aepfelbacher, 2003).  
5.3.1.2 Structure and Regulation of Src kinases – The Src Homology Domains 
The organization of the different Src kinases is very similar. These 52-62 kDa proteins are 
composed of six distinct functional regions (Martin, 2001, Roskoski, 2004, Thomas and Brugge, 
1997). At the N-terminal end, the SH4-domain is located which is required for membrane 
association (fig. 12A). This domain is followed by a stretch of amino acids that is distinct for the 
different Src kinases (Unique-domain). The three subsequent domains represent modular 
structures in many classes of cellular proteins. The SH2- and SH3-domains are protein-binding 
domains as found in phosphatases, lipid kinases, cytoskeletal proteins, adaptor molecules, 
transcription factors and other proteins as well. The SH1-domain is connected to the SH2-
domain by a linker region and embodies the kinase domain required for phosphorylation of 
several cellular targets. At the C-terminal end a short negative regulatory tail is located.  
In its dormant state, in which the Src kinase shows basal activity only, the protein is 
phosphorylated at amino acid residue Y527 in the regulatory tail. This phosphorylation is mainly 
performed by C-terminal Src kinase (Csk) and Csk-homologous kinase (Chk) and results in an 
intramolecular binding of the tail region to the SH2-domain leading to a sterical hindrance of the 
SH2- as well as the SH3-domain, both required for protein-protein interactions. This 
autoinhibition is released via dephosphorylation of Y527 by a tyrosine phosphatase. 
Subsequently, amino acid residue Y416 can undergo autophosphorylation by another Src kinase 
molecule, stabilizing the enzyme in its active state with accessible SH2- and SH3-domains  
(fig. 12B). 
Interestingly, the v-Src protein differs from c-Src mainly by a lack of the regulatory tail and its 
phosphorylation site. The site in Src kinases corresponding to position Y418 in c-Src is 
constantly phosphorylated in oncogenic enzymes. The SH3-domain is important for intra- as 
well as for intermolecular interactions regulating Src catalytic activity, Src localization and 
recruitment of substrates. With contribution of neighboring amino acid residues, SH3-domains 
bind to short proline rich amino acid sequences with a core consensus sequence of P-X-X-P 
(where P is proline and X is any amino acid). The SH2-domain is also required for protein-
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protein interactions regulating the catalytic activity of the Src kinase as well as its localization or 
that of its binding partner. SH2-domains bind to short amino acid stretches containing 
phosphotyrosine and the subsequent 3-5 amino acid residues defining the specificity (Martin, 
2001, Roskoski, 2004, Thomas and Brugge, 1997). 
Figure 12: Organization and regulation of Src kinases. 
(A) Schematic presentation of Src kinases. At the N-terminal end the SH4-domain is located which is often 
posttranslationally modified by myristoylation and palmitoylation for efficient membrane targeting. The Unique 
region represents a stretch of amino acids that are specific for the respective Src kinase. The SH3- and SH2-domains 
are required for protein-protein interactions. The SH1-domain is the kinase domain of the enzyme followed by the 
regulatory tail. Phosphorylation at amino acid residue Y416 inside the SH1-domain leads to full activation, whereas 
phosphorylation of Y527 in the regulatory domain results in deactivation of kinase activity. Organization and 
numbering system are based on chicken c-Src. (B) Regulation of Src kinases. Dormant Src kinases are 
phosphorylated in their regulatory tail as described in A resulting in an intramolecular binding to the SH2-domain. 
This autoinhibition is released by dephosphorylation of the tail making the SH2- and SH3-domains accessible for 
substrate interactions. This conformation is further stabilized by phosphorylation of amino acid Y416 in the kinase 
domain (Martin, 2001). 
Additionally, the Unique-domain, that is distinct for each member is thought to mediate 
interactions with receptors or proteins that are specific for each Src kinase (Summy et al., 2003). 
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The targeting of Src kinases and other proteins to cellular membranes is mediated by the SH4-
domain. 
5.3.1.3 SH4-Domains Mediate Membrane Targeting 
In Src kinases, the N-terminal stretch of 18 amino acid residues is denoted as SH4-domain. 
These short sequences are sufficient to mediate membrane association and are also found in 
other cellular and pathogenic proteins: The α subunits of heterotrimeric G proteins as well as 
several retroviral Gag proteins and the HIV-1 Nef protein are targeted to the PM in this way 
(McCabe and Berthiaume, 1999, Resh, 1999). An SH4-domain is also found in the surface coat 
protein of Leishmania parasites, the hydrophilic acetylated surface protein B (HASPB) (Denny et 
al., 2000, Nickel, 2005). Although the overall amino acid homology between these SH4-domains 
is less conserved, a common feature is the posttranslational modification by acetylation with 
fatty acids. All SH4-domains have a glycine at position 2 (G2) in common (fig. 13).  
 
Figure 13: SH4-domains. 
(A) Schematic presentation of SH4-domains. Located at the N-terminal end of various peripheral PM proteins, SH4-
domains are myristoylated (red) and can be additionally palmitoylated (blue) or have a basic cluster (+ + +) of 
positively charged amino acid residues (Lys or Arg), respectively, to mediate PM targeting. (B) Examples of two 
SH4-domains. Depicted are the first 18 amino acid residues of the myristoylated Src kinases c-Src that furthermore 
conatin a basic cluster and Yes, that is palmitoylated as well. Selected residues are written in bold letters (basic 
cluster) or highlighted by light colors (red: myristoylated; green: palmitoylated; required for efficient 
myristoylation: Ser or Thr (cyan) and Arg or Lys (yellow)). 
During translation of the protein, this specific glycine is myristoylated by N-myristoyl 
transferase (NMT), an enzyme catalyzing the transfer of myristate from myristoyl-CoA 
(coenzyme A) to its substrate. Since the glycine has to be located at the very N-terminal end to 
be recognized by NMT, the methionine at position 1 (M1) is initially removed by a methionine 
amino peptidase. The consensus sequence for efficient myristoylation is M-G-X-X-X-S/T-
K/R/X-K/R/X (where G is glycine, K is lysine, M is methionine, R is arginine, S is serine, T is 
threonine and X is any amino acid) and can be found in almost all SH4-domains (Resh, 1999). 
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Myristate is a 14-carbon saturated fatty acid and is introduced hydrophobically into the lipid 
bilayer of a membrane. However, although myristoylation is required, it is not sufficient for 
stable membrane binding, since these interactions are relatively weak. A second signal is 
necessary and may be provided in two ways: first, the SH4-domain possesses a stretch of basic 
amino acids downstream the recognition site for myristoylation. These positively charged amino 
acid residues electrostatically interact with the headgroups of acidic phospholipids. These are 
primarily localized at the inner leaflet of the bilayer, causing a net negative charge to the 
cytoplasmic leaflet surface. Examples for myristoylated SH4-domains possessing a basic cluster 
are c-Src and the viral proteins HIV-1 Gag and HIV-1 Nef (Resh, 1999). The second possibility 
to assure efficient membrane binding includes an additional acetylation step. In SH4-domains, 
cysteins that follow the G2 are usually palmitoylated, most likely with the help of the enzyme 
palmitoyl acyl transferase (Bijlmakers and Marsh, 2003, Resh, 1999). In this reaction, which is 
performed after translation of the whole protein, a 16-carbon saturated fatty acid palmitate 
molecule is linked via a thioester linkage to the sulfhydryl group of a cysteine. Although the 
consensus sequence for palmitoylation M-G-C (where C is cysteine, G is glycine and M is 
methionine) is highly conserved and can be found in for instance the Src kinases Fyn, Lck and 
Yes. However, HASPB which shows a serine instead of a cysteine at position 3 (C3) is 
palmitoylated as well, but at position 5 (C5) (Denny et al., 2000). Since palmitoyl acyl 
transferase localizes at membranes as well, palmitoylation is thought to occur directly at this site. 
Therefore, the first signal that is provided by myristic acid is required for membrane targeting of 
the SH4-domain, where its localization is than assured by the following palmitoylation step. 
Interestingly, for HASPB it is thought that palmitoylation of its SH4-domain at Golgi 
membranes is required to target the protein to the PM (Denny et al., 2000, Stegmayer et al., 
2005). Since both myristate and palmitate possess a saturated hydrocarbon chain, SH4-domains 
show a high affinity to liquid-ordered domains inside the PM like lipid-rafts and in particular 
caveolae, which are small invaginations of the PM (Resh, 1999, Simons and Toomre, 2000). 
However, additional functions of SH4-domains beyond membrane targeting have not been 
described so far. 
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6 OBJECTIVES OF THE STUDY 
The phenomenon of PM blebbing on animal cell surfaces describes a type of PM dynamization 
that results in the formation and retraction of large spherical protrusions with distinct kinetics. It 
is linked to various physiological processes such as apoptosis (Mills et al., 1999, Zhang et al., 
1998), secretion (MacKenzie et al., 2001, Mehul and Hughes, 1997), cytokinesis (Boss, 1955, 
Laster and Mackenzie, 1996) and tumor cell invasion (Sahai and Marshall, 2003, Wyckoff et al., 
2006), but has also been observed as a constant process in cell lines lacking distinct structural or 
regulatory proteins (Cunningham, 1995, Gadea et al., 2007) or expressing SH4-domains (this 
study). Although cellular triggers for its induction are unique and might originate from different 
internal or external signals, the machinery required for PM blebbing is thought to be equal 
(Charras et al., 2005, Sahai and Marshall, 2003). It is defined by a Rho-ROCK dependent 
contractility of the microfilament system as well as its dynamic reorganization. A ubiquitous 
family of regulated Rho-GTPase effector proteins actively reorganizing the actin cytoskeleton by 
nucleation of actin filament polymerization is represented by the diaphanous related formins 
(Drfs). This group of formin homology domain containing proteins plays a crucial role in 
cytokinesis, embryonal development, endocytosis and cell migration. Nevertheless, their 
individual function is thought to be unique (Faix and Grosse, 2006, Goode and Eck, 2007, 
Wallar and Alberts, 2003). A less characterized member of this family is the formin homology 
domain 2 containing 1 (FHOD1) protein. This Drf has been shown to interact with the Rho-
GTPase Rac1 but functions in a ROCK dependent manner (Gasteier et al., 2003, Westendorf, 
2001). Thus, a direct interplay for FHOD1 and ROCK1 has been suggested linking the activity 
of the two different Rho-GTPases Rac1 and Rho that are responsible for distinct cellular 
functions (Gasteier et al., 2003).  
 
Several aspects concerning PM blebbing and characterization of possible key players were to be 
addressed in the course of this study: 
 
1. Is there a functional interaction of FHOD1 and ROCK1 in mammalian cells? Therefore, 
co-expression studies should be performed, a possible phenotype characterized and this 
interaction functionally mapped in comparison with in vitro binding experiments.  
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2. What is the physiological function of endogenous FHOD1? Since the knowledge on 
FHOD1 was so far exclusively based on over-expression studies, the distribution and 
function of endogenous FHOD1 should be analyzed with the help of a specific antibody 
in combination with specific RNAi based knockdown of the protein.   
 
3. What is the mechanism that is required for PM blebbing? Based on findings that have 
been obtained during this study regarding the induction of PM blebbing by SH4-domains 
and the role for FHOD1 in ROCK1 mediated PM blebbing, the functional interplay of 
Src kinases, ROCK proteins and FHOD1 had to be analyzed by addressing their 
individual contribution to different types of PM blebbing.   
 
4. Is there a physiological relevance for SH4-domain induced PM blebbing? Since 
triggering of PM blebbing was a novel finding that had not been linked to SH4-domains 
before, its functional relevance for cellular processes had to be analyzed. 
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7 MATERIAL AND METHODS 
7.1 Materials 
7.1.1 Reagents 
Reagents were purchased from the following companies: Metafectene (Biontex); (-) Blebbistatin, 
BrdU Cell Proliferation Assay, Cycloheximide, Cytochalasin D, immersion oil, Latrunculin B, 
Nocodazole, PP1-analog, Rho-Kinase inhibitor H-1152, SU6656, Y27632, zVAD-fmk 
(Calbiochem, Merck); [32P]-γATP (Hartmann Analytic); Annexin V-Alexa-Fluor-568,  
dextran-Alexa-Fluor-568/647 (10 kDa), Lipofectamine 2000, Oligofectamine, phalloidin-Alexa-
Fluor-350/660 (Invitrogen, Molecular Probes); Lin-Mount (Linaris); Nucleobond PC 500 
(Machery-Nagel); ECL-solution, Micro BCA Protein Assay Kit (Pierce); rhTNFα (Promega); 
HiPerFect Transfection Reagent (Qiagen); Paraformaldehyde (Riedel de Haën);  
TUNEL = "In situ Cell Death Detection Kit, TMR red" (Roche); bovine serum albumin (Roth); 
BrefeldinA, Chlorpromazine, doxicycline, Etoposide, Hoechst 33268, myosin light chain, myelin 
basic protein, Naphtol blue black, phalloidin-TRITC/FITC, poly-L-lysine, protease inhibitor 
cocktail, sodium orthovanadate (Sigma). 
Reagents and chemicals not specifically listed were purchased from the following companies: 
AppliChem, Riedel de Haën, Roche, Roth, Serva, Sigma, Zentrallager INF. 
7.1.2 Consumables 
Consumption items were purchased from the following companies: HiTrap NHS activated HP 
affinity column, Glutathione Sepharose 4B, ProteinA Sepharose CL-4B (Amersham 
Biosciences); plastic pipettes for cell culture (Costar); 8 µm ThinCert cell culture inserts 
(Greiner Bio-One); coverslips with a diameter of 12 mm, object slides (Marienfeld); PVDF 
membrane (Millipore); Lab-Tek chamber slides (Nunc), parafilm (Pechiney); CL-XPosure film, 
Clear Blue X-Ray film (Pierce); Protran nitrocellulose transfer membrane, Whatman paper 
(Schleicher & Schuell); plastic materials for cell culture (TPP). 
Further consumption items were purchased from the following companies: Corning, Eppendorf, 
Greiner Bio-One, neoLab. 
7.1.3 Sterilization 
Media were autoclaved at 121°C and 1 bar positive pressure for 20 min. Other substances and 
solutions were either autoclaved or, if temperature sensitive, sterilized by filtration (pore width 
0.22 μm). 
7.1.4 Cell Culture Media and Solutions 
• freezing medium: 90 % (v/v) heat inactivated fetal calve serum (FCS, Bio Whittaker, 
Invitrogen), 10 % (v/v) DMSO. 
• phosphate buffered saline (PBS, see chapter 7.1.11). 
• trypsin/EDTA: 10 % (v/v) trypsin/EDTA (10x, Biochrom), 90 % PBS. 
• OptiMEM I: "Reduced Serum Medium" (Invitrogen). 
 
The following media were usually supplemented with 10 % heat inactivated FCS, 2.0 mM 
glutamate (Invitrogen), 50 U/ml penicillin and 50 µg/ml streptomycin (Invitrogen). Furthermore, 
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if indicated, media were additionally supplemented with 0.1 mM non essential amino acids 
(NEA, Invitrogen) and 1 mM sodium pyruvate (Invitrogen): 
• DMEM-high: "Dulbecco's Modified Eagle Medium", 4,500 mg/l glucose (Invitrogen). 
• DMEM-low: "Dulbecco's Modified Eagle Medium", 1,000 mg/l glucose (Invitrogen). 
• MEM-alpha: "Minimal Essential Medium alpha", 1,000 mg/l glucose (Invitrogen). 
7.1.5 Bacterial Growth Media 
• Luria Bertani (LB)-Medium: bacto-tryptone 1.0 % (w/v)  
 yeast extract 0.5 % (w/v)  
 NaCl 170 mM  
 NaOH 5 mM  
 pH 7.5; autoclaved 
 
   
• LB agar plates: LB medium was supplemented with 12.5 g/l agar, autoclaved and appropriate 
amounts were added to 10 cm Petri dishes. 
• Antibiotics for selection of resistant bacterial strains were prepared as concentrated stock 
solutions, sterilized by filtration and added to the medium after autoclavation (final 
concentrations: 100 µg/ml ampicillin, Roth; 50 µg/ml kanamycin, Roth). 
7.1.6 Eukaryotic Cell Lines 
• CHO-MCAT-TAM2:  
CHO cells with stably integrated cDNAs encoding the murine cation transporter MCAT-1, 
the doxicycline-sensitive transactivator rtTA2-M2 and a truncated version of the cell surface 
protein CD2 (Engling et al., 2002). 
Origin: Chinese hamster ovary (Puck et al., 1958). 
Morphology: epithelial-like cells, adherent monolayer. 
Cell culture medium: Alpha MEM. 
Passaging: 1:20. 
 
• CHO-GFP:  
CHO-MCAT-TAM2 cells with stably integrated cDNA encoding for eGFP which was 
initially cloned into pREV-TRE2 vector (Clontech) containing a transactivator/doxicycline-
responsive element for retroviral transduction (Engling et al., 2002).  
Cell culture medium: Alpha MEM.  
Passaging: 1:20. 
 
• CHO-N18-c-Src-GFP, CHO-N18-Fyn-GFP, CHO-N18-HASPB-GFP, CHO-N18-ΔMyr-
HASPB-GFP, CHO-N18-ΔPal-HASPB-GFP, CHO-N18-Lck-GFP, CHO-N18-Yes-GFP:
   
CHO-MCAT-TAM2 cells with stably integrated cDNA encoding for ProteinA linked SH4-
domains of c-Src, Fyn, HASPB, Lck or Yes or the respective mutants which were initially 
cloned into pREV-TRE2 vector (Clontech) containing a transactivator/doxicycline-
responsive element for retroviral transduction. These cell lines were generated by Stella 
Tournaviti (BZH, University of Heidelberg) similarly to CHO-GFP cells (Engling et al., 
2002). 
Cell culture medium: Alpha MEM.  
Passaging: 1:20. 
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• HeLa:  
Origin: human cervical adenocarcinoma (Scherer et al., 1953).  
Morphology: epithelial-like cells, adherent monolayer.   
Cell culture medium: DMEM-high.   
Passaging: 1:10. 
 
• HeLa-N18-HASPB-GFP, HeLa-N18-ΔMyr-HASPB-GFP, HeLa-N18-ΔPal-HASPB-GFP, 
HeLa-N18-Yes-GFP, HeLa-N18-ΔMyr-Yes-GFP, HeLa-N18-ΔPal-Yes-GFP:  
HeLa cells with stably integrated cDNA encoding for SH4-domains of HASPB or Yes or the 
respective mutants which were initially cloned into pREV-TRE2 vector (Clontech) 
containing a transactivator/doxicycline-responsive element for retroviral transduction. These 
cell lines were generated by Julia Ritzerfeld (BZH, University of Heidelberg) similarly to 
CHO-GFP cells (Engling et al., 2002).  
Cell culture medium: DMEM-high.   
Passaging: 1:10. 
 
• NIH3T3:  
Origin: contact-inhibited NIH Swiss mouse embryo (Aaronson and Todaro, 1968).  
Morphology: fibroblastic cells, adherent monolayer.   
Cell culture medium: DMEM-low.   
Passaging: 1:10. 
 
• MEF:  
Origin: mouse embryo.   
Morphology: fibroblastic cells, adherent monolayer.   
Cell culture medium: DMEM-high.   
Passaging: 1:20. 
 
• MDA-MB-435:  
These cells were kindly provided by Robert Grosse (Pharmacology, University Hospital 
Heidelberg).   
Origin: human breast carcinoma (Cailleau et al., 1978).  
Morphology: epithelial-like cells, round, loosely attached monolayers.   
Cell culture medium: DMEM-high, supplemented with NEA and Na-pyruvate.   
Passaging: 1:10. 
 
• SYF -/-:   
These cell lines were kindly provided by Klemens Rottner (HZI, Braunschweig).   
Origin: mouse embryo harboring functional null mutations in both alleles of the Src kinases 
c-Src, Yes, and Fyn. Cells were immortalized with SV40 large T antigen (Klinghoffer et al., 
1999).  
Morphology: fibroblastic cells, adherent monolayer.   
Cell culture medium: DMEM-high, 0.1 mM NEA and 1 mM Na-pyruvate.   
Selection medium: cell culture medium supplemented with 400 µg/ml hygromycin.   
Passaging: 1:10. 
 
• SYF + c-Src:  
These cell lines were kindly provided by Klemens Rottner (HZI, Braunschweig).   
Origin: mouse embryo harboring functional null mutations in both alleles of the Src kinases 
c-Src, Yes, and Fyn. Cells were immortalized with SV40 large T antigen. Wild type c-Src 
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was stably reintroduced into SYF -/- cells via the retroviral vector pLXSH (Klinghoffer et 
al., 1999).  
Morphology: fibroblastic cells, adherent monolayer.   
Cell culture medium: DMEM-high, 0.1 mM NEA and 1 mM Na-pyruvate.   
Selection medium: cell culture medium supplemented with 400 µg/ml hygromycin.   
Passaging: 1:20. 
7.1.7 Bacterial Strains 
For amplification of plasmid DNA the following bacterial strain was used: 
• Escherichia coli DH5α (Invitrogen): F- φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 
hsdR17(rk-, mk+) phoA supE44 thi-1 gyrA96 relA1 λ-. 
7.1.8 siRNA Oligonucleotides 
All siRNA oligonucleotides used in this work are listed in tab. 1 and were purchased at MWG 
Biotech. 
Table 1: List of synthetic siRNA oligonucleotides. 
Oligonucleotide Target sequence (sense) Specificity 
   
Unspecific control (MWG) 5'-AGGUAGUGUAAUCGCCUUGUU-3' – 
FHOD1-specific P1 5'-UACCAGAGCUACAUCCUUAUU-3' human, rodent 
FHOD1-specific P2 5'-GGUCAACGCUAUCUUGGAAUU-3' human 
   
 
7.1.9 Plasmids 
All plasmids used in this work are listed in tab. 2. 
Table 2: List of plasmids for mammalian cells. 
Plasmid Description Reference 
   
Vectors:   
pEGFP-C1/N1 Vector for expression of enhanced green 
fluorescent protein (eGFP) in mammalian cells 
Clontech 
pMRFP-N1 Vector for expression of monomeric red 
fluorescent protein (mRFP) in mammalian cells 
Michel et al., 2006 
pMCherry Monomeric Cherry fluorescent protein Shaner et al., 2004 
pEF-HA Vector for expression of hemagglutinin (HA) 
epitope tag in mammalian cells 
Alberts et al., 1998 
pRev-TRE2 MoMuLV derived retroviral vector for expression 
of a gene of interest from the tet-response 
element (TRE) 
Clontech 
   
   
Rho GTPase and related constructs:  
pGEX-RhoA-GFP c-Myc-fusion protein of wildtype RhoA A. Alberts, Van Andel 
Institute, Grand 
Rapids 
pEGFP-C3ex GFP-fusion protein of Clostridium botulinum 
TAT-C3 transferase 
Watanabe et al., 1999 
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pGEX-Rac1-GFP c-Myc-fusion protein of wildtype Rac1 Moreau et al., 2000 
pGEX-Rac1-N17-GFP GFP-fusion protein of a dominant negative form 
of Rac1 with a point mutation at aa residue 17 
(Thr to Asn) 
Moreau et al., 2000 
pGEX-Cdc42-GFP c-Myc-fusion protein of wildtype Cdc42 Moreau et al., 2000 
pGEX-Cdc42-N17-GFP GFP-fusion protein of a dominant negative form 
of Cdc42 with a point mutation at aa residue 17 
(Thr to Asn) 
Moreau et al., 2000 
pRK5-c-Myc-RhoA-wt c-Myc-fusion protein of wildtype RhoA A. Hall, Cancer 
Research UK, London 
pRK5-c-Myc-RhoA-V14 c-Myc-fusion protein of a constitutively active 
form of RhoA with a point mutation at aa residue 
14 (Gly to Val) 
A. Hall, Cancer 
Research UK, London 
pRK5-c-Myc-C3 c-Myc-fusion protein of Clostridium botulinum 
TAT-C3 transferase 
S. Offermanns, 
Molecular 
Pharmacology, 
Heidelberg 
pRK5-c-Myc-Rac1-wt c-Myc-fusion protein of wildtype of Rac1 A. Hall, Cancer 
Research UK, London 
pRK5-c-Myc-Rac1-L61 c-Myc-fusion protein of a constitutively active 
form of Rac1 with a point mutation at aa residue 
61 (Gln to Leul) 
A. Hall, Cancer 
Research UK, London 
pRK5-c-Myc-Rac1-L61A37 c-Myc-fusion protein of a constitutively active 
form of Rac1 with point mutations at aa residues 
61 (Gln to Leu) and 37 (Phe to Ala) 
 
Lamarche et al., 1996 
pRK5-c-Myc-Rac1-L61C40 c-Myc-fusion protein of a constitutively active 
form of Rac1 with point mutations at aa residues 
61 (Gln to Leu) and 37 (Tyr to Cys) 
Lamarche et al., 1996 
pRK5-c-Myc-Rac1-N17 c-Myc-fusion protein of a dominant negative form 
of Rac1 with a point mutation at aa residue 17 
(Thr to Asn) 
A. Hall, Cancer 
Research UK, London 
pRK5-c-Myc-Cdc42-wt c-Myc-fusion protein of wildtype Cdc42 A. Hall, Cancer 
Research UK, London 
pRK5-c-Myc-Cdc42-V14 c-Myc-fusion protein of a constitutively active 
form of Cdc42 with a point mutation at aa 
residue 12 (Gly to Val) 
A. Hall, Cancer 
Research UK, London 
pRK5-c-Myc-Cdc42-N17 c-Myc-fusion protein of a dominant negative form 
of Cdc42 with a point mutation at aa residue 17 
(Thr to Asn) 
A. Hall, Cancer 
Research UK, London 
pCAG-c-Myc-ROCK1-wt c-Myc-fusion protein of wildtype ROCK1 Ishizaki et al., 1997 
pCAG-c-Myc-ROCK1-Δ3 c-Myc-fusion protein of constitutively active 
ROCK1 that is C-terminally truncated (aa 1-727)  
Ishizaki et al., 1997 
   
   
FHOD1 constructs:   
pCMV5-HA-1-FHOD1-wt HA-fusion protein of wildtype FHOD1 Westendorf et al., 
1999 
pCMV5-HA-1-FHOD1-ΔC HA-fusion protein with constitutively active 
FHOD1 that is C-terminally truncated (Δ aa 
residues 1011-1164) 
Westendorf et al., 
1999 
pEF-HA-FHOD1-ΔFH1 HA-fusion protein with FHOD1 lacking its FH1-
domain (Δ aa residues 570-611) 
Gasteier et al., 2003 
pEF-HA-FHOD1-ΔFH1 HA-fusion protein with FHOD1 lacking its core Gasteier et al., 2003 
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FH2-domain (Δ aa residues 807-866) 
pEF-HA-FHOD1-Δ4 HA-fusion protein with FHOD1 aa residues 486-
1068 
J. Gasteier 
pEF-HA-FHOD1-Δ5 HA-fusion protein with FHOD1 aa residues 570-
1068 
J. Gasteier 
   
   
SH4-domain constructs:   
pREV-TRE2- 
HASPB 
The Leishmania HASPB surface coat protein W. Nickel, BZH, 
Heidelberg 
pREV-TRE2- 
HASPB-GFP 
GFP-fusion protein of the Leishmania HASPB 
surface coat protein 
W. Nickel, BZH, 
Heidelberg 
pREV-TRE2- 
N18-HASPB-GFP-PA 
GFP-ProteinA-fusion protein of the HASPB-SH4-
domain including a TEV cleavage site 
S. Tournaviti, BZH, 
Heidelberg 
pREV-TRE2- 
N18-Δmyr-HASPB-GFP-PA 
GFP-ProteinA-fusion protein of the non-
myristoylated and non-palmitoylated HASPB-
SH4-domain mutant including a TEV cleavage 
site 
S. Tournaviti, BZH, 
Heidelberg 
pREV-TRE2- 
N18-Δpal-HASPB-GFP-PA 
GFP-ProteinA-fusion protein of the non-
palmitoylated HASPB-SH4-domain mutant 
including a TEV cleavage site 
S. Tournaviti, BZH, 
Heidelberg 
pREV-TRE2- 
N18-HASPB-GFP 
GFP-fusion protein of the HASPB-SH4-domain  J. Ritzerfeld, BZH, 
Heidelberg 
pREV-TRE2- 
N18-Δmyr-HASPB-GFP 
GFP-fusion protein of the non-myristoylated and 
non-palmitoylated HASPB-SH4-domain mutant 
J. Ritzerfeld, BZH, 
Heidelberg 
pREV-TRE2- 
N18-Δpal-HASPB-GFP 
GFP-fusion protein of the non-palmitoylated 
HASPB-SH4-domain mutant 
J. Ritzerfeld, BZH, 
Heidelberg 
pREV-TRE2- 
N18-HASPB-MCherry 
mCherry-fusion protein of the HASPB-SH4-
domain  
J. Ritzerfeld, BZH, 
Heidelberg 
pREV-TRE2- 
N18-YES-GFP-PA 
GFP-ProteinA-fusion protein of the YES-SH4-
domain including a TEV cleavage site 
S. Tournaviti, BZH, 
Heidelberg 
pREV-TRE2- 
N18-Δmyr-YES-GFP-PA 
GFP-ProteinA-fusion protein of the non-
myristoylated and non-palmitoylated YES-SH4-
domain mutant including a TEV cleavage site 
S. Tournaviti, BZH, 
Heidelberg 
pREV-TRE2- 
N18-Δpal-YES-GFP-PA 
GFP-ProteinA-fusion protein of the non-
palmitoylated YES-SH4-domain mutant including 
a TEV cleavage site 
S. Tournaviti, BZH, 
Heidelberg 
pREV-TRE2- 
N18-YES-GFP 
GFP-fusion protein of the YES-SH4-domain  J. Ritzerfeld, BZH, 
Heidelberg 
pREV-TRE2- 
N18-Δmyr-YES-GFP 
GFP-fusion protein of the non-myristoylated and 
non-palmitoylated YES-SH4-domain mutant 
J. Ritzerfeld, BZH, 
Heidelberg 
pREV-TRE2- 
N18-Δpal-YES-GFP 
GFP-fusion protein of the non-palmitoylated 
YES-SH4-domain mutant 
J. Ritzerfeld, BZH, 
Heidelberg 
pEGFP-Lck GFP-fusion protein of the Src kinase Lck C. Haller 
pREV-TRE2- 
N18-Lck-GFP-PA 
GFP-ProteinA-fusion protein of the Lck-SH4-
domain including a TEV cleavage site 
S. Tournaviti, BZH, 
Heidelberg 
pREV-TRE2- 
N18-Fyn-GFP-PA 
GFP-ProteinA-fusion protein of the Fyn-SH4-
domain including a TEV cleavage site 
S. Tournaviti, BZH, 
Heidelberg 
pREV-TRE2- 
N18-Src-GFP-PA 
GFP-ProteinA-fusion protein of the c-Src-SH4-
domain including a TEV cleavage site 
S. Tournaviti, BZH, 
Heidelberg 
   
   
Miscellaneous constructs:   
pMRFP-β-Actin mRFP-fusion protein with β-actin Pacholsky et al., 2004 
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pVSVG3-SP-FP-CFP CFP-fusion protein of a temperature sensitive 
mutant of the vesicular stomatitis virus 
glycoprotein (ts-045-G-CFP) 
Keller et al., 2001 
p3D.Afos Reporter plasmid encoding for firefly luciferase 
(pGL3, Promega) controlled by 3D.ACAT 
promotor sequences 
Geneste et al., 2002 
pRL-TK Reporter plasmid encoding for renilla luciferase Promega 
   
aa = amino acid. 
7.1.10 Antibodies 
Specific detection of proteins via Western blot analysis or immuno-fluorescence was performed 
by usage of specific primary antibodies directed against endogenous proteins or protein tags  
(tab. 3) and secondary antibodies coupled to enzymes or fluorophores (tab. 4). 
Table 3: List of primary antibodies. 
Antibody Source (catalog number) Usage/Dilution 
   
pc-rabbit-α-14-3-3 (C-16) Santa Cruz Biotechnology (sc-731) WB 1:500 
mc-mouse-α-CM1A10 (coatomer) Wegmann et al., 2004 IF 1:200 
pc-goat-α-EEA1 Santa Cruz Biotechnology (sc-6414) IF 1:500 
pc-rabbit-α-FHOD1  
(aa1-14 & aa345-369) 
Gasteier et al., 2005; this work IF 1:50; WB: 1:500;  
EM undiluted 
mc-mouse-α-FLNa (PM6/317) Santa Cruz Biotechnology (sc-58764) WB 1:200 
pc-rabbit-α-phospho-FLNa-S2152 Cell Signaling (#4761) WB 1:1000 
mc-mouse-α-GFP (GFP-20) Sigma (G6539) WB 2000 
mc-mouse-α-HA (F-7) Santa Cruz Biotechnology (sc-7392) WB 1:200 
pc-rabbit-α-HA (Y-11) Santa Cruz Biotechnology (sc-805) IF 1:200; WB 1:200 
mc-mouse-α-MLC (MY-21) Sigma (M4401) WB 1:1000 
pc-rabbit-α-MLC2 Cell Signaling (#3672) IF 1:100; WB 1:1000 
pc-rabbit-α-phospho-MLC2-Ser19 Cell Signaling (#3671) IF 1:100; WB 1:1000 
mc-mouse-α-CD63 (MVB) BD Pharmingen (556019) IF 250 
mc-mouse-α-c-Myc (9E10) Santa Cruz Biotechnology (sc-40) IF 1:200; WB 1:500; 
mc-mouse-α-c-Myc-FITC Sigma (F2047) IF 1:200 
pc-rabbit-α-c-Myc Sigma (C3956) WB 1:1000 
mc-mouse-α-P115/TAP B. Brügger, BZH Heidelberg IF 1000 
mc-mouse-α-ROCK1 BD Pharmingen (611137) WB 1:500 
mc-mouse-α-c-Src (B-12) Santa Cruz Biotechnology (sc-8056) IF 1:100; WB 1:200 
pc-rabbit-α-phospho-c-Src-Y418 Biosource, Invitrogen (44-660G) IF 1:100; WB 1:1000 
mc-mouse-α-TfR (H68.4) Zymed, Invitrogen (13-6800) IF 1:200; WB 1:500 
pc-sheep-α-TGN-46 Serotec (AHP500G) IF 1:300 
mc-mouse-α-ts-045-G Scales et al., 1997 IF 1:100 
mc-mouse-α-α-tubulin (B-5-1-2) Sigma (T5168) IF 1:500; WB 1:500 
   
aa = amino acid residues, mc = monoclonal, pc = polyclonal, IF = immuno-fluorescence, EM = electron microscopy, 
WB = Western blot. 
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Table 4: List of secondary antibodies. 
Antibody Source Usage/Dilution 
   
pc-donkey-α-goat-Alexa-Fluor-488 Molecular Probes, Invitrogen (A11055) IF: 1:2,000 
pc-donkey-α-goat-Alexa-Fluor-568 Molecular Probes, Invitrogen (A11057) IF: 1:2,000 
pc-donkey-α-goat-Alexa-Fluor-680 Molecular Probes, Invitrogen (A21084) WB: 1:20,000 
pc-donkey-α-sheep-Alexa-Fluor-568 Molecular Probes, Invitrogen (A21099) IF: 1:2,000 
pc-goat-α-mouse-Alexa-Fluor-350 Molecular Probes, Invitrogen (A21049) IF: 1:2,000 
pc-goat-α-mouse-Alexa-Fluor-488 Molecular Probes, Invitrogen (A11011) IF: 1:2,000 
pc-goat-α-mouse-Alexa-Fluor-568 Molecular Probes, Invitrogen (A11004) IF: 1:2,000 
pc-goat-α-mouse-Alexa-Fluor-660 Molecular Probes, Invitrogen (A21054) IF: 1:2,000 
pc-goat-α-mouse-Alexa-Fluor-680 Molecular Probes, Invitrogen (A21057) WB: 1:20,000 
pc-goat-α-mouse-HRP Jackson Immuno Research WB: 1:5,000 
pc-goat-α-rabbit-Alexa-Fluor-350 Molecular Probes, Invitrogen (A11069) IF: 1:2,000 
pc-goat-α-rabbit-Alexa-Fluor-488 Molecular Probes, Invitrogen (A11008) IF: 1:2,000 
pc-goat-α-rabbit-Alexa-Fluor-568 Molecular Probes, Invitrogen (A11036) IF: 1:2,000 
pc-goat-α-rabbit-Alexa-Fluor-660 Molecular Probes, Invitrogen (A21074) IF: 1:2,000 
pc-goat-α-rabbit-Alexa-Fluor-680 Molecular Probes, Invitrogen (A21076) WB: 1:20,000 
pc-goat-α-rabbit-HRP Jackson Immuno Research WB: 1:5,000 
pc-rat-α-goat-HRP Jackson Immuno Research WB: 1:5,000 
   
pc = polyclonal. 
7.1.11 Standard Buffers 
• AB-buffer: 
 HEPES 10.0 mM  
 NaCl 140.0 mM  
 CaCl2 2.5 mM  
 
• Amido-black staining solution 
 Amido-black 10B 30 mg/ml  
 in H2O    
 
• Destain-buffer 
 Acetic acid 10 % (v/v)  
 Isopropanol 8 % (v/v)  
 
• DNA loading buffer: 
 Tris-HCl, pH 7.5 50 mM  
 EDTA 50 mM  
 Glycerol 50 % (v/v)  
 Bromphenol blue  0.25 % (v/v) 
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• EM-Fix I 
 PHEM 100 mM  
 Paraformaldehyde 4 % (w/v)  
 Glutaraldehyde 0.1 % (w/v)  
 in PBS    
 
• EM-Fix II 
 PHEM 100 mM  
 Paraformaldehyde 4 % (w/v)  
 in PBS    
 
• Endocytosis-Detachment (ED) buffer 
 EDTA 50 mM  
 Trypsin 2 mg/ml  
 in PBS    
 
• Endocytosis-FACS (E-FACS) buffer 
 FCS 2 % (v/v)  
 in PBS    
 
• Endocytosis-Stop (E-Stop) solution 
 FCS 7 % (v/v)  
 in PBS    
 
• Endocytosis-washing (EW) buffer 
 Sodium acetate, pH 5.5 100 mM  
 NaCl 50 mM  
 in PBS    
 
• Kinase-activation buffer (KAB): 
 HEPES, pH 8.0 50 mM  
 EDTA 5 mM  
 NaCl 150 mM  
 MgCl2 10 mM  
 Triton X-100 0.02 % (v/v)  
     
• P1-buffer: 
 NaHCO3, pH 8.3 200 mM  
 NaCl 500 mM  
     
• P2-buffer: 
 HCl 1.0 mM  
     
• P3-buffer: 
 Ethanolamine 500 mM  
 NaCl 500 mM  
 HCl, pH 8.3    
     
• P4-buffer: 
 Acetic acid 100 mM  
 NaCl 500 mM  
 NaOH, pH 4.0    
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• P5-buffer: 
 Na2HPO4, pH 7.0 500 mM  
 NaN3 0.1 %  
     
• Paraformaldehyde (PFA): 
 Paraformaldehyde 3 % (w/v)  
 in PBS, pH 7.2    
     
• PBS (Phosphate buffered saline): 
 NaCl 96.0 mM  
 Na2HPO4 x 2H2O 10.0 mM  
 NaH2PO4 x H2O 2.3 mM  
 pH 7.4    
     
• PBS-T: 
 NaCl 96.0 mM  
 Na2HPO4 x 2H2O 10.0 mM  
 NaH2PO4 x H2O 2.3 mM  
 Tween 20 1.0 mM  
 pH 7.4    
     
• PFA (Paraformaldehyde): 
 Paraformaldehyde 3 % (w/v)  
 in PBS, pH 7.2    
     
• R1-buffer: 
 PBS 100 %  
     
• R2-buffer: 
 Tris-HCl, pH 8.0 50 mM  
 NaCl 500 mM  
     
• R3-buffer: 
 Tris-HCl, pH 9.0 50 mM  
 NaCl 500 mM  
     
• R4-buffer: 
 Glycine-HCl, pH 2.5 50 mM  
 NaCl 150 mM  
     
• R5-buffer: 
 Tris-HCl, pH 8.0 1 M  
     
• ROCK-Lysis buffer 
 Tris-HCl, pH 7.5 10 mM  
 Na4P2O7 x 10 H2O  40 mM  
 EDTA 5 mM  
 NaCl 150 mM  
 NP-40 1 % (v/v)  
 Na-Deoxycholate 0.5 % (v/v)  
 SDS 0.025 % (v/v)  
 Na3VO4 (fresh) 1 mM  
 protease inhibitors (fresh) 1: 1000  
 filtration (0.45 µm)    
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• ROCK-Wash buffer 
 Tris-HCl, pH 7.5 50 mM  
 Na4P2O7 x 10 H2O 40 mM  
 MgCl2 x 6 H2O 10 mM  
 NaCl 50 mM  
 Glycerole 10 % (v/v)  
 Brij-35 0.03 % (v/v)  
 DTT (fresh) 1 mM  
 Na3VO4 (fresh) 1 mM  
 protease inhibitors (fresh) 1: 1000  
 filtration (0.45 µm)    
     
• SDS-PAGE-Running buffer: 
 Tris-HCl, pH 6.8 250 mM  
 Glycine 200 mM  
 SDS 0.1 %  
     
• SDS-PAGE-Running gel stock-solution: 
 Tris-HCl, pH 8.8 1.5 M  
 SDS 0.4 % (v/v)  
     
• SDS-PAGE-Stacking gel stock-solution: 
 Tris-HCl, pH 6.8 0.6 M  
 SDS 0.4 % (v/v)  
     
• SDS-SB (SB, 2x): 
 Tris-HCL, pH 6.8 130 mM  
 β-Mercaptoethanol 10 % (v/v)  
 Glycerol 10 % (v/v)  
 SDS 6 % (w/v)  
 Bromphenol blue  tip of a spatula  
     
• SDS-SB (6x): 
 Tris-HCL, pH 6.8 390 mM  
 β-Mercaptoethanol 30 % (v/v)  
 Glycerol 30 % (v/v)  
 SDS 10 % (w/v)  
 Bromphenol blue  tip of a spatula  
     
• TAE-buffer (50x): 
 Tris-acetic acid, pH 7.8 2 M  
 Sodium acetate 250 mM  
 EDTA 500 µM  
     
• TBS (Tris buffered saline) 
 Tris-HCl, pH 7.6 20 mM  
 NaCl 140 mM 
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• TBS-T 
 Tris-HCl, pH 7.6 20 mM  
 NaCl 140 mM  
 Tween 20 1 mM  
     
• TE-buffer: 
 Tris-HCl, pH 7.8 10 mM  
 EDTA 1 mM  
     
• TFB I: 
 Sodium acetate, pH 5.8 30 mM  
 MnCl2 50 mM  
 NaCl 100 mM  
 CaCl2 10 mM  
 Glycerol 15 % (v/v)  
     
• TFB II: 
 MOPS, pH 6.5 10 mM  
 CaCl2 75 mM  
 NaCl 10 mM  
 Glycerol 15 % (v/v)  
     
• Transfer-buffer: 
 Tris-HCl, pH 8.8 25 mM  
 Glycine 192 mM  
 Methanol 20 % (v/v)  
 SDS 0.05 % (w/v)  
     
 
7.1.12 Software 
The software used for this study is listed in tab. 5. 
Table 5: Analytical and processing software. 
Software Version Source 
   
Adobe Photoshop CS2 9.0x211 Adobe Systems 
CellQuestPro 4.0.2 BD Biosciences 
analySIS 3.0 Soft Imaging System 
ImageJ 1.36b http://rsb.info.nih.gov/ij 
Imaris — Bitplane 
Leica Confocal Simulator 2.5.1227a Leica 
Leica FW4000 — Leica 
Odyssey Application Software 2.0.40 LI-COR Biosciences 
Quantity One 1-D Analysis Software 4.4.1 http://www.bio-rad.com 
VirtualDub 1.6.14 http://www.virtualdub.org 
Zeiss LSM Image Browser 4.2 http://www.zeiss.de 
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7.2 Molecular Biology 
7.2.1 Transformation of Bacteria 
E. coli cells were grown aerobically in 500 ml autoclaved LB medium containing the required 
additives. When the culture reached an optical density OD578 of 0.6 cells were harvested by 
centrifugation (10 min at 6,000 x g and 4°C), suspended in 200 ml TFB1 and incubated on ice 
for 5 min. After subsequent centrifugation (5 min at 3,000 x g and 4°C) cells were suspended in 
two volumes of TFB2 (referring to the volume of the cell sediment), incubated on ice for 30 min 
and divided into 40 μl aliquots. These were either immediately used for transformation or stored 
at – 80°C 
Transformation of chemo-competent cells was applied as standard transformation method. 40 μl 
of CaCl2-competent cells were combined with 1-2 μl DNA solution (50 μg/ml) and subjected to 
a heat shock for 60 s at 42°C. Immediately after the transformation cells were cooled on ice for  
2 min. Afterwards 1 ml of preheated antibiotic free LB medium was added and cells were 
incubated at 37°C for 30 min (ampicillin resistance) or 1 h (kanamycin resistance). Depending 
on the expected colony density, different volumes were streaked on agar plates containing the 
appropriate antibiotics and plates were incubated overnight at 37°C. 
7.2.2 Preparation of Plasmid DNA 
Plasmid DNA was purified via alkaline lysis in combination with anion exchange 
chromatography using the "NucleoBond PC 500 Kit" (Macherey-Nagel). Purification was 
performed according to the manufacturer's instructions. Briefly, 250 ml (Maxi preparation) of an 
overnight culture were harvested by centrifugation (20 min at 5,000 x g and 4°C) and bacterial 
cells suspended in 11 ml S1 buffer. Following addition of 11 ml S2 buffer, the sample was 
carefully mixed by inverting the tube and incubated at RT for 5 min. Next, 11 ml S3 buffer were 
added, the sample was again carefully mixed and further incubated on ice for 5 min. Following 
centrifugation (15 min at 15,000 x g and 4°C) and filtration for removal of cell debris, the 
supernatant was loaded on N2 buffer equilibrated anion exchange cartridges for further 
purification. Therefore, the cartridge was washed twice with 18 ml N3 buffer and plasmid DNA 
was eluted with 15 ml N5 buffer and precipitated by addition of 11 ml isopropanol at RT. 
Following centrifugation (20 min at 15,000 x g and -20°C), the DNA was washed in washed 
twice with 70 % (v/v) ethanol. After all traces of ethanol had evaporated, the DNA was 
solubilized in 200 µl TE buffer. Following a first determination of DNA concentration, the 
concentration was adjusted to 1.0 µg/µl by addition of respective amounts of TE buffer. Finally, 
quality of the DNA and identity of the clone were verified by digestion with restriction 
endonucleases and electrophoretic separation. 
7.2.3 Determination of DNA Concentration 
The concentration of a DNA solution was determined by measuring the absorbance at 260 nm 
and additionally at 280 nm in a photometer to account for protein impurities. For a pure DNA 
solution an OD260 of one corresponds to a dsDNA concentration of 50 ng/µl. The purity of the 
DNA solution can be deduced from the ratio of OD260 to OD280: With an OD260/OD280 ratio of 
1.8-2.0 the DNA was considered as pure. 
7.2.4 Digestion of DNA with Restriction Endonucleases 
Restriction of plasmid-DNA was carried out using restriction endonucleases purchased from 
Fermentas. Reaction buffers as well as concentrations of enzymes and DNA were chosen 
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according to the manufacturer’s instructions. The digestion was allowed to proceed for 2-3 h at 
37°C or over night at RT and was, if possible, followed by heat inactivation of the restriction 
endonucleases (20 min at 65°C or 80°C, depending on the enzyme). 
7.2.5 Electrophoretic Separation of DNA 
For analytical separation of DNA fragments, agarose gels consisting of 1 % (w/v) agarose and 
0.7 µg/ml ethidium bromide in TAE buffer were prepared. Depending on the gel size, a voltage 
of 80-100 V was applied. DNA fragments migrate towards the anode with a velocity that is 
proportional to the negative logarithm of their size. Prior to loading, DNA samples were mixed 
with DNA loading dye to facilitate loading and to indicate the progress of the samples in the gel. 
GeneRuler DNA Ladder Mix was used as size standard according to the manufacturer’s 
instructions. After electrophoresis, DNA was detected via its fluorescence under UV light  
(λ = 254 nm). 
7.3 Biochemistry 
7.3.1 Production of Cell Lysates 
For SDS-PAGE, Western blotting, IP and IVKA, adherent cells in cell culture dishes were 
washed with PBS and subjected to sufficient amounts of ice-cold ROCK-Lysis (Coleman et al., 
2001) buffer (6 well: 100 µl; 6 cm: 200 µl; 10 cm: 450 µl). Following detachment with a plastic 
cell scraper on ice, cells were thoroughly lysed by pipetting and lysates were subsequently 
transferred to a tube. After centrifugation (15 min at 13,000 rpm and 4°C) supernatants were 
transferred into a new tube, stored at -20°C or immediately subjected to IP, IVKA or 
determination of overall protein concentrations, respectively. 
7.3.2 Determination of Overall Protein Concentration 
Overall protein concentrations of cell lysates were determined using the "Micro BCA Protein 
Assay Kit" (Pierce) according to manufacturer’s instructions. The bicinchoninic acid (BCA) 
protein assay combines the reduction of Cu2+ to Cu+ by protein in an alkaline medium with the 
highly sensitive and selective colorimetric detection of the cuprous cation (Cu+) by bicinchoninic 
acid. The intensity of the color produced is proportional to the number of peptide bonds 
participating in the reaction. Briefly, 200 µl of BCA solution (BCA reagent A + 2 % (v/v) BCA 
reagent B) were added to 10 µl of at least two dilutions of cell lysates in a 96-well plate in a 
duplicate experiment. Following 30 min of incubation at 37°C, absorption at a wavelength of 
540 nm was photometrically measured in an ELISA-reader (Labsystems Original Multiskan 
MS). Values were normalized to background levels obtained by lysis buffer only and protein 
concentrations were calculated relative to a standard curve obtained with bovine serum albumin 
(BSA). 
7.3.3 Discontinuous SDS-PAGE 
Proteins were analyzed by SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel 
electrophoresis) as described by Laemmli (Laemmli, 1970) with modifications by Righetti 
(Righetti, 1990) for discontinuous SDS-PAGE. Cell lysates were denatured by heating to 95°C 
for 5 min in 6 x SDS sample buffer (SB). Equal amounts of overall protein were loaded onto the 
gel (tab. 6) which was run at 25 mA in SDS-PAGE-Running buffer. During electrophoresis, 
proteins were first focused in the stacking gel and subsequently separated according to their 
relative molecular mass in the running gel. The size standard employed was a broad range 
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prestained protein molecular weight marker (broad range prestained protein molecular weight 
marker, 6-175 kDa; New England Biolabs). Following SDS-PAGE, gels were subjected to 
Western blotting. 
Table 6: Production of a SDS-PAGE gel. 
Compound Stacking gel Running gel 
  8 % 10 % 14 % 
     
MQ-water 0.8 ml 1.9 ml 1.7 ml 1.1 ml 
SDS-PAGE-Stacking gel stock-solution 0.3 ml –  –  –  
SDS-PAGE-Running gel stock-solution –  1.0 ml 1.0 ml 1.0 ml 
Acrylamide/Bisacrylamide (30 %) 0.2 ml 1.1 ml 1.3 ml 1.8 ml 
APS (10 %) 8.0 µl 13.0 µl 13.0 µl 13.0 µl 
TEMED 3.0 µl 6.0 µl 6.0 µl 6.0 µl 
     
APS = Ammonium persulfate, TEMED = N,N,N',N'-Tetramethylethylenediamine. 
 
7.3.4 Western Blotting 
Proteins separated by SDS-PAGE were transferred in a semi-dry process onto a nitrocellulose or 
polyvinylidenfluorid (PVDF)-membrane, which bind the proteins by polar interactions. 
Therefore, PVDF-membranes were additionally incubated in methanol for 10 min before they 
were incubated in transfer-buffer, similarly to the SDS-gel, the Whatman-blotting paper and the 
nitrocellulose-membrane. They were assembled in the following order on the blotting apparatus: 
Cathode, Whatman-blotting paper, membrane, SDS-gel, Whatman-blotting paper, anode. A 
current of 2 mA/cm2 was applied for 90-120 min at 8 V. Nonspecific binding sites of the 
membrane were saturated in blocking-solution (5 % milk powder (w/v)) at RT for 20 min and 
slight shaking. Proteins immobilized on the membrane were specifically probed with primary 
antibodies (tab. 3) over night at 4°C in blocking solution and under slight shaking. Next, 
membranes were washed three times for 10 min with washing-buffer and incubated for 45 min at 
RT or over night at 4°C with the secondary antibody. Secondary antibodies were directed against 
the respective primary antibody and were either coupled to horse radish peroxidase for 
evaluation by enhanced chemiluminescence (ECL) or to Alexa Fluor-680 for evaluation with the 
LI-COR-System (tab. 4). After three additional washing steps with washing-buffer for 10 min, 
membranes were washed with PBS or TBS, respectively and were evaluated with the respective 
method: For ECL, membranes were incubated with SuperSignal West Pico reagent (Pierce) that 
was supplemented with SuperSignal West Femto reagent at low signals, subjected to a 
photosensitive film and subsequently developed. For evaluation with the LI-COR-System, 
membranes were scanned (LI-COR Odyssey) and analyzed with the LI-COR software. 
7.3.5 Immunoprecipitation (IP) and in vitro Kinase Assay (IVKA) 
To analyze the influence of FHOD1 expression on ROCK1 activity level, an IVKA was 
performed. Therefore, HeLa cells in a 6 well plate were transfected with combinations of 
expression plasmids encoding for vector only, Myc-ROCK-wt and HA-FHOD1-wt. At the 
following day and a 90 % cell confluency, medium was removed and cells carefully scraped with 
a cell scraper in 2 ml ice cold PBS. After centrifugation (5 min at 2,000 rpm and 4°C), pellet was 
lysed in 250 µl ice cold ROCK-Lysis buffer by thoroughly pipetting and subsequently incubation 
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on a rotator for 20 min at 4°C. Afterwards, the lysate was centrifuged (15 min at 13,000 rpm and 
4°C) and 50 µl of the supernatant subjected to Western blotting (input control), whereas the rest 
residual amounts were transferred into a new 1.5 ml cup (safe lock. Next, 2.0 µl antibody (mc-
mouse-α-c-Myc, 9E10) was added and the solution incubated on a rotator for 1 h at 4°C. 
Following addition of 20 µl thoroughly suspended ProteinA-sepharose beads, the solution was 
again incubated on a rotator for 2 h at 4°C. Subsequently, the beads were washed three times 
with 500 µl ice cold ROCK-Wash buffer and two times with 500 µl ice cold kinase-activation 
buffer (KAB). At the last step, 50 µl of the mixture were removed and subjected to Western 
blotting (IP control). Following centrifugation (5 min at 2,000 rpm and 4°C), supernatant was 
removed and beads were subjected to kinase reaction. Therefore, they were suspended in 30 µl 
KAB containing 4 µCi [32P]-γATP, 10 mM ATP 1 µg substrate (myelin basic protein, Sigma) 
and either 5.5 µl MQ or 5.5 µl ROCK inhibitor (Y-27632, final concentration 900 µM) were 
added for specificity control. After 30 min shaking at 30°C, 7 µl 6xSDS-SB were added, the 
samples boiled for 5 min at 96°C and subsequently centrifuged (20 s at 13,000 rpm and RT). 
Samples were loaded on a SDS-PAGE (14 %) and after separation were transferred by Western 
blotting to a nitrocellulose membrane which was finally incubated for 24 h with a photosensitive 
film. 
7.3.6 Purification of rabbit-α-FHOD1 Antibody 
For production of polyclonal antiserum directed against FHOD1 protein, two synthetically 
produced peptides present in human and mouse FHOD1 protein (#20403: amino acid residues  
1-14, MAGGEDRGDGEVSC; #20404: amino acid residues 356-370, KPSSEEGKKSRRSLEC; 
Peptide Specialty Laboratories) as previously described (Gasteier et al., 2005). For purification 
of antibodies the final bleeding of immunized rabbits was subjected to affinity chromatography. 
7.3.6.1 Preparation of the Affinity Column 
For subsequent purification of antibodies an affinity column (HiTrap NHS activated HP Column, 
Amersham Biosciences) with a bed volume of 1 ml was initially loaded with FHOD1 derived 
synthetic peptides used for production of polyclonal antiserum. Therefore, the column was three 
times washed at a maximum speed of 1 drop/2 s with 2 ml of ice cold P2-buffer and 
subsequently incubated with 1 ml P1-buffer containing 10 mg synthetic peptides  
(5 mg #20403 + 5 mg #20404) for 30 min at RT. Afterwards, the column was washed three times 
with 2 ml P3-buffer, three times with 2 ml P4-buffer and three times with P3-buffer, incubated 
for 30 min at RT and washed again, three times with 2 ml P4-buffer, three times with 2 ml P3-
buffer and finally three times with 2 ml P4-buffer. The column was stored in P6-buffer at 4°C. 
7.3.6.2 Purification of FHOD1 Specific Antibodies by Affinity Chromatography 
To affinity purify specific antibodies directed against FHOD1 from the final bleeding of an 
immunized rabbit (#1641) the prepared column was initially washed at a maximum speed of  
1 drop/2 s with 10 ml R1-buffer, followed by washing with 5 ml R2-buffer, 5 ml R3-buffer and 
10 ml R1-buffer. For specific interaction of antibodies with the column bound synthetic peptides, 
the column was loaded with rabbit serum and incubated for 1 h at RT. Subsequently, the column 
was rinsed with 6 ml R5-buffer while flow through (FT) was collected in three fractions (FT1-3). 
The bound antibodies were stripped by rinsing with 4 ml R4-buffer. Therefore, eluate was 
collected on ice in reaction cups containing either 200 µl (fraction #E1 + 800 µl eluate) or 400 µl 
ice cold R5-buffer (#E2, #E3, each with 1600 µl eluate). The column was washed again with  
10 ml R1-buffer, 5 ml R2-buffer, 5 ml R3-buffer and 10 ml R1-buffer and was stored in P5-
buffer at 4°C. To evaluate purification efficiency, 5 µl of each fraction (FT1, FT2, FT3, #E1, 
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#E2 and #E3) were spotted on a nitrocellulose membrane. To analyze total amounts of protein, 
the membranes were incubated by slow shaking for 10 min at RT with Amido-black staining 
solution, twice for 5 min at RT with destain-buffer and finally washed with water for 10 min. 
Eluate fractions containing protein (#E2 and #E3) were pooled and concentrated with a R1-
buffer equilibrated spin concentrator (Vivaspin 2 ml, 10,000 MWCO, Vivascience) by 
centrifugation (10-15 min at 4,500 rpm and 4°C) to a volume of 400 µl (10 fold concentration). 
Antibody solution was aliquoted and stored at -20°C, whereby unfrozen samples were stored at 
4°C for maximal two weeks. 
7.3.6.3 Specificity Test of Purified Antibodies 
To analyze the specificity of the affinity purified antibodies, 20 µl antibody solution were 
incubated on ice for 1 h with 32 µg synthetic peptides (16 µg #20403 + 16 µg #20404) used for 
rabbit immunization and affinity purification. Subsequently, either cellular lysates (Western blot) 
or cells (immuno fluorescence, EM), respectively, were then probed with the purified antibody 
or epitope inhibited antibody as described in the previous chapters. 
7.4 Cell Biology 
7.4.1 Cultivation of Adherent Cell Lines 
Usually, adherent cell lines were cultivated in 75 cm2 cell culture flasks, covered with approx.  
15 ml half synthetic cell culture medium which contained vitamins, amino acids, salt, glucose 
and a pH indicator in combination with a fresh supplement of heat inactivated fetal calve serum 
(FCS), glutamate and antibiotics (see chapter 7.1.4). Cells were kept in an incubator at 37°C with 
a humid atmosphere containing 5 % CO2. For subculturing every 2-3 days, adherent cells were 
washed with sterile PBS and treated with 2 ml trypsin/EDTA for approx. 5 min at RT or 37°C 
till cells were detached from the cell culture flask. Following addition of 5 ml medium, cells 
were carefully separated by repeated pipetting. Depending on the cell line, a defined amount of 
these cells was further cultivated in 15 ml fresh medium. 
7.4.1.1 Cryo-Conservation of Cell Lines 
For cryo-conservation, adherent cells were cultivated in a 150 cm2 cell culture flask to approx. 
75 % confluency with the appropriate cell culture medium. Following detachment with 4 ml 
trypsin/EDTA and addition of 9 ml medium, cells were centrifuged (5 min at 1,200 rpm and RT) 
and carefully suspended in 5 ml freezing medium by repeated pipetting. 1 ml cell suspension was 
transferred into cryo-conservation tubes, wrapped in tissue and subjected to refreezing at -80°C 
for 2 days. Finally, cells were stored under fluid nitrogen. 
For further cultivation, cells were rapidly thawed at 37°C, washed with cell culture medium and 
usually transferred to a 25 cm2 flask containing fresh medium. 
7.4.2 Transient Transfection of Animal Cells 
Plasmid DNA was transiently introduced into animal cells by lipofection. This method describes 
a form of transfection based on complexation of the negatively charged DNA by positively 
charged cationic lipids. These complexes can be internalized by the cells resulting in an 
expression of the encoded proteins when the plasmid DNA localizes inside the nucleus. In 
contrast to stable transfection, in which the genetic information is stably introduced into the 
host's genome, the introduced genetic information in transiently transfected cells is subsequently 
lost over time. 
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For lipofection, glass coverslips with cells seeded at the previous day at a density yielding to 50-
70 % confluency for transfection, were transferred into a 24 well plate, washed with PBS and 
covered with 400 µl OptiMEM I. Afterwards, 100 µl OptiMEM I were combined with 1 µg 
plasmid DNA in a 1.5 ml test tube. For co-expression experiments of different proteins, equal 
amounts of the respective plasmids were used, whereupon the total amount of DNA did not 
exceed 1 µg. The solution was mixed by pipetting and incubated for 10 min at RT. Next, 2 µl 
Lipofectamine 2000 or 2.5 µl Metafectene were added and the solution again mixed by pipetting. 
Following incubation for 15 min at RT, the mixture was carefully added to the cells dropwise. 
The cells were incubated for 3 h at 37°C in the incubator. Next, the transfection mixture was 
removed, medium was added and the cells were incubated for additional 20-24 h for expression 
of the respective proteins. 
The described amounts used for transfection are related to a 24 well format. For transfections in 
6 well plates, 6 cm and 10 cm dishes please refer to tab. 7. 
Table 7: Transient transfection of animal cells by lipofection. 
Cells Transfection solution 
Dish OptiMEM I 
[ml] 
OptiMEM I
[µl] 
Plasmid DNA 
[µg] 
Lipofectamine 2000 
[µl] 
or Metafectene
[µl] 
        
24 well 0.4 100  1.0 2.0  2.5 
6 well 0.8 200  2.0 4.0  5.0 
6 cm 2.0 500  5.0 10.0  12.5 
10 cm 4.0 1000  10.0 15.0  20.0 
        
 
7.4.3 RNAi Based Knockdown of Endogenous FHOD1 
RNA interference (RNAi) describes a basic mechanism of eukaryotic cells for post-
transcriptional regulation of gene expression and was identified in 1998 by C. C. Mello and A. 
Fire (Fire et al., 1998). Mediated by the antisense strand of a short doublestranded RNA 
(dsRNA) oligonucleotide (19 to 21 nucleotides) termed small interfering RNA (siRNA) the 
complementary cellular messenger RNA (mRNA) encoding for a gene product is repressed or 
degraded, resulting in a reduced production or knockdown of the respective protein. 
In this work, dsRNA oligonucleotides directed against FHOD1 were transfected into target cells 
by lipofection. Depending on the cell line, different transfection methods and reagents were used 
(tab. 8). For transfection, the indicated amounts of cells were seeded respective to the used dish 
format. On the following day, cells were washed twice with PBS before OptiMEM I was added 
as indicated. For transfection with Oligofectamine or Lipofectamine 2000, the transfection 
reagent and dsRNA were separately resolved in OptiMEM I, mixed, incubated for 10 min at RT, 
combined and incubated again for 15 min at RT. Finally, the mixture was carefully added to the 
cells dropwise. For transfection with HiPerfect, dsRNA fast first added to OptiMEM I, mixed 
and incubated for 10 min at RT. Afterwards, HiPerFect was added, the solution carefully mixed, 
incubated for 15 min at RT and finally added to the cells dropwise. After 3 h of incubation in the 
incubator, either twofold amounts of medium was added to the transfection solution 
(Oligofectamine, HiPerFect) or transfection solution was removed first before medium was 
added (Lipofectamine 2000). 
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Table 8: RNAi based knockdown of FHOD1 in different cell lines. 
Cells Transfection solution 
Cell line 
 
Dish 
 
Seeding 
[cells] 
OptiMEM I
[ml] 
OptiMEM I
[µl] 
dsRNA [5 µM]
[µl] 
Transfection reagent 
[µl] 
           
CHO 6 well 1.5 x 105 1.0 100 P1 2.5 HiPerFect 6.0 
CHO 6 cm 3.0 x 105 2.75 200 P1 6.25 HiPerFect 12.0 
           
HeLa 6 well 3 .0 x 105 1.0 2 x 100 P1, P2 2.5 Oligofectamine 4.0 
HeLa 6 cm 6.0 x 105 2.5 2 x 250 P1, P2 6.25 Oligofectamine 10.0 
HeLa 10 cm 2.0 x 106 5.0 2 x 500 P1, P2 18.75 Oligofectamine 20.0 
           
MEF 6 well 1.5 x 105 1.0 2 x 100 P1 2.5 Lipofectamine 2000 2.0 
           
NIH3T3 6 well 1.5 x 105 1.0 2 x 100 P1 2.5 Lipofectamine 2000 2.0 
NIH3T3 6 cm 3.0 x 105 2.5 2 x 250 P1 6.25 Lipofectamine 2000 4.0 
NIH3T3 10 cm 1.2 x 106 5.0 2 x 250 P1 12.5 Oligofectamine 24.0 
           
P1, P2: see tab. 1 
On the following day, cells were split and seeded on coverslips in the respective dish format. 48 
h after the first transfection, cells were again transfected as described. Further transfections with 
plasmid DNA were subsequently performed as described (see chapter 7.4.2) or expression of 
SH4-domains was induced by addition of 1 µg/ml dox. On the following day, coverslips were 
fixed and cells were harvested for knockdown control via Western blotting. 
7.4.4 Induction of Gene Expression 
In this study, HeLa and CHO cell lines were employed that stably or transiently expressed SH4-
domains controlled by a dox inducible promotor based on the Tet-on/off system (Gossen and 
Bujard, 1992). For induction of gene expression, 1 µg/ml dox was added to medium for at least 
24 h. 
7.4.5 Microscopy 
7.4.5.1 Fixation, Permeabilization and Staining of Cells 
For microscopical analysis of protein localizations in cells that were grown on coverslips, cells 
were fixed with 3 % PFA (w/v) for 10 min at 4°C. Subsequently they were washed with PBS and 
were stored for up to one week at 4 °C or were immediately processed. Therefore, coverslips 
were transferred to a sheet of parafilm and cells were covered for 60 s with a solution of 0.1 % 
Triton X-100 (v/v) in PBS for permeabilization. Following brief washing with PBS, cells were 
treated for 20 min with blocking solution consisting of 1 % BSA (w/v) in PBS. Thereafter, cells 
were exposed to 100 µl of staining solution containing 1 % BSA (v/v) in PBS and primary 
antibody as indicated in tab. 3 for 1 h at RT in darkness. Coverslips were carefully washed three 
times with PBS and were subsequently incubated with 100 µl staining solution containing PBS 
and the respective fluorescently labeled secondary antibody as outlined in tab. 4. After 1 h at RT 
in darkness, coverslips were carefully washed four times with PBS and once with MQ. For 
mounting, the carefully drained but not completely dry coverslips were placed upside down onto 
a drop of 15-25 µl mounting medium (Lin-Mount) spotted onto a glass slide. 
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For stain of F-actin or chromatin, fluorescently labeled Phalloidin or Hoechst 33258, 
respectively, was added, diluted in PBS as depicted in tab. 9 directly after permeabilization for 
30 min at RT in darkness or in combination with the secondary antibody.  
Table 9: Staining of F-actin filaments and chromatin. 
Substance Source (catalog number) Usage/Dilution 
   
Phalloidin-Alexa-Fluor-350 Molecular Probes, Invitrogen (A22281) IF 1:600 
Phalloidin-Alexa-Fluor-633 Molecular Probes, Invitrogen (A22284) IF 1:600 
Phalloidin-Alexa-Fluor-660 Molecular Probes, Invitrogen (A22285) IF 1:600 
Phalloidin-FITC Sigma (P5282) IF 1:1,000 
Phalloidin-TRITC Sigma (P1951) IF 1:1,000 
Hoechst 33258 Sigma (861405) IF 1:10,000 
   
IF = immuno-fluorescence 
For phospho-specific stain, all solutions were prepared in TBS instead of PBS and treatment with 
primary antibodies occurred for at least 12 h at 4°C in darkness. Therefore, coverslips were 
placed upside down onto 75 µl staining solution spotted onto parafilm in a chamber 
supplemented with wet tissues for a humid atmosphere. 
7.4.5.2 Microscopy of Fixed Cells 
Cells fixed and stained on coverslips were analyzed either by fluorescence microscopy using an 
Olympus IX70 inverted microscope (UPlanApo 40x/1.00 oil ∞/-; PlanApo 60x/1.40 Oil ∞/0.17; 
UPlanFL 100x/1.30 Oil) or by confocal microscopy using a Zeiss LSM 410 confocal 
microscope. 
7.4.5.3 Live Cell Microscopy for Real-Time Imaging 
For live cell imaging, CHO cells were seeded in Lab-Tek chamber slides (Nunc) one day before 
analysis. Mid-cell z-sections of blebbing cells were obtained by usage of a Zeiss LSM 410 
confocal microscope at RT. 2D and 3D real-time sequences were acquired using a PerkinElmer 
Life and Analytical Sciences Ultraview LCI spinning disc confocal (Boston) mounted on a 
Nikon Eclipse TE200 microscope stand equipped with a Nikon Plan Apo 60x 1,4NA oil 
objective. The microscope was kept at 37°C in a microscope incubator box (EMBL Heidelberg). 
Time-lapses of single sections were acquired for up to 10 min with 150 ms exposure time  
(6.6 fps) using binning 1x1. 
4D series were acquired for up to 15 min with 50 ms exposure time per section and a step size of 
0.5 μm between sections covering the whole cell body. Kymographs of the 2D real-time 
sequences were created using "ImageJ" plugins as described (Pepperkok et al., 2005) employing 
only steps 6-8 in the section "Analyzing the Kinetics of Transport Carriers". Visualization of  
4D data was perfomred using "Imaris" (Bitplane). 
7.4.5.4 Electron Microscopy (EM) 
For EM, 24 h after second RNAi treatment HeLa cells grown in a 6 well plate at a confluency of 
approx. 90 %, washed in PBS, treated for 3 min with 20 mM EDTA in PBS at 37°C and 
carefully scraped in PBS with a cell scraper. To determine knockdown efficiency, 50 % of the 
cells were subjected to Western blot analysis as described, whereas the rest was transferred to a 
1.5 ml cup. Cells were centrifuged (5 min at 2,000 rpm and RT), suspended in 1 ml EM-Fix I 
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solution, centrifuged again and incubated for 90 min at RT without suspension. After additional 
centrifugation, EM-Fix I solution was substituted with 1 ml ice cold EM-Fix II solution and cells 
were stored at 4°C. Following embedding, sectioning and staining for endogenous FHOD1  
(tab. 3) in combination with 5-10 nm ProteinA gold, sections were examined with a Zeiss EM10 
microscope. 
7.4.5.5 Scanning Electron Microscopy (SEM) 
For SEM, stable CHO cells grown on a coverslip were induced for SH4-domain expression for 
24 h and fixed with 2.5 % glutaraldehyde (v/v) in 100 mM PBS with 1 % sucrose (w/v), 
dehydrated in a graded series of ethanol and critical-point dried using carbon dioxide. 
Afterwards, cells were rotary-coated by electron beam evaporation using a BAF 300 freeze-
etching device (Bal-Tec) with a single layer of platinum-carbon (coating thickness 3 nm). The 
samples were imaged in a Hitachi S-5200 in-lens field emission scanning electron microscope at 
an accelerating voltage of 4 kV using the secondary electron signal. 
7.4.6 Inhibition of PM Blebbing by Drug-Treatment 
To investigate the influence of cellular determinants on PM blebbing, cells grown on coverslips 
were treated with various inhibitory drugs. Initially for synchronization of PM bleb formation, 
PM blebbing was efficiently abrogated by treatment with 10-90 μM Y-27632 for 2 h. After 
extensive washing of the cells with PBS, de novo bleb formation was allowed for 3 hours in 
medium containing a solvent control or a specific drug in the indicated amounts as depicted in 
tab. 10. Cells stably expressing SH4-domains were drug treated in the presence of 1000 ng/ml 
dox during the whole procedure. Subsequently, the cells were fixed and stained for F-actin and 
α-tubulin, respectively. 
Table 10: Drug-treatment for inhibition of PM blebbing. 
Drug Solvent Source (catalog number) Cell line Final concentration
[µM] 
     
(-) Blebbistatin DMSO Calbiochem, Merck (203391) CHO/Hela 100 
Cytochalasin D Ethanol Calbiochem, Merck (250255) CHO 1 
Cytochalasin D Ethanol  HeLa 2 
Latrunculin B DMSO Calbiochem, Merck (428020) HeLa 25 
Nocodazole DMSO Calbiochem, Merck (487928) CHO 100 
Nocodazole DMSO  HeLa 384 
PP1 DMSO Calbiochem, Merck (529579) CHO 1 
PP1 DMSO  CHO 10 
PP1 DMSO  HeLa 50 
SU-6656 DMSO Calbiochem, Merck (572636) CHO 1 
SU-6656 DMSO  CHO 10 
Y-27632 MQ Calbiochem, Merck (688001) CHO/HeLa 10 
Y-27632 MQ  CHO/HeLa 90 
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7.4.7 Induction, Detection and Inhibition of Apoptosis 
Apoptosis or programmed cell death is a highly regulated process resulting in cellular decease. 
For induction of apoptosis, HeLa cells grown on coverslips were treated for 3 h with a 
combination of 50 µg/ml recombinant human tumor necrosis factor-α (rhTNF-α) and 5 µg/ml 
Cycloheximide (Chx). Apoptotic HeLa cells were either determined by stain with Hoechst 33268 
for detection of condensed chromatin or by an Annexin V mediated surface specific stain of 
externalized phosphatidyl-serine (PS). Therefore, living cells were carefully washed with AB-
buffer and incubated with staining solution consisting of AB-buffer fluorescently labeled 
Annexin V-Alexa-Fluor-568 at a dilution of 1:50 (v/v) for 15 min at RT in darkness. Finally, 
cells were fixed and stained as already described. 
CHO cells grown on coverslips were induced for apoptosis either by treatment with 4 % DMSO 
(v/v) in medium for 5 h or by treatment with 200 µg/ml Etoposide (Eto) in combination with  
200 µg/ml Chx in medium for 12 h. For apoptosis detection, cells were either stained with 
Hoechst 33268 for identification of cells with condensed chromatin or apoptosis was evaluated 
by a transferase-dUTP nick end labeling (TUNEL) assay (Gavrieli et al., 1992). During TUNEL 
reaction, the enzyme deoxynucleotidyl transferase (TdT) specifically binds to terminal 3'-OH 
ends of fragmented DNA and incorporates dUTP fluorescently labeled with tetramethyl 
rhodamine (TMR). Therefore, cells were fixed, permeabilized and subjected to TUNEL reaction 
by incubation with staining solution consisting of enzyme solution, label solution and PBS 
(1:10:20) for 1 h at RT in darkness (In situ Cell Death Detection Kit, TMR red, Roche). Finally, 
cells were stained for F-actin and chromatin.  
For inhibition of caspase mediated apoptosis, cells were cultured in the presence of 100 µM 
zVAD-fmk. 
7.4.8 VSV-G Transport Assay 
The capacity for Golgi mediated protein transport can be evaluated by the usage of specific cargo 
proteins such as the temperature sensitive vesicular stomatitis virus (VSV) ts-045-G 
glycoprotein. At the non-permissive temperature of 39.5°C the cargo marker accumulates in the 
ER due to a reversible folding defect. When shifted to the permissive temperature of 31°C, 
correctly folded ts-045-G is rapidly transported from the ER through the Golgi apparatus to the 
cell surface, where its appearance can be monitored using an antibody against the lumenal 
domain of the glycoprotein (Pepperkok et al., 1993). Therefore, 5 h after the second RNAi 
treatment for FHOD1 knockdown, HeLa cells were transformed with DNA encoding ts-045-G 
fused to CFP by infection with adenoviruses (MOI of 10) for 17 h at 39.5°C. At the following 
day, medium was supplemented with 1 M HEPES buffer (pH 7.5) to a final concentration of  
25 mM HEPES and temperature was shifted to 31°C for up to 90 min. Cell were fixed and 
stained without permeabilization with mc-mouse-α-ts-045-G antibody (tab. 3). Following 
analysis of the cells by fluorescence microscopy, internal and external amounts of ts-045-G-CFP 
protein were determined by quantification of the respective mean grey values from single cells 
using the "Freehand selection" tool in combination with the "Measurement" tool of "ImageJ" 
software. The relative protein transport of single cells was calculated by the ratio of external to 
total signal. 
7.4.9 Adhesion and Proliferation Assay 
To determine cellular adherence capacity of FHOD1 knockdown cells, 1.0 x 104 HeLa cells/well 
were seeded 3 h after second RNAi treatment in 96 well plates either non-coated or coated with 
different matrix proteins. For coating, wells were previously covered either with 40 µg/ml 
fibronectin in PBS, 1 mg/ml collagen in PBS, or with 0.01 % (w/v) poly-L-lysine solution, 
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respectively, for 1 h at 37°C and finally washed with PBS. In parallel, 3 x 105 cells were seeded 
in 6-well plates for determination of knockdown efficiency on the following day. Adherence in 
96-well plates was allowed for 2 h. Afterwards cells were fixed, stained for chromatin with 
Hoechst 33258 without permeabilization and bulk fluorescence was measured in a fluorimeter 
(356 nm/458 nm). The number of attached cells was calculated by normalization to a standard 
curve, the experiments were performed in triplicates for each condition. 
Proliferation rate for control and FHOD1 knockdown cells was measured by an ELISA based 
assay (BrdU Cell Proliferation Assay, Calbiochem, Merck) with antibodies probing for 
Bromodeoxyuridine (BrdU), a thymidine analog which is internalized in newly synthesized 
DNA during mitosis. Following seeding of HeLa in 96-well plates as described for the adhesion 
assay, medium was replaced with 120 µl medium containing 20 % (v/v) BrdU labeling solution 
after 2 h. 24 h later, cells were fixed by addition of fixative/denaturing solution for 30 min and 
treated according to manufacturer's instructions. The measured signals were normalized to the 
results of adhesion assays performed in parallel to exclude a possible interference of different 
adhesion capacity. The experiments were performed in triplicates for each condition. 
7.4.10 Measurement of Cell Size 
For determination of cell size, HeLa cells grown on coverslips were fixed, permeabilized and 
stained for F-actin 2 d after second RNAi treatment for FHOD1 knockdown. Subsequently, they 
were analyzed by fluorescence microscopy and cell size was determined by measurement of the 
area captured by a single cell using the "Freehand selection" tool in combination with the 
"Measurement" tool of "ImageJ" software. 
7.4.11 SRE Transcription Assay 
To investigate the influence of FHOD1 on Rho-GTPase and ROCK1 mediated activation of SRE 
transcription, 3 h after second RNAi treatment 3.5 x 105 NIH3T3 cells were seeded in a 6 cm 
dish for knockdown control and 5 x 104 NIH3T3 cells were seeded in a 12 well for subsequent 
transfection on the following day. Therefore, 1 µg of plasmid DNA encoding the respective 
constructs was mixed with 24 ng p3D.Afos and 10 ng pRL-TK reporter plasmids. 3 h after 
transfection, cells were subjected to starving medium containing 0.5 % FCS. At the following 
day, knockdown control cells were harvested as described and transfected cells were lysed in  
100 µl "Passive Lysis buffer" (Dual-Luciferase Reporter Assay System, Promega). Lysates were 
processed according to the manufactures instructions. For measurement, 50 µl supernatant was 
added to a 96 well plate (white, non-transparent) and was mixed with 50 µl "Luciferase Assay II" 
solution. Following detection of firefly luciferase activity at the luminometer (Luminoskan 
Ascent luminometer, Thermo Labsystems) for 1 s, 50 µl "Stop & Glow" buffer was added, 
carefully mixed and renilla luciferase activity was measured for 5 s. For calculation of SRE 
activity, background values obtained for untransfected cells were subtracted from the respective 
values obtained for firefly and renilla luciferase. Subsequently, firefly luciferase activity was 
normalized to renilla luciferase activity. The experiments were performed in triplicates for each 
condition. For comparison with further experiments, SRE activity was expressed relative to 
control RNAi treated FHOD1-ΔC transfected cells which were arbitrarily set to 100. 
7.4.12 Wound Healing Assay for 2D-Motility 
Due to cell-cell contact-inhibition, migration of animal cells on 2D planar surfaces is inhibited 
under cell culturing conditions which are characterized by high cell confluency. In a wound 
healing assay, a unilateral loss of this contact-inhibition is achieved by scratching a 100 % 
confluent layer of cells resulting in a distinct area without cells referred to as wound. This trigger 
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in combination with chemotactic orientation induces a directional migration of the adjacent cells 
into the wound. 
To investigate the wound healing efficiency of FHOD1 knockdown cells (HeLa, MEF, NIH3T3) 
or SH4-domain expressing CHO cells, confluent layers of cells in 6-well plates either 24 h after 
second RNAi treatment or 24 h after addition of 1000 ng/ml dox, respectively, were scratched 
with a pipette tip to cause a cell layer wound of about 200-300 µm in distance. Wound closure 
was monitored over 24 h at 37°C in medium supplemented with 20 mM HEPES by live cell 
imaging which was performed immediately after wounding for 18 h at 37 °C using a Leica CTR 
MIC microscope. Pictures were acquired every 30 min with a motor-controlled Leica DC  
350 FX camera using the Leica software "FW4000", which enables simultaneous recordings 
from multiple wells. Subsequently, single pictures were assembled to a movie using the "Import 
Image Sequence" tool of the "ImageJ" software. 
7.4.13 Chemotaxis Assay 
Chemotaxis defines a type of cell motility in which cells migrate towards a chemo-attractant 
stimulus. To investigate the role of FHOD1 in chemotaxis driven motility, NIH3T3 cells in a  
6 cm dish were serum starved with medium containing 0.5 % FCS (v/v) immediately after 
second RNAi treatment. 24 h later, cells were treated for 5 min at 37°C with a solution of 5 mM 
EDTA in PBS. After detachment, 2.75 x 103 cells were seeded on the bottom of a transwell 
insert with a pore size of 8 μm (ThinCert cell culture insert for 24 well plates, Greiner Bio-One) 
for 1 h at 37°C and the rest was used for determination of knockdown efficiency. Subsequently, 
transwell inserts were transferred to a 24-well plate and cells were allowed to migrate along a 
gradient of FCS for 8 h. Therefore, 550 µl 0.5 % FCS (v/v) was added to an individual well and 
100 µl 10 % FCS (v/v) for the gradient or 100 µl 0.5 % FCS (v/v) for control, respectively, were 
given to the a single transwell insert. To maintain the gradient of FCS, medium was exchanged 
in a frequency of 1 h. Thereafter, cells at the transwell membrane were fixed and stained for  
F-actin and chromatin. Finally, the number of cells at the transwell membrane was quantified at 
the confocal microscope (Leica TCS SP2) and the relative number of cells migrated across the 
membrane was calculated. 
7.4.14 Invasion Assay for 3D-Motility 
For determination of cell invasiveness, a transwell assay was performed as described by Hooper 
and colleges (Hooper et al., 2006). Therefore, membranes of transwell inserts with a pore size of 
8 μm (ThinCert cell culture insert for 24 well plates, Greiner Bio-One) were coated with 20 μl of 
undiluted growth factor reduced matrigel (BD Biosciences). For the analysis of inducible CHO 
cell lines, cells were kept in the presence of 1 µg/ml dox. Following 12 h dox induction in the 
presence of 10 % FCS, cells were starved for 12 h in medium containing 0.5 % FCS, harvested 
and counted. 106 cells were seeded in the upper chamber of the transwell insert in medium 
supplemented with 0.5 % FCS, whereas the lower chamber was filled with medium 
supplemented with 10 % FCS (fig. 14)  
Figure 14: Invasion assay. 
Serum starved cells were seeded on top of the matrigel and 
migrated along a gradient of FCS for 48 h. Following fixation, 
removal of the matrigel and stain with Hoechst 33258, cells 
appearing at the lower side of the transwell insert membrane 
(pore size 8 µm) were quantified (Hooper et al., 2006). 
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After 48 h incubation at 37°C, cells in the upper chamber were carefully removed with a cotton 
swab and the cells that had traversed the membrane were fixed with 4 % PFA, stained with 
Hoechst 33258 and counted at the microscope (Leica DMIRE2). To account for potential 
differences in cell seeding and/or proliferation during the 48 hours invasion period, cells were 
also plated in parallel in culture plates without matrigel, fixed at the timepoint of harvest of the 
invasion samples and stained with Hoechst 33258. The number of nuclei in five representative 
areas was quantified and the number of invaded cells was normalized to the total number of 
cells. Maximum differences in cell numbers observed were 1.5 fold in parallel assays and 
increased cell proliferation observed in individual experiments was not correlated with the 
expression of any of the transgenes analyzed. 
7.4.14.1 Confocal Microscopy and 3D Reconstructions 
3D analyses were performed as described (Kitzing et al., 2007). Briefly, CHO cells stably 
expressing N18-HASPB-GFP were transfected with an mRFP-actin expression plasmid. 24 h 
later cells were counted and seeded directly into Matrigel (BD Biosciences) and placed into  
μ-Slide VI chambers (ibidi). Cell morphologies were analyzed by taking z intervals of 1 μm with 
a 40x objective using confocal microscopy (Leica TCS SP2). 3D reconstructions and animations 
of the z-sections were performed using Leica "Confocal Simulator Software". 
7.4.15 Golgi Disruption Assay 
To analyze the localization of endogenous FHOD1 during disruption and reassembly of the 
Golgi apparatus, NIH3T3 cells grown for 1 d on coverslips were treated for either 10 min or  
30 min with 5 µg/ml (+) Brefeldin A (BFA), respectively. Cells were immediately fixed or 
initially thoroughly washed three times with PBS and incubated for 1 h at 37°C for reassembly 
of the Golgi. Cells were permeabilized, stained for endogenous FHOD1 and coatomer (tab. 3) 
and were subjected to confocal microscopy. 
7.4.16 Measurement of F-actin Content by Flow Cytometry 
For evaluation of FHOD1s influence on intracellular steady state levels of polymerized F-actin, 
HeLa cells in a 10 cm dish at a confluency of approx. 75 % were detached 24 h after second 
RNAi treatment by trypsin/EDTA for 5 min. To determine knockdown efficiency, 20 % of the 
cells were subjected to Western blot analysis as described, whereas the rest was transferred to a 
1.5 ml cup on ice, washed twice with PBS and finally suspended in 200 µl ice cold 3 % (w/v) 
PFA for fixation. After 30 min on ice, cells were centrifuged (5 min at 2,000 rpm and 4°C), 
subsequently resuspended in 1000 µl staining solution consisting of Phalloidin-Alexa-Fluor-633 
(1:600) in ice cold PBS for F-actin stain and incubated for 45 min on ice in darkness. Following 
a final washing step in PBS, cells were suspended in 300 µl PBS and subjected to FACS 
analysis. 
7.4.17 Endocytosis Assays 
In order to investigate the influence of SH4-domains on different endocytotic pathways, the 
capacity of CHO cells for fluid-phase uptake as well as for clathrin mediated endocytosis was 
measured by microscopy and flow cytometry (FACS). 
7.4.17.1 Analysis of Fluid-Phase Uptake by Microscopy 
To qualitatively investigate fluid-phase uptake, stable CHO cells were seeded on coverslips and 
expression of respective proteins was either induced or not by addition of 1000 ng/ml dox for  
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24 h. Subsequently, cells were treated in a 24 well plate for up to 180 min at 37°C with 200 µl 
medium supplemented with 1 mg/ml fluorescently labeled dextran-TMR (10 kDa or 70 kDa). To 
evaluate the contribution of macropinocytosis, dextran-uptake was also measured in the presence 
of either 100 µM 5-(N-ethyl-N-isopropyl)-amiloride (EIPA) including a pretreatment for 1 h 
with the inhibitory drug or 200 nm phorbol myristate acetate (PMA) for induction of 
macropinocytosis, respectively. Cells were fixed, stained for F-actin and chromatin and were 
subjected to microscopy. 
7.4.17.2 Quantification of Fluid-Phase Uptake by Flow Cytometry 
To quantitatively investigate fluid-phase uptake, stable CHO cells were seeded in a density of 
0.5 x 105 cells/well (24 well plate) and expression of respective proteins was either induced or 
not by addition of 1000 ng/ml dox for 24 h. Subsequently, cells were treated for up to 180 min at 
37°C with 200 µl medium supplemented with 0.1 mg/ml fluorescently labeled dextran-Alexa-
Fluor-647 (10 kD). As described above, control cells were treated either with EIPA or with 
PMA. To stop internalization, 24 well plates were transferred to ice and 800 µl ice cold PBS was 
added per well. Following three washing steps with ice cold PBS, cells were covered for 10 min 
with 200 µl ice cold EW buffer (Meier et al., 2002) in darkness. After detachment with 300 µl 
ice cold ED buffer for 25 min in darkness, 700 µl E-Stop solution was added. The cells were 
carefully suspended by pipetting, transferred to a 1.5 ml cup and subsequently centrifuged (5 min 
at 2,000 rpm and 4°C). Following suspension in 300 µl E-FACS buffer, the cells were subjected 
to FACS analysis (flow cytometer FACSCalibur, Beckton Dickinson). 
7.4.17.3 Quantification of Clathrin Mediated Endocytosis by Flow Cytometry 
To quantitatively investigate clathrin mediated endocytosis, stable CHO cells were seeded in a 
density of 0.5 x 105 cells/well (24 well plate) and expression of respective proteins was either 
induced or not by addition of 1000 ng/ml dox for 24 h. Subsequently, cells were treated for up to 
180 min at 37°C with 200 µl medium supplemented with 5 mg/ml fluorescently labeled 
transferrin-Alexa-Fluor-647. Finally, cells were treated and analyzed by FACS as described for 
fluid-phase uptake. 
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8 RESULTS 
8.1 SH4-Domain Mediated PM Blebbing 
SH4-domains represent the N-terminal membrane anchors of several membrane attached 
proteins including Src kinases as well as the Leishmania HASPB virulence factor, HIV-1 Nef 
and HIV-1 Gag proteins (Resh, 1993, Resh, 1994, Stegmayer et al., 2005, Welker et al., 1998). 
SH4-domains reveal no highly conserved amino acid sequence homology, but a common feature 
is posttranslationally modification by acetylation with myristoleic acid mediating their 
membrane targeting. They are additionally palmitoylated or possess a basic cluster consisting of 
positively charged residues like Lys or Arg (fig. 15) (McCabe and Berthiaume, 1999, Resh, 
1994). 
Figure 15: Alignment of SH4-domains 
investigated in this study. 
Depicted are the first 18 residues of 
Leishmania HASPB as well as of the Src 
kinases Fyn, Lck, c-Src and Yes. The 
grades of homology are denoted by the 
shown color code (with "-" = minimal and 
"+" = maximal homogeneity). Selected 
residues are written in bold letters (basic 
cluster) or highlighted by light colors 
(red: myristoylated; green: palmitoylated; 
required for efficient myristoylation: Ser 
or Thr (cyan) and Arg or Lys (yellow)). 
Appropriate subcellular localization and membrane attachment are prerequisites for the 
biological activity of Src kinases e.g. in oncogenic transformation (Kaplan et al., 1988, Sigal et 
al., 1994). Roles of SH4-domains beyond this targeting function, however, have not been 
described to date. 
8.1.1 Generation of Stable SH4-Domain Cell Lines 
To study the biology of SH4-domains, stable CHO cell lines (kindly provided by S. Tournaviti, 
group of W. Nickel, BZH, Heidelberg) and HeLa cell lines (kindly provided by J. Ritzerfeld, 
group of W. Nickel, BZH, Heidelberg) were generated as described previously (Engling et al., 
2002, Stegmayer et al., 2005). In a doxicycline (dox) inducible manner, the CHO cell lines 
stably express eGFP fusion proteins of the 18 amino acid SH4-domain either from the HASPB 
protein or from the proto-oncogenic Src kinases c-Src, Fyn, Lck, Yes or their mutants  
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(Δmyr, Δpal), respectively, linked to a TEV cleavage site and a ProteinA tag for potential 
purification (fig. 16A).  
Figure 16: Generation of cell 
lines stably expressing SH4-
domains. 
(A) SH4-domain constructs. 
Expression cassettes encoding the 
first 18 residues of either the 
Leishmania HASPB protein or the 
Src kinases c-Src, Fyn, Lck or Yes, 
respectively, linked to a TEV 
cleavage site followed by GFP and 
ProteinA were cloned into a pREV-
TRE2 vector containing a 
transactivator/doxicycline (dox)-
responsive element and were stably 
integrated into the genome of CHO 
cells by viral transduction. GFP-
positive cells were sorted by FACS. 
For HeLa cells, the integrated 
constructs are not linked to 
ProteinA. (B+C) Analysis of CHO 
cells induced for N18-HASPB-GFP 
expression with increasing amounts 
of dox for 24 h. (B) Western blot: 
The N18-HASPB-GFP signal (see 
insert) was normalized to the 
GAPDH loading control following 
quantification by the LI-COR 
Odyssey infrared imaging system. 
Relative expressions levels are 
depicted. (C) FACS: GFP 
fluorescence intensities of the cells 
were analyzed by flow cytometry 
and the relative expression levels 
presented are arithmetic means of 
three independent experiments + 
standard deviation (SD). Values for 
1000 ng/ml dox were set to 100 % 
(kindly provided by S. Tournaviti). 
 
As shown for N18-HASPB-GFP and investigated by Western blot and FACS analysis, induction 
of SH4-domain expression in stable CHO cell lines with increasing amounts of dox for 24 h 
resulted in rising protein production. Both methods revealed low background levels and low 
leakiness of the expression system without dox, but maximal expression by addition of  
1000 ng/ml dox (fig. 16B/C). While these conditions yielded the most efficient SH4-domain 
production levels, they were applied for further experiments. 
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8.1.2 Expression of SH4-Domains Induces PM Blebbing 
Since production of the generated GFP fusion proteins was successful, their cellular localization 
was analyzed by confocal microscopy on live CHO cells. According to the confocal 
micrographs, GFP linked to the HASPB-SH4-domain (N18-HASPB-GFP) was efficiently 
targeted to the PM as well as to cytoplasmic vesicular structures whereas GFP alone showed its 
typical cytoplasmic and nucleic distribution (fig. 17Aa-b).  
 
Figure 17: Expression of SH4-domains resulted in PM blebbing. 
(A) Cellular localization of SH4-domains and triggering of PM blebbing. Live confocal microscopy of either CHO 
cell lines expressing GFP (a) or GFP fusion proteins of the SH4-domain of Leishmania HASPB (b) or the Src 
kinases c-Src (c), Fyn (d), Lck (e) or Yes (f), respectively, or CHO cells transfected with full length (FL) proteins of 
HASPB (g) or Lck (i) fused to GFP or not fused to GFP but co-transfected with mRFP-actin (h). Expression was 
induced with 1000 ng/ml dox for 24 h. Presented are representative mid-cell z-sections. Scale bars = 10 µm. (B) PM 
blebbing induction was correlated with expression levels of the HASPB-SH4-domain. To induce N18-HASPB-GFP 
expression, CHO cells were treated with the indicated concentrations of dox for 24 h. Following fixation, blebbing 
cells were quantified by confocal microscopy. Given is the overall percentage of cells displaying PM blebs. Black 
and grey columns indicate the fraction of blebbing cells with high (more than 5 blebs per cell) or low (less than  
5 blebs per cell) blebbing activity, respectively (arithmetic means of at least three independent experiments + SD 
with > 100/condition). (C) Blebbing efficiency of cells depicted in selected panels of A. Percentage of cells 
displaying PM blebs (arithmetic means of at least three independent experiments + SD with > 100/condition; kindly 
provided by S. Tournaviti). 
Surprisingly, the HASPB-SH4-domain drastically altered the PM morphology and caused 
extensive PM blebbing on the cellular surface. Although even low dox concentrations were 
sufficient to induce moderate PM blebbing by N18-HASPB-GFP, expression levels induced with 
at least 300 ng/ml dox resulted in efficient PM blebbing in over 80 % of the cells (fig. 17B). A 
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further increase up to 1000 ng/ml dox led to maximal protein production (fig. 16B/C) and 
enhanced PM blebbing per cell (fig. 17B). This PM blebbing was also observed in Hela cells, but 
was less pronounced which might be due to lower expression levels (data not shown). Similar 
results were obtained by expression of SH4-domains derived from the Src kinases c-Src, Fyn, 
Lck and Yes (fig. 17Ac-f). These SH4-domains efficiently targeted the coupled GFP to the PM 
and to other cytoplasmic membranes: Whereas N18-Lck-GFP and N18-Yes-GFP showed an 
internal distribution that was similar to N18-HASPB-GFP and reminded of Golgi related 
vesicles, N18-Fyn-GFP additionally revealed a more diffuse cytoplasmic dispersion. This also 
applied to N18-Src-GFP, although its vesicular localization appeared more outspread, which is in 
line with a previously described attachment to endocytotic vesicles like macropinosomes 
(Kasahara et al., 2007). Nevertheless, all constructs potently induced PM blebbing with slight 
variations in morphology, size and bleb number per cell as well as in bleb induction efficiencies 
(fig. 17A/C and data not shown). Compared to the SH4-domains only, equally efficient PM 
blebbing combined with a similar cellular distribution was found upon transient expression of 
full length Lck or HASPB fused to GFP or co-transfection of mRFP-actin with a non-tagged 
version of full length HASPB, whereas expression of GFP alone had no such effect  
(fig. 17Ag-i/C).  
In summary, by fusion of GFP to various SH4-domains, the protein was efficiently targeted to 
the PM. These SH4-domains were sufficient to potently induce PM blebbing by a mechanism 
depended on their expression level but not related to the GFP-ProteinA tag. Therefore, induction 
of PM blebbing is a conserved function of SH4-domains from different sources, including proto-
oncogenic Src kinases. 
8.1.3 Localization of the SH4-Domain to the PM is Required for Production of 
PM Blebs 
Since a common feature of all of these SH4-domains was their targeting to the PM, the 
correlation between PM localization and bleb induction was investigated. PM targeting of SH4-
domains mainly depends on acetylation of specific residues within this domain: The site for 
myristoylation is highly conserved in SH4-domain containing proteins and is located at position 
Gly2, whereas palmitoylation takes place on cysteins located in the amino acid residues three to 
seven (fig. 15B) (McCabe and Berthiaume, 1999, Resh, 1994). Therefore, two different mutants 
of N18-HASPB-GFP were used: N18-Δmyr-HASPB-GFP lacks both, its myristoylation and 
palmitoylation signal (Gly2 substituted by alanine: G2A) resulting in cytoplasmic and nucleic 
localization (fig. 18Ab).  
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Figure 18: Induction of PM blebbing required PM targeting. 
(A) Live confocal microscopy of CHO cell lines expressing GFP fusion proteins of the HASPB-SH4-domain  
(a: N18-HASPB-GFP) or mutants that are defective in PM targeting (b: N18-Δmyr-HASPB-GFP;  
c: N18-Δpal-HASPB-GFP). Depicted are representative mid-cell z-sections. Scale bars = 10 µm. (B) Blebbing 
efficiency of cells depicted in panel A (arithmetic means of at least three independent experiments + SD with  
> 100/condition). (C) Confocal microscopy of fixed CHO cell lines expressing GFP fused mutants of the  
HASPB-SH4-domain (a-c: N18-HASPB-GFP; d-f: N18-Δmyr-HASPB-GFP). Following fixation, cells were stained 
for F-actin with Phalloidin-TRITC (b/e). Depicted are representative mid-cell z-sections. Scale bars = 10 µm (kindly 
provided by S. Tournaviti: A/B). 
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N18-Δpal-HASPB-GFP lacks solely its palmitoylation signal (Cys5 substituted by serine: C5S) 
resulting in accumulation at perinuclear membranes (most likely the Golgi apparatus (Denny et 
al., 2000, Stegmayer et al., 2005) and exclusion from nuclei (fig. 18Ac). Interestingly, CHO cell 
lines expressing these mutants showed no PM blebbing in live cell imaging (fig. 18A/B). To 
further study this effect, cells were fixed and stained for F-actin (fig. 18C). Confocal microscopy 
again showed potent PM blebbing upon expression of N18-HASPB-GFP. The generated blebs 
were F-actin enriched at the limiting membrane and particularly at their neck (fig 18Cb). Again, 
no PM blebbing was found in cells expressing the acetylation deficient PM targeting mutants of 
the HASPB-SH4-domain (fig 18Cd-f). These results were confirmed by scanning electron 
micrographs (SEMs) of CHO cells transfected with the Yes-SH4-domain: Although all cells 
displayed peripheral membrane ruffling and microvilli like structures on their surface that are 
typical for these epithelial cells (Porter et al., 1973), N18-Yes-GFP expressing cells showed an 
increased ruffling in combination with spherical structures on their surface resembling PM blebs 
in fluorescence microscopy (fig. 19BA). Consistent with the results obtained by confocal 
microscopy, these blebs were variable in size and number. Interestingly, they reminded of blebs 
that were previously described for G1-phase CHO cells (Porter et al., 1973). Nevertheless, these 
structures were absent in N18-Δmyr-Yes-GFP (G2A) producing cells that were indistinguishable 
from mock transfected cells (fig. 19B and data not shown). 
 
Figure 19: Expression of SH4-domains altered cellular surface morphology. 
(A+B) Scanning electron micrographs (SEMs) of surfaces of fixed CHO cells transfected with either the PM 
blebbing inducing SH4-domain N18-Yes-GFP (A) or its myristoylation deficient mutant N18-Δmyr-Yes-GFP  
(B) that was not capable of PM blebbing induction. Scale bars = 10 µm (Pictures were generated with the help of  
P. Walther, Electron Microscopy Facility, University Ulm, Germany). 
In summary, the potent induction of PM blebbing and formation of F-actin rich PM blebs by 
SH4-domains required their localization at the inner leaflet of the cell limiting PM. 
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8.1.4 N18-HASPB Induced PM Blebs are Highly Dynamic 
PM blebbing is a highly dynamic process: M2 melanoma cells, for instance, that are deficient in 
the F-actin filament cross linking protein FLNa reveal constant PM blebbing with distinct 
kinetics due to local breakdowns of the cortical actin layer (Charras et al., 2005, Cunningham, 
1995). Similar behavior was observed for blebs of apoptotic cells that are also formed and 
retracted constantly in the beginning. Subsequently, they are shed as apoptotic bodies from the 
cell during late apoptotic phases (Barros et al., 2003, Mills et al., 1999, Zhang et al., 1998). 
Furthermore, PM blebs that are induced during ATP induced secretion of IL-1ß, regularly pinch 
off from the cell surface (MacKenzie et al., 2001). To characterize appearance and dynamics of 
SH4-domain induced PM blebs, N18-HASPB-GFP expressing CHO cells were analyzed by 
confocal real time imaging that was performed by S. Terjung (Advanced Light Microscopy Core 
Facility, EMBL, Heidelberg): A 4D surface reconstruction revealed that blebbing activity 
occurred at the whole surface, but was most pronounced at the edges of the cell (fig. 20A).  
 
Figure 20: Expression of SH4-domains altered cellular surface dynamics. 
(A+B) Representative image of a 4D time-lapse surface reconstruction of CHO cells expressing  
(A) N18-HASPB-GFP or (B) N18-Δmyr-HASPB-GFP. Over a time period confocal stacks (step size 0.5 µm) were 
taken and the raw data was filtered and visualized with Imaris (Bitplane) with a 3x3x3 median filter followed by an 
edge preserving filter (width = 0.140 µm). The PM is represented by iso surface rendering. Grid size = 5 µm (kindly 
provided by S. Terjung). 
As a control N18-Δmyr-HASPB-GFP expressing cells revealed markedly reduced PM dynamics 
(fig. 20B). Consistently, a 2D confocal stack projection of stably N18-HASPB-GFP expressing 
CHO cells in a time lapse showed that PM blebbing occurred at the entire surface of the cells but 
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not at cell-cell or cell-substratum contacts (2D time-lapse, 10 minutes, 150 ms per frame;  
fig. 21A).  
 
Figure 21: HASPB-SH4-domain induced PM blebbing was a highly dynamic and constantly performed 
process. 
(A-C) HASBP-SH4-domain induced PM blebs were of different size and are constantly formed and retracted 
without shedding. (A) Representative confocal image of a fast 2D time-lapse (10 minutes, 150 ms per frame) of 
CHO cells stably expressing N18-HASPB-GFP. Scale bars = 10 µm. (B+C) Kymographs (time-space-plots) along 
the axis perpendicular to the bleb base and stills of two blebs framed by rectangles in A showed that PM blebbing is 
divided in three phases: expansion, retention and retraction. Note the different time intervals between the stills 
(formation: 1 s; retention and retraction: 3 s). (D-F) Kinetics of N18-HASPB-GFP induced PM blebbing revealed a 
fast expansion phase followed by a prolonged retention phase and a slow retraction phase. Average time (D), 
average distance (E) bleb move and average speed (F) during expansion, retention and retraction phase of  
40 individual blebs is plotted for all analyzed blebs (light gray), stationary blebs (medium gray) and laterally motile 
blebs (dark gray) + SD (kindly provided by S. Terjung). 
According to kymographic tracing of individual blebs, their formation and retraction occurred on 
average within 44 s (fig. 21A-D). In line with previous characterizations of PM blebbing in  
M2 melanoma cells (Charras et al., 2005, Cunningham, 1995), the life span of individual blebs 
consisted of three distinct steps: fast expansion (in average 6 s, 0.332 µm/s) followed by an 
extended retention phase (in average 12 s, 0.012 µm/s) and a subsequent slow retraction period 
(in average 26 s, 0.071 µm/s; fig. 21A-D/F). While most of the quantified blebs formed at and 
retracted to the identical position at the PM, a subpopulation of blebs displayed lateral mobility 
with accelerated apparent bleb expansion and retraction. Both types of blebs reached a similar 
size of approx. 1.7 µm in diameter at maximum extension and retracted completely  
(fig. 21A-C/E). During retraction, the previously round shape of the blebs typically turned into a 
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less homogenous, wave-like morphology. In contrast to blebbing observed during ATP-induced 
secretion of IL-1ß (MacKenzie et al., 2001), real time microscopy analysis revealed that  
N18-HASPB-GFP mediated PM blebbing did not cause detectable shedding of SH4-domain 
positive vesicles into the cell culture supernatant. 
Together, PM blebs induced by SH4-domains were highly dynamic: They were constantly 
formed and retracted and occurred at cell surfaces only but not at cell-cell or cell-surface contact 
sites. They also showed distinct kinetics and dimensions that were comparable to blebs 
constantly produced in M2 melanoma cells. 
8.1.5 N18-HASPB Induced PM Blebs are Non-Apoptotic 
Although PM blebs mediated by SH4-domain expression showed similar kinetics to M2 cells 
and PM blebbing was a constant process without any apparent damage of the cells, this 
phenotype reminded of apoptotic cells. Apoptosis or programmed cell death is a highly 
organized process. During apoptosis, cells round up and PM blebbing is induced. This process is 
thought to be involved in DNA fragmentation and initiation of immune responses (Fadeel, 2004, 
Martinez et al., 2005). At late stages, apoptotic bodies are generated which pinch off the surface 
of apoptotic cells leading finally to their disruption (Mills et al., 1999, Zhang et al., 1998). 
Various different analyses were performed to test whether SH4-domain expressing cells were 
undergoing apoptosis. First, a transferase-dUTP nick end labeling (TUNEL) assay was 
performed (Gavrieli et al., 1992), during which deoxynucleotidyl transferase (TdT) specifically 
binds to terminal 3'-OH ends of fragmented DNA and incorporates fluorescently labeled dUTP 
allowing microscopical examination of apoptotic cells (Huerta et al., 2007). Cells expressing 
N18-HASPB-GFP for 24 h were strictly negative for TUNEL reaction, whereas treatment of 
these cells with 200 µg/ml Etoposide (Eto) in combination with 200 µg/ml Cycloheximide (Chx) 
for 12 h potently induced apoptosis (fig. 22A/B). Second, the viability of cultured cells was 
verified by a microscopic analysis of cellular DNA. Chromosomal DNA condensates during 
apoptosis and is fractionated during this process (Huerta et al., 2007). As depicted in fig. 22, 
only DMSO treated (4 %, 5 h), but not untreated NI8-HASPB-GFP expressing CHO cells 
showed chromatin condensation after specific stain for DNA (fig. 22C/D). 
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Figure 22: HASPB-SH4-domain expressing 
cells showed PM blebbing but are not 
apoptotic. 
(A+B) SH4-blebbing cells showed no positive 
TUNEL signal. (A) CHO cells stably 
expressing N18-HASPB-GFP for 24 h were 
treated either with solvent or 200 µg/ml 
Etoposide (Eto) and 200 µg/ml Cycloheximide 
(Chx) for 12 h to induce apoptosis, fixed, 
subjected to TUNEL reaction and analyzed for 
apoptosis by confocal microscopy. Scale  
bars = 10 µm. (B) Percentage of blebbing and 
TUNEL positive cells depicted in A. Amounts 
of apoptotic cells following treatment with 
Eto/Chx was set to 100 % (arithmetic means of 
three independent experiments + SD with  
> 100/condition). (C-D) SH4 blebbing cells 
showed no chromatin condensation. (C) CHO 
cells stably expressing N18-HASPB-GFP for 24 
h were treated either with solvent or 4 % 
DMSO for 5 h to induce apoptosis, fixed, 
stained with Hoechst 33268 for chromatin and 
analyzed for apoptosis by confocal microscopy. 
Scale bars = 10 µm. (D) Percentage of blebbing 
and cells with condensed chromatin as depicted 
in C. Amounts of apoptotic cells following 
treatment with DMSO was set to 100 % 
(arithmetic means of three independent 
experiments + SD with > 100/condition). 
Finally, these cells were also negative for surface exposure of phosphatidyl serine (data not 
shown), which is externalized by cells in early stages of apoptosis presumably to attract 
phagocytotic cells (Fadok et al., 1992, Huerta et al., 2007). Thus, SH4-domain expressing cells 
were negative for apoptotic markers. In line with these findings, induction of PM blebbing by 
SH4-domains was also insensitive to treatment with zVAD-fmk (100 µM, 24 h, data not shown), 
a universal inhibitor for caspases. These regulatory proteases are activated during apoptosis 
where they play a central role in signaling events (Rupinder et al., 2007). 
Together, SH4-domain expressing cells showed PM blebbing but no detectable sign for 
enhanced apoptotic activity. 
8.1.6 SH4-Domain Mediated PM Blebbing is a Rho Regulated Process 
The above basal characterization of SH4-domain induced PM blebbing revealed a highly 
dynamic and structured process indicating an active control and regulation by intrinsic 
determinants. In eukaryotic cells, several basic processes such as cell polarity, adhesion and 
motility as well as membrane trafficking are regulated through the family of Rho-GTPases. By 
affecting the actin cytoskeleton, Rho-GTPases control the formation of cell protrusions like 
membrane ruffles, lamellipodia and filopodia which are important for cell motility (Ridley, 
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2006). They are also involved in F-actin dynamics that are critical for the formation of various 
types of PM blebs (Leverrier and Ridley, 2001, Sahai and Marshall, 2003, Verhoef et al., 2004). 
To determine the role of small Rho-GTPases in SH4-domain mediated PM blebbing, their 
intracellular localization was analyzed. Expression of GFP fusion proteins of the wild type (wt) 
GTPases RhoA, Rac1 and Cdc42 in CHO cells revealed their partial PM attachment without the 
induction of PM blebbing (data not shown). However, PM blebbing was induced by  
co-expression of N18-Yes-GFP with a wt GTPase fused to a Myc-tag. Confocal microscopy of 
fixed cells revealed significant amounts of RhoA as well as Rac1 in the limiting membrane but 
not the lumen of the blebs. In contrast, Cdc42 could only be detected in marginal amounts in 
some of the analyzed blebs. Thus, all tested Rho GTPases were incorporated into SH4-domain 
induced blebs albeit with different efficiency (fig. 23A).  
 
Figure 23: SH4-domain mediated PM blebbing was regulated by the Rho-GTPase Rho. 
(A) Rho-GTPases were incorporated into Yes-SH4-domain blebs with different efficiency. Confocal micrographs of 
fixed and stained CHO cells transiently co-expressing N18-Yes-GFP and a Rho-GTPase as indicated fused to a Myc 
tag. Scale bars = 10 µm. (B) Rho activity was required for HASPB-SH4-domain induced PM blebbing.  
N18-HASPB fused to mCherry and the indicated GTPase or TAT-C3 transferase fused to GFP were co-expressed in 
CHO cells and analyzed by live cell confocal microscopy. Shown is the percentage of cells displaying pronounced 
PM blebbing. (arithmetic means of at least three independent experiments + SD with > 100/condition; kindly 
provided by S. Tournaviti: B). 
To gain further insight into the cellular signal transduction pathway governing SH4-domain-
mediated PM blebbing, the HASPB-SH4-domain fused to the fluorescent mCherry protein  
(N18-HASPB-mCherry) was co-expressed with GFP fusion proteins of wt GTPases, dominant 
negative (N17) Rac1 or Cdc42, or Clostridium botulinum TAT-C3 transferase to inhibit the 
activity of RhoA, RhoB and RhoC, respectively (Sahai and Olson, 2006). Although all GTPases 
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localized in SH4-domain induced PM blebs, only TAT-C3-mediated inhibition of Rho 
significantly reduced bleb formation (fig. 23B). Even though no blebbing was observed,  
N18-HASPB-mCherry still localized at the PM in the presence of TAT-C3 (data not shown). 
This indicated that SH4-domains were targeted to the PM in a Rho independent manner but 
utilized a signaling cascade downstream of Rho to trigger PM blebbing.  
In summary, SH4-domain mediated PM blebbing but not targeting was shown to be exclusively 
regulated by the Rho-GTPase Rho, although RhoA, Rac1 as well as Cdc42 were present in these 
PM blebs. 
8.1.7 Signaling Events Downstream of Rho are Involved in SH4-Domain 
Induced PM Blebbing 
Since SH4-domain blebbing was regulated by the Rho-GTPase Rho, the regulation cascades 
downstream of this GTPase was analyzed in the following: Rho directly regulates the activity of 
the Rho effector kinase ROCK (Riento and Ridley, 2003). Active ROCK itself triggers the 
activity of its substrate the myosin II regulatory part MLC by direct phosphorylation as well as 
by phosphorylation mediated dissociation of MLCP. Myosin-activity then facilitates bundling of 
F-actin filaments and leads to contractility. For most types of PM blebbing it was shown that 
acto-myosin contractility is required for active bleb turnover (Leverrier and Ridley, 2001, 
Morelli et al., 2003, Sahai and Marshall, 2003). Consequently, the involvement of several steps 
of the Rho-ROCK pathway in SH4-domain mediated PM blebbing was investigated. Therefore, 
cells expressing N18-HASPB-GFP for 24 h were treated for 2 h with 90 µM (or 10 µM, data not 
shown) of the ROCK-specific inhibitor Y-27632 (Davies et al., 2000, Jacobs et al., 2006) and 
were analyzed for PM blebbing. Blocking ROCK activity potently interfered with SH4-mediated 
PM blebbing, whereas wash out and additional incubation for 3 h with medium effectively 
retrieved PM blebbing (fig. 24A/C). Hence, a 2 h pretreatment with Y-27632 was used in the 
following to strip already formed blebs in order to investigate the formation of new ones. 
Treatment with 100 µM Blebbistatin (BS), a drug specifically interfering with the ATPase 
activity of the myosin II motor protein (Allingham et al., 2005, Ramamurthy et al., 2004, 
Straight et al., 2003), efficiently blocked PM bleb formation, indicating a mechanistic role for 
myosin (fig. 24A/C). Myosins regulate the F-actin network for instance by facilitating bundling 
and contractility forces (Riento and Ridley, 2003). In fact, microscopical analysis demonstrated 
some enrichment of F-actin at the limiting membrane and in particular at the neck of SH4-
domain induced PM blebs (fig. 18Cb and 24A). Consistently, disruption of F-actin filaments by 
treatment of the cells with 1 µM Cytochalasin D (CytoD) potently interfered with their formation 
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(fig. 24A/C). A second element of the cytoskeleton is represented by microtubules. Similarly to 
the results obtained for F-actin, depolymerization of microtubules with 100 µM Nocodazole 
efficiently inhibited SH4-domain mediated PM blebbing (fig. 24B/C). 
 
Figure 24: Functionality of the Rho pathway as well as F-actin and microtubule integrity was required for 
SH4-domain mediated PM blebbing. 
(A) PM blebs were dependent on ROCK and myosin II activity as well as on an intact microfilament system. 
Confocal micrographs of CHO cells stably expressing N18-HASPB-GFP for 24 h were treated with Y-27632 for 2 h 
and subsequently with solvent or the indicated drugs for 3 h (90 µM Y27632, 1 µM Cytochalasin D, 100 µM 
Blebbistatin), fixed and stained for F-actin. Scale bars = 10 µm. (B) PM blebs were dependent on an intact 
microtubule architecture. Cells were treated and handled as described in A, but were treated with 100 µM 
Nocodazole and were additionally stained for α-tubulin. Scale bars = 10 µm. (C) Percentage of blebbing cells 
depicted in A and B (arithmetic means of at least three independent experiments + SD with > 100/condition). 
Concordantly, a specific stain of β-tubulin showed perinuclear enrichment and cytoplasmic 
distribution of the filaments, but no localization at SH4-domain induced PM blebs (fig. 24B).  
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Together, induction of PM blebs by the HASPB-SH4-domain depended on the integrity of both 
F-actin and microtubule networks and required ROCK activity as well as myosin II functionality. 
These results revealed a novel link between Rho-ROCK activity and SH4-domains. 
8.1.8 The Cortical Actin of SH4-Domain Induced PM Blebs is Enriched in 
Active MLC 
The cortical actin is enriched in myosin II and directly linked to different kinds of PM blebbing 
(Eisenmann et al., 2007, Huot et al., 1998, Mills et al., 1999). FLNa deficient M2 melanoma 
cells have a defect in F-actin filament cross linking. Therefore, local contractility of the acto-
myosin system leads to a local destablization of the cortical actin meshwork and results in bleb 
formation due to intracellular pressure (Charras et al., 2005). Furthermore, myosin activity is 
also required for bleb retraction in those cells (Charras et al., 2006). Thus, the role of FLNa and 
myosin was investigated in the following. First of all, the effect of SH4-domain expression on 
bulk protein levels of FLNa and its active and phosphorylated form FLNa (S2151) were evaluated 
(fig. 25). Lysates of HeLa cells which were either induced or not induced for expression of N18-
Yes-GFP, N18-Δmyr-Yes-GFP or N18-Δpal-Yes-GFP were separated by SDS-PAGE and 
analyzed by Western blotting. Following probing with specific antibodies, no differences in the 
amounts of FLNa or FLNa (S2151) were detected in any case. This indicated that SH4-domain 
mediated PM blebbing was not due to alterations in overall levels and activity of FLNa. 
Figure 25: Overall expression levels of 
FLNa were not changed upon  
SH4-domain expression. 
Expression of either N18-Yes-GFP,  
N18-Δmyr-Yes-GFP or N18-Δpal-Yes-GFP 
was induced (+) or not induced (-) in HeLa 
cells for 24 h. After lysis, equal amounts of 
total protein were separated by SDS-PAGE, 
subjected to Western blotting and probed 
with specific antibodies for total FLNa or 
pFLNa (S2151), for endogenous transferrin 
receptor (Tfr, loading control) and GFP 
(expression control), respectively.  
Besides FLNa, myosins also play a crucial role in cortical actin dynamics of M2 cells. These 
motor proteins are actin associated and directly facilitate contractility during cell motility and 
PM blebbing (Charras et al., 2006, Mills et al., 1998, Riento and Ridley, 2003). The necessity of 
active myosin and its regulatory kinase ROCK in SH4-domain mediated PM blebbing was 
shown in the previous chapter. To obtain further insight into the role of ROCK in this process, 
the intracellular localization of MLC and its active and phosphorylated form pMLC (S19) was 
Results 
 
  
 
76
investigated as an indicator for ROCK activity and localization. Confocal micrographs of CHO 
cells transiently expressing GFP, N18-Δmyr-Yes-GFP or N18-Yes-GFP showed a MLC and 
pMLC (S19) association to F-actin stress fibers as well as to the cortical actin (fig. 26). 
 
Figure 26: Total (MLC and active pMLC (S19) localized in and at the basis of Yes-SH4-domain blebs. 
(A+B) Confocal micrographs of fixed and stained CHO cells transiently expressing GFP, N18-Yes-Δmyr or  
N18-Yes-GFP, were fixed and stained for (A) endogenous MLC or (B) pMLC (S19). Scale bars = 10 µm. 
In blebbing cells, both, MLC and pMLC (S19) additionally localized at the basis and the outer 
rim of the blebs, whereas the lumen of some blebs was also enriched with pMLC (S19) (see 
arrows, fig. 26). 
Figure 27: Overall expression levels 
of myosin light chain (MLC) were not 
changed upon SH4-domain 
expression. 
Expression of either N18-HASPB-GFP, 
N18-Δmyr-HASPB-GFP or N18-Δpal-
HASPB-GFP was induced (+) or not 
induced (-) in CHO cells for 24 h. After 
lysis, equal amounts of total protein 
were separated by SDS-PAGE, 
subjected to Western blotting and 
probed with specific antibodies for total 
MLC or pMLC (S19), for endogenous 
transferrin receptor (Tfr, loading 
control) and GFP (expression control). 
This suggested a local ROCK activity at the site of PM blebbing. To further investigate this 
activity, bulk levels of MLC and pMLC (S19) were analyzed by western blot similar to FLNa and 
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pFLNa (S2151) as described above. However, neither a change in MLC nor in pMLC (S19) levels 
could be observed by induction of HASPB-SH4-domain expression in CHO cells (fig. 27). 
In conclusion, induction of PM blebbing by SH4-domains did not alter bulk levels of active 
MLC or FLNa. Nevertheless, active MLC localized in the cortical actin beyond blebs and was 
enriched in their lumen, indicating either a local activation or a recruitment of active ROCK to 
the site of PM blebbing. 
8.1.9 SH4-Domain Induced PM Blebbing Depends on Endogenous Src Activity 
Next, the contribution of endogenous Src kinases was investigated. Src kinases were shown to 
play a key role in regulation of several intracellular signaling pathways involved in cell division, 
differentiation, survival, adhesion, motility and vesicular trafficking (Thomas and Brugge, 1997). 
So far, a contribution of Src kinases in any kind of PM blebbing was not suggested. However, 
some of the SH4-domains used in this work are the PM anchors for Src kinases such as c-Src, 
Fyn, Lck and Yes. Therefore, a role of endogenous Src kinase activity in SH4-domain mediated 
PM blebbing was hypothesized. To remove already formed PM blebs, CHO cells expressing 
N18-HASPB-GFP or N18-Fyn-GFP were treated with 10 µM Y-27632 for 2 h. Their 
reappearance was analyzed in the presence of the two well established, structurally distinct and 
specific Src kinase inhibitors PP1 and SU6656 (Bishop et al., 1999, Blake et al., 2000). 
Treatment with both inhibitors at 1 µM already markedly reduced PM blebbing (fig. 28A/B).  
 
 
Figure 28: Induction of PM blebbing by SH4-domains required activity of endogenous Src kinases. 
(A+B) CHO cells stably expressing either (A) N18-HASPB-GFP or (B) N18-Fyn-GFP were treated with 10 µM  
Y-27632 for 2 h to remove already formed blebs, washed and treated with medium or the indicated Src kinase 
inhibitors (PP1, SU6656) for additional 3 h. Cells were fixed, stained for F-actin and evaluated for newly formed 
blebs (arithmetic means of three independent experiments + SD with > 100/condition). 
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When 10 µM inhibitor was used, blebbing inhibition was well within the range of that observed 
with addition of the ROCK inhibitor Y-27632. Similar results were obtained for the SH4-
domains of c-Src, Yes and Lck (data not shown).  
These results could be verified by usage of SYF -/- mouse fibroblastic cells that are deficient in 
the Src kinases c-Src, Yes and Fyn (Klinghoffer et al., 1999). In these cells expression of  
N18-Yes-GFP did not result in PM blebbing, whereas blebbing was readily observed in c-Src 
reconstituted SYF + c-Src cells (fig. 29A/B). 
 
 
Figure 29: Endogenous Src kinases were necessary for SH4-domain mediated induction of PM blebbing. 
(A) Confocal micrographs of either SYF -/- cells depleted for endogenous c-Src, Yes and Fyn (a-b) or SYF + c-Src 
cells reconstituted with c-Src (c-f) were transfected with GFP or N18-Yes-GFP and treated with solvent or the Src 
kinase inhibitor PP1 in the indicated amounts. Scale bars = 10 µm. (B) Percentage of blebbing cells depicted in A. 
Values for GFP transfected cells are shown in white bars, for N18-Yes-GFP cells in black bars (arithmetic means of 
three independent experiments + SD with > 100/condition).  
Since this rescue was sensitive to PP1 treatment, not only presence but also activity of the 
reconstituted c-Src was required. These results demonstrated that endogenous Src activity was 
involved in the induction of SH4-domain mediated PM blebbing. To test whether endogenous 
Src kinases were activated during induction of PM blebbing, bulk levels of c-Src and  
pc-Src (Y418) were analyzed by western blotting similar to FLNa and pFLNa (S2151) as described 
above (fig. 30). Neither a change in Src nor in pSrc (Y418) levels could be observed by induction 
of Yes-SH4-domain expression in HeLa cells. Note that varying signal intensities for c-Src in 
uninduced (-) and induced (+) N18-Yes-GFP cells were due to different amounts of loaded lysate 
as it is depicted in the loading control (TfR). 
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Figure 30: SH4-domains did not 
alter the overall activation levels of 
endogenous c-Src. 
Expression of either N18-Yes-GFP, 
N18-Δmyr-Yes-GFP or N18-Δpal-
Yes-GFP was induced (+) or not 
induced (-) in HeLa cells for 24 h. 
After lysis, equal amounts of total 
protein were separated by SDS-
PAGE, subjected to Western blotting 
and probed with specific antibodies 
for total c-Src or pc-Src (Y418), for 
endogenous transferrin receptor (Tfr, 
loading control) and GFP (expression 
control), respectively.  
 
Nevertheless, analysis of the distribution of endogenous c-Src in CHO cells transiently 
expressing N18-Yes-GFP revealed a modest but significant localization of the kinase in the 
membrane of PM blebs (fig. 31A). No significant relocalization was observed upon expression 
of SH4-domains, suggesting that Src incorporation into blebs may reflect its genuine partial PM 
localization. This included the lack of displacement of c-Src from the PM upon SH4-domain 
over-expression which indicated that the expressed SH4-domain did not saturate PM docking 
sites of endogenous c-Src. In contrast and in line with the inhibitory effects on bleb formation of 
the Src inhibitors PP1 and SU6656, active pc-Src (Y418) accumulated in the lumen of  
N18-Yes-GFP mediated blebs similarly to active pMLC (S19) (fig. 26B and 31B). 
 
Figure 31: Active pc-Src (Y418), but not total Src accumulated in Yes-SH4-domain blebs. 
Confocal micrographs of fixed and stained CHO cells transiently expressing GFP, N18-Yes-Δmyr or N18-Yes-GFP, 
respectively, were fixed and stained for (A) endogenous Src or (B) pc-Src (Y418). Scale bars = 10µm. 
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In summary, induction of PM blebbing by SH4-domains required the activity of endogenous Src 
kinases, although overall c-Src activation was not increased. Nevertheless, active c-Src was 
enriched in SH4-domain induced PM blebs suggesting a recruitment of active c-Src or a local 
activation of the kinase. 
This initial characterization of SH4-domain PM blebbing is summarized in a manuscript 
(Tournaviti et al., in press) that was accepted for publishing during preparation of this thesis. 
8.1.10 SH4-Domains Mediate Uptake of Dextran 
Under physiological conditions, there are several situations in which PM blebbing is involved: 
As already discussed, during apoptosis PM blebbing is thought to support DNA fragmentation 
and initiation of immune responses (Fadeel, 2004, Martinez et al., 2005). However, in this work 
it could be demonstrated that SH4-domain expressing cells were not apoptotic. Furthermore, PM 
blebbing also occurs during secretion of different proteins such as IL-1β and galectin 3 
(MacKenzie et al., 2001, Mehul and Hughes, 1997). Interestingly, the surface coat protein 
HASPB of the Leishmania parasite was shown to be secreted by mammalian cells (Denny et al., 
2000, Stegmayer et al., 2005). Nevertheless, vesicle shedding from the surface was not observed 
for cells expressing the HASPB-SH4-domain. Additionally, block of PM blebbing by treatment 
of the cells with the ROCK inhibitor Y-27632 did not inhibit release of GFP fused to the 
HASPB-SH4-domain (C. Stegmayer, personal communication). However, PM blebbing was also 
observed during particle-uptake as well: Simultaneously to their own entry, Vaccinia viruses 
induce PM blebbing nearby the entry site (A. Helenius and J. Mercer: 58. Mosbacher 
Kolloquium 2007). Similarly, during clathrin-mediated endocytosis of Adenoviruses, they 
induce PM ruffling nearby the entry site in parallel which is correlated to enhanced 
macropinocytosis (Meier et al., 2002, Meier and Greber, 2003). Both PM blebbing and 
endocytosis are processes that bear PM dynamization. In general, endocytosis describes a 
cellular process for specific or non-specific uptake of fluids, molecules or particles and is 
characteristic for all eukaryotic cells. One has to distinguish between several types of different 
endocytotic mechanisms that sometimes are cell type specific as well as stimulus dependent 
(Marsh and Helenius, 2006, Nichols and Lippincott-Schwartz, 2001). Clathrin independent 
macropinocytosis in particular allows actin-dependent, nonselective uptake of solute 
macromolecules from the fluid phase of the extra cellular milieu. During macropinocytosis large 
(> 1µm in diameter) vesicles of irregular size, called macropinosomes are developed on the cell 
surface presumably by merge of PM ruffles (Cardelli, 2001, Meier and Greber, 2003, Swanson 
and Watts, 1995). Their formation and trafficking depends on Src kinase activity (Kasahara et 
Results 
 
  
 
81
al., 2007). Hence, the possible correlation between SH4-domain induced PM blebbing and 
macropinocytotic uptake was investigated. 
Initially, the basal capacity of CHO cells for internalization of fluorescently labeled dextran  
(10 to 70 kDa) was analyzed. Fluorescence microscopy of CHO-GFP cells revealed incorporated 
dextran in a cytoplasmic distribution as well as localization in bright intracellular spots after  
60 min (fig. 32A). This basal dextran-uptake was confirmed by FACS-analysis with Alexa 
Fluor-647 labeled dextran: After gating for the living cells in the SSC/FSC channel (fig. 32Ba), 
dot plots of GFP expressing cells showed a certain level of internalized dextran. Comparison of 
the mean fluorescence intensities (MFIs) of high (gate R4: MFI = 1078), low (gate R3:  
MFI = 622) or no (gate R2: MFI = 780) GFP expressing cells demonstrated that the uptake 
ability was uncoupled from GFP expression or if any, slightly reduced, indicating no effect for 
GFP itself. Consistent with this, internalization could be similarly blocked for cells of all 
expression levels by treatment with 100 µM 5-(N-ethyl-N-isopropyl)-amiloride (EIPA), a 
specific inhibitor for macropinocytosis (R3: 5.5 fold reduction; fig. 32Bb). In contrast, addition 
of a macropinocytosis stimulatory drug like phorbol myristate acetate (PMA, 200 nM), increased 
internalization for all expression levels by 1.9 fold (fig. 32Bb). Again, this enhanced uptake was 
sensitive to treatment with EIPA (data not shown). These results indicated that CHO cells 
themselves were able to perform macropinocytotic uptake of dextran. Next, the impact of SH4-
domains on this internalization was investigated. CHO cells expressing N18-HASPB-GFP were 
analyzed by confocal microscopy. Interestingly, they showed a similar distribution of 
internalized dextran compared to GFP expressing cells (fig. 32C). Dextran also localized inside 
the lumen of PM blebs. Bleb specific accumulation of dextran in earlier time points representing 
bleb specific uptake, however, was not observed (fig. 32C and data not shown). Thus, a direct 
correlation of PM blebbing with dextran-uptake could not be verified by this method. 
Nevertheless, in order to investigate a possible effect of SH4-domains on dextran-uptake, a 
FACS analysis was performed for N18-HASPB-GFP expressing cells: The uptake-capacity for 
cells with no (gate R2: MFI = 857) or low (gate R3: MFI = 845) N18-HASPB-GFP expression 
was similar to GFP expressing cells (fig. 32Bd). In contrast, cells with high expression levels 
(gate R4: MFI = 1337) showed a specific increase in dextran-uptake. Quantification of the MFIs 
resulted in a 2.0-fold increased dextran internalization compared to GFP expressing cells  
(fig. 32B/D). 
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Figure 32: Uptake of dextran into CHO cells was increased upon expression of the HASPB-SH4-domain. 
(A) CHO cells were capable of dextran-uptake. CHO cells stably expressing GFP were treated with TMR labeled 
dextran (70 kDa) for up to 180 min, fixed, and subjected to fluorescence microscopy. Scale bars = 10 µm.  
(B) HASPB-SH4-domains increased the ability for dextran-uptake. CHO cells stably expressing either GFP (a-b) or 
N18-HASPB-GFP (c-d) were treated with Alexa Fluor-647 labeled dextran (10 kDa) in the presence of the indicated 
macropinocytosis stimulatory (200 nM PMA) or inhibitory drugs (100 µM EIPA) for 180 min, washed with PBS 
and washing buffer (pH 5.5) and subjected to FACS analysis. Dot plots show side scatter (SSC) signals and forward 
scatter (FSC) signals of all cells (a+c) as well as signals obtained for internalized fluorescently labeled dextran and 
expressed GFP of gated living cells (b+d). Gates were set for non- (R2), low- (R3) and high- (R4) expressing cells 
and corresponding mean fluorescence intensities (MFIs) were indicated. (C) Dextran diffusely localized in the 
cytoplasm and in HASPB-SH4-domain blebs as well as in intracellular vesicle like structures. CHO cells stably 
expressing N18-HASPB-GFP for 24 h were treated as described in A but analyzed by confocal microscopy. Scale 
bars = 10 µm. (D) Relative mean values of cells gated for high expression levels (R4) as depicted in B (ratio of 
R4/(R2 of medium treated cells)) and fold differences. 
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Since two lasers were used for measurement, an artifact due to less compensation can be ruled 
out. Similar results were obtained with N18-Src-GFP and N18-Fyn-GFP (data not shown). 
Moreover, treatment with PMA enhanced (R3: 1.8 fold) and EIPA reduced (R3: 2.5 fold 
reduction) dextran-uptake for all expression levels. However, compared to GFP expressing cells, 
dextran-internalization of high N18-HASPB-GFP expressing cells was 4.8-fold increased in 
EIPA, but only 2.1-fold in PMA treated cells. This indicated that the SH4-domain mediated 
effect on dextran-uptake was not solely related to macropinocytosis (fig. 32B/D). To investigate 
whether other internalization pathways were involved as well, clathrin-dependent endocytosis 
was tested with fluorescently labeled transferrin analyzed by FACS (fig. 33A/B).  
 
 
Figure 33: The HASPB-SH4-domain had no influence on transferrin-uptake. 
(A) CHO cells stably expressing either GFP (a-b) or N18-HASPB-GFP (c-d) were treated with TMR labeled 
transferrin in the presence of the indicated drugs (200 nM PMA; 100 µM EIPA) for 180 min, washed with PBS and 
washing buffer (pH 5.5) and subjected to FACS analysis. Dot plots show side scatter (SSC) signals and forward 
scatter (FSC) signals of all cells (a+c) as well as signals obtained for internalized fluorescently labeled transferrin 
and expressed GFP of gated living cells (b+d). Gates were set for non- (R2), low- (R3) and high- (R4) expressing 
cells and corresponding MFIs were indicated. (B) Relative mean values of cells gated for high expression levels 
(R4) as depicted in C (ratio of R4/(R2 of medium treated cells)). 
In a control experiment uptake of transferrin was neither stimulated by PMA nor inhibited by 
EIPA in CHO-GFP cells. Furthermore, expression of N18-HASPB-GFP did not alter transferrin-
internalization at any expression level.  
As shown in the previous part, expression of SH4-domains induced PM blebbing, but expression 
of non acetylated mutants that were deficient in PM targeting did not. To check whether PM 
blebbing is the driving force for increased dextran internalization the effect of the non-blebbing 
mutants N18-Δmyr-HASPB-GFP and N18-Δpal-HASPB-GFP were investigated. Fluorescence 
microscopy showed a reduced capacity of dextran-uptake for these mutants comparable to GFP 
expressing cells (fig. 34A). 
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Figure 34: Uptake of dextran was reduced in HASPB-SH4-domain mutants not capable of PM blebbing 
induction. 
(A) CHO cells stably expressing either GFP, N18-HASPB-GFP, N18-Δmyr-HASPB-GFP or  
N18-Δpal-HASPB-GFP for 24 h were treated with Alexa Fluor-568 labeled dextran (70 kDa) for up to 180 min, 
fixed, and subjected to fluorescence microscopy. Scale bars = 10 µm. (B) FACS analysis of CHO cells stably 
expressing either GFP, N18-HASPB-GFP, N18-Δmyr-HASPB-GFP or N18-Δpal-HASPB-GFP for 24 h. Cells were 
treated with Alexa Fluor-647 labeled dextran (10 kDa) for 180 min, washed with PBS and washing buffer (pH 5.5) 
and subjected to FACS analysis. Depicted are the relative mean values of cells gated for high expression levels (R4) 
(ratio of R4/R2; statistical analysis by Student's t-test: GFP to N18-HASPB-GFP: p = 0.016; N18-HASPB-GFP to 
N18-Δmyr-HASPB-GFP: p = 0.076; N18-HASPB-GFP to N18-Δpal-HASPB-GFP: p = 0.338). 
This was confirmed by FACS analysis which shows an intermediate uptake capacity in CHO 
cells compared to GFP or N18-HASPB-GFP (fig. 34B). However, calculation of p-values by 
Sudent's t-test revealed no statistically significance (GFP to N18-HASPB-GFP: p = 0.016;  
N18-HASPB-GFP to N18-Δmyr-HASPB-GFP: p = 0.076; N18-HASPB-GFP to  
N18-Δpal-HASPB-GFP: p = 0.338) and indicated that PM blebbing and dextran-uptake could 
not be directly correlated. 
Together, SH4-domains had the capacity to induce dextran-uptake by a clathrin-independent 
pathway that was not related to macropinocytosis. Furthermore, this effect on internalization 
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could not be directly correlated with their competence to induce PM blebbing indicating that 
other mechanisms might be involved. 
8.1.11 N18-HASPB Mediated PM Blebbing Does not Alter Wound Healing 
Motility 
PM blebbing on motile cells has long been described for cells during embryonic development 
and cells located at the leading edge of cellular sheets (Dipasquale, 1975, Trinkaus, 1973). To 
investigate whether SH4-domains had an influence on motility on planar surfaces, a wound 
healing assay was performed. Therefore, a confluent layer of CHO cells was scratched with a 
pipette tip to yield a wound of approx. 200-300 µm (fig. 35A). 
 
Figure 35: The SH4-domain of HASPB did not influence wound healing motility. 
(A+B) The wound closure time was not altered in HASPB-SH4-domain expressing cells. (A) Representative images 
of a wound healing assay performed with GFP expressing CHO cells. A confluent cell layer was wounded and 
subsequently monitored by microscopy over time (24 h, 1 picture/30 min). Scale bars = 100 µm. (B) Quantification 
of wound closure time. Wound sizes of layers of cells expressing either GFP, N18-HASPB-GFP or  
N18-Δmyr-HASPB-GFP were measured with "ImageJ" software. Values are the arithmetic means of at least three 
wounds per condition + SD. 
Cell migration was monitored for 24 h by a frequency of 1 picture/30 min and the distances were 
measured using ImageJ software (fig. 35B). Compared to GFP expressing cells, expression of 
blebbing N18-HASPB-GFP or not blebbing N18-Δmyr-HASPB-GFP had no influence on wound 
closure time. 
Neither a function of SH4-domain mediated PM blebbing nor an intrinsic effect of SH4-domains 
on wound closure was detectable. 
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8.1.12 SH4-Domain Induced PM Blebbing Correlates with Enhanced Cell 
Invasion in 3D Matrices 
Another form of bleb related cell motility occurs in tumor cells during the amoeboid mode of 
invasion into 3D environments like tissues or 3D matrices that consist of ECM proteins. (Sahai 
and Marshall, 2003, Wolf et al., 2003, Wyckoff et al., 2006). This amoeboid or rounded mode of 
invasion depends on the active generation of PM blebs by F-actin polymerization and is clearly 
distinct from the mesenchymal or elongated mode of invasion that is related to motility on planar 
surfaces, but depends on secretion of metalloproteases to disrupt the surrounding ECM. 
Interestingly, both invasion modes are stimulated by internalization of external signal peptides 
and growth factors (Sahai, 2005, Yamazaki et al., 2005). To test the functional consequences of 
SH4-domain mediated PM blebbing on cell motility in 3D matrices a well-established matrigel 
transwell assay was used (Hooper et al., 2006). Serum starved CHO-cells were seeded on top of 
undiluted growth factor reduced matrigel placed inside a transwell insert (pore size 8 µm). After 
48 h incubation in a gradient of FCS (0.5–10 %) the percentage of cells that invaded the matrigel 
and crossed the transwell membrane was determined (fig. 14). Following induction of transgene 
expression, N18-HASPB-GFP (+ dox) cells migrated significantly faster in 3D than control cells 
expressing GFP (p = 0.019; Student's t-test) or N18-Δmyr-HASPB-GFP (p = 0.03; fig. 36A).  
 
Figure 36: HASPB-SH4-domain induced PM blebbing correlated with enhanced 3D motility. 
(A) Invasiveness of CHO cells was increased by expression of the bleb inducing SH4-domain of HASPB. Either 
serum starved CHO cells induced (+ dox) or not induced (- dox) for expression of GFP (+), N18-HASPB-GFP (+/-), 
N18-Δmyr-HASPB-GFP (+) or N18-Δpal-HASPB-GFP (+) or serum starved MDA-MB-435 breast cancer cells 
serving as positive control were assessed for cell migration across undiluted growth factor reduced matrigel coated 
transwells (pore size 8 µm) for 48 hours along a gradient of FCS (0.5-10 %). Invasiveness is given in relation to 
GFP expressing cells. Values are the arithmetic means of three independent experiments performed as duplicates 
with the indicated S.E.M. Statistical significance was evaluated by Student’s t-test (relative to N18-HASPB-GFP 
(+): GFP p = 0.019, N18-Δmyr-HASPB p = 0.03, N18-HASPB-GFP (-) p = 0.14; relative to GFP:  
N18-HASPB-GFP (-) p = 0.12, N18-Δpal-HASPB p = 0.001). (B) HASPB-SH4-domain expressing cells showed 
PM blebbing in 3D matrices. 3D reconstruction of confocal stacks of serum starved CHO cells co-expressing actin-
mRFP and GFP or N18-HASPB-GFP. Cells were seeded in 50 % growth factor reduced matrigel and migrated for 
24 h along a gradient of FCS (0.5-10 %). Scale bars = 10 µm (with the help of T. Kitzing). 
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The invasiveness of N18-HASPB-GFP cells closely matched that of metastatic MDA-MB-435 
human breast carcinoma cells that served as positive control. Uninduced N18-HASPB-GFP  
(- dox) cells showed intermediate invasiveness and could not statistically be separated from 
induced N18-HASPB-GFP cells (+ dox; p = 0.14; Student's t-test) or GFP expressing cells  
(p = 0.12). This might be due to a leakiness of the expression system without dox resulting in 
low background levels of N18-HASPB-GFP expression (fig. 16). Nevertheless, N18-Δpal-
HASPB-GFP also significantly increased 3D motility compared to GFP cells (p = 0.001). 
Interestingly, most of N18-HASPB-GFP expressing cells seeded for 24 h in 50 % matrigel 
showed a blebbing morphology as well as filopodia surface structures. In contrast, CHO-GFP 
cells only revealed some filopodia like structures in 3D (fig. 36B). 
These results indicated that SH4-domain induced PM blebbing correlated with induction of cell 
invasion. However, the non-blebbing variant N18-Δpal-HASPB-GFP also induced 3D invasion 
even though fewer cells were affected. Thus it is not clear, whether enhanced invasiveness is 
directly linked to SH4-domain induced PM blebbing or whether the SH4-domains had other 
effects on cellular signaling events. Interestingly, both invasion and PM blebbing of tumor cells 
in 3D matrices were shown to be related to ROCK activity (Sahai and Marshall, 2003) and were 
recently linked to the presence of Drfs (Kitzing et al., 2007). 
 
8.2 The Role of the Drf FHOD1 in PM Blebbing 
In this work it was shown that SH4-domain mediated PM blebbing depended on several cellular 
determinants: Src and Rho are regulatory proteins, but also effector proteins like ROCK and 
myosin were necessary as well as the microfilament and the microtubule systems. A family of 
proteins that is capable of organizing the cytoskeleton are the formins and in particular the Drfs. 
As a surprising result of this study, the Drf FHOD1 was identified in knockdown experiments to 
be involved in SH4-domain related blebbing (see chapter 8.2.6). Therefore, a detailed analysis of 
its contribution to PM blebbing in combination with a further characterization of the Drf is 
addressed in the subsequent chapters. 
8.2.1 FHOD1 Specifically Interacts with ROCK1 
Drfs are thought to be partially regulated by Rho-GTPases. Even though Rac1 and not Rho have 
been identified to interact with FHOD1 (Westendorf, 2001), expression of the C-terminal 
truncated and therefore constitutively active form of FHOD1 (FHOD1-ΔC) causes F-actin cable 
formation in a ROCK dependent manner (Gasteier et al., 2003). Thus, to investigate a direct 
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binding of FHOD1 and ROCK proteins, a Yeast-two-hybrid screen was performed by J. Bouchet 
(group of S. Benichou, Institut Cochin, Paris). Therefore, mutants of FHOD1 as bait (LexA) and 
mutants of ROCK1 or ROCK2 as prey (Gal4AD), respectively, were expressed in the L40 yeast 
strain which was analyzed for histidine auxotrophy as readout for a direct interaction (fig. 37).  
 
Figure 37: FHOD1 specifically interacted with ROCK1, but not with ROCK 2. 
(A) Scheme of the employed constructs. Depicted are described domains and features of the protein. Residues are 
highlighted by their position-number. (B) FHOD1 interacted with ROCK1, but not with ROCK2. Yeast-two-hybrid 
screens in the L40 yeast strain expressing the indicated pairs of FHOD1 and ROCK constructs fused to LexA (left 
column) or Gal4AD (right column) were analyzed for histidine auxotrophy and β-gal activity. Double transformants 
were patched on selective medium with histidine (+His) and were replica plated on medium without histidine (-His) 
and on Whatman filters for subsequent β-gal assays. Growth in the absence of histidine and expression of β-gal 
activity indicated interaction between hybrid proteins. The specificity of the binding was verified by the absence of 
respective reporter gene activation in cells expressing LexA-FHOD1 in combination with the Gal4AD-Raf hybrid. 
(C) Parts of the FH2 domain of FHOD1 are important for its interaction with ROCK1. Shown is a Yeast to hybrid 
analysis as described in B but with different FHOD1 constructs for mapping its interaction to ROCK1 (kindly 
provided by J. Bouchet, group of S. Benichou, Institut Cochin, Paris). 
Interestingly, FHOD1 was found to interact with full length ROCK1 as well as with a mutant 
consisting of the region located downstream its kinase domain (residues 368-1357), but not with 
its homolog ROCK2 (fig. 37B and data not shown).  
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Figure 38: FHOD1 directly interacted with ROCK1. 
(A-C) Direct interaction of FHOD1 and ROCK1. Lysates (Input) from COS cells expressing the indicated HA 
tagged FHOD1 (wt: 1-1164; Δ4: 486-1068; Δ5: 570-1068; ΔC: 1-1010, see also fig. 37) and Myc tagged ROCK1 
constructs were subjected to immunoprecipitation (IP) with an anti-Myc antibody. Cell lysates and 
immunoprecipitates were separated by SDS–PAGE and analyzed by Western blotting with either anti-HA or  
anti-Myc antibodies. (A) IP of ROCK1-wt. (B) IP of ROCK1-Δ3 (1-727). (C) IP of empty vector. (D) FHOD1s FH1 
and FH2 domains were not required for direct interaction with ROCK1. IP performed as described in A but with the 
indicated HA tagged constructs of FHOD1 (wt: 1-1164; ΔFH1 = Δ570-611; ΔFH2 = Δ807-866) and Myc tagged 
ROCK1-wt (kindly provided by R. Madrid, group of S. Benichou, Institut Cochin, Paris). 
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Further mapping also showed a potent binding for the C-terminal truncated mutant FHOD1-ΔC 
to ROCK1 and roughly narrowed the interacting region down to FHOD1s amino acid residues 
611 to 807 (fig. 37C), located in the supposed N-terminal region of its FH2 domain (Schonichen 
et al., 2006). The FHOD1-ROCK1 interaction was confirmed by co-immunoprecipitation (co-IP) 
experiments that were performed by R. Madrid (group of S. Benichou, Institut Cochin, Paris). 
An IP of either Myc-ROCK1-wt or a C-terminally truncated version Myc-ROCK1-Δ3 (1-727) 
that was shown to induce stress fiber and F-actin star formation (Ishizaki et al., 1997) expressed 
in COS cells co-precipitated co-expressed HA-FHOD1-wt, whereas a control with empty vector 
did not (fig. 38A-C). This narrowed the interaction site of ROCK1 down to amino acid residues 
368-727. However, co-precipitation of HA-FHOD1-ΔC was not observed by ROCK1-wt, but in 
some experiments by ROCK1-Δ3 (fig. 38A-C and data not shown). Additionally,  
Myc-ROCK1-wt and Myc-ROCK1-Δ3 also co-precipitated mutants of HA-FHOD1 either 
including the FH1 and FH2 domains (FHOD1-Δ4, 486-1068; FHOD1-Δ5, 570-1068) or lacking 
its FH1 domain (ΔFH1 = Δ570-611) or parts of its FH2 domain (ΔFH2 = Δ807-866), 
respectively (fig. 38A-D and data not shown). Presumably due to stability problems, transient 
expression of HA-FHOD1-1-611 in NIH3T3 or HeLa cells was not successful.  
Together, FHOD1 specifically interacted with ROCK1 but not ROCK2. An interaction site could 
be roughly mapped to residues 368-727 in ROCK1 and 612-806 in FHOD1. 
8.2.2 FHOD1 Increased ROCK1 Induced Non-Apoptotic PM Blebbing 
It has previously been shown, that constitutively active FHOD1-ΔC induced the formation of 
stress fibers and F-actin bundles that were decorated by the Drf, whereas expression of FHOD1 
had no detectable effect on the cells appearance and the Drfs localization (Gasteier et al., 2003). 
Since FHOD1 specifically bound to ROCK1 in vitro this interaction might have an in vivo 
consequence for the cell as well as for FHOD1s localization. Therefore, expression plasmids 
encoding HA tagged FHOD1 and Myc tagged ROCK1 were co-transfected in HeLa cells for  
24 h. After fixation and stain for F-actin and the over-expressed proteins the cells were analyzed 
by fluorescence or confocal microscopy. About 62 % of solely ROCK1 expressing cells showed 
PM blebbing as it has been published before (Coleman et al., 2001, Sebbagh et al., 2001). The 
PM blebs revealed a pronounced F-actin localization at the basis as well at the outer rim. 
ROCK1 was similarly distributed and was furthermore found in the lumen of some blebs  
(fig. 39Ab-e/B).  
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Figure 39: FHOD1 enhanced ROCK1 induced PM blebbing. 
(A-B) FHOD1 increased the number of blebbing cells induced by ROCK1. (A) HeLa cells were transfected with the 
indicated Myc tagged ROCK1 and HA tagged FHOD1 constructs, fixed, stained for F-actin and the transiently 
expressed proteins and analyzed by fluorescence (a/f/k) or confocal microscopy (b-e/g-j/l-o). (B) Percentage of 
transfected cells revealing PM blebbing as described in A (arithmetic means of at least three independent 
experiments + SD with > 100/condition). Values for ROCK1 alone and ROCK1/FHOD1 together were statistically 
different (p = 0,00018, Student's t-test). (C-D) FHOD1 induced PM blebs are (C) reduced in size but (D) increased 
in number. Size and number of blebs on HeLa cells quantified in B were estimated (less than 3.5 µm or more than 
12 blebs/cell; arithmetic means of at least three independent experiments + SD with > 100/condition). 
Surprisingly, nearly all cells (93 %) that were positive for ROCK1 and FHOD1 also showed PM 
blebbing demonstrating a significant increase in PM blebbing induction (p = 0.00018, Student's 
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t-test, fig. 39Ak-o/B), whereas expression of FHOD1 or vector alone did not induce PM blebbing 
(9-13 % blebbing cells, fig. 39Af-j/B). In contrast to the ROCK1 distribution, most of these PM 
blebs were enriched with FHOD1 and F-actin (fig. 39Al-n). They were very similar to SH4-
domain induced PM blebs (see chapter 8.1): In average, most of the cells showed more than  
12 blebs per cell (approx. 75 % compared to 40 % of ROCK1 expressing cells, fig. 39D) and the 
size of an individual PM bleb tended to be smaller than 3.5 µm in diameter (approx. 75 % 
compared to 50 % in ROCK1 expressing cells, fig. 39C).  
Interestingly, this FHOD1 mediated increase in PM blebbing depended on a functional FHOD1 
protein: Co-expression of ROCK1 in combination with FHOD1 mutants that either lack their 
FH1-domain (FHOD1-ΔFH1) or their FH2-domain (FHOD1-ΔFH2) did not increase PM 
blebbing like the wt FHOD1 protein (fig. 40). Since these mutants lost their nucleation ability 
(Gasteier et al., 2003), they served as a proper negative control and also indicated that F-actin 
polymerization was involved in PM blebbing.  
 
Figure 40: FHOD1 required a functional FH1 and FH2 domain as well as additional residues for efficient 
enhancement of PM blebbing. 
HeLa cells were transfected with the indicated constructs of FHOD1 (wt, ΔFH1, ΔFH2, Δ4, Δ5 and ΔC see also  
fig. 37) and ROCK1. After 24 h, cells were fixed, stained for transiently expressed proteins and F-actin and analyzed 
by fluorescence microscopy. Depicted are the percentages of blebbing cells (arithmetic means of at least three 
independent experiments + SD with > 100/condition). As calculated by Student's t-test only values for 
ROCK1/FHOD1-Δ4 were statistical different to values of ROCK1 (p = 0.0008) and ROCK1/FHOD1-wt  
(p = 0.00019). 
However, this increase in PM blebbing was also blocked with the constitutively active  
FHOD1-ΔC that still potently induced stress fiber formation, what might have influenced the 
bleb phenotype (fig. 40 and data not shown). A similar result was obtained for FHOD1-Δ5, 
which also did not enhanced bleb formation, although it bound to ROCK1, possessed the FH1 
and FH2 domain and did not induce F-actin stress fibers (fig. 40 and data not shown). In 
contrast, FHOD1-Δ4 increased ROCK1 mediated PM blebbing to intermediate levels of approx. 
73 % that were statistically different as calculated by Student's t-test to values obtained by 
ROCK1 alone (56 %, p = 0.0008) or by ROCK1/FHOD1-wt co-expression (93 %, p = 0.00019; 
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fig. 40). This indicated that parts of the Rac1 binding region that localized between FHOD1s 
residue 486 and its FH1-domain (Gasteier et al., 2003, Westendorf, 2001) were involved in PM 
blebbing. This region either contributed to ROCK1 association by stabilization of the protein 
fragment or it was required for activation of ROCK1 or FHOD1, respectively. 
During apoptosis, ROCK1 is directly involved in PM blebbing due to its caspase-3 mediated 
cleavage and therefore constitutive activation. Anyway, neither expression of ROCK1 nor its  
C-terminally truncated version (ROCK1-G1114opa or ROCK1-Δ1) are capable to induce 
apoptosis on their own (Coleman et al., 2001, Sebbagh et al., 2001). To test whether this held 
true for ROCK1/FHOD1 induced PM blebbing as well, cells were analyzed for apoptosis either 
by stain with Hoechst 33268 for chromatin fragmentation (fig. 41A) or with fluorescently 
labeled Annexin V for visualization of externalized phosphatidyl serine (PS, fig. 41B-C).  
 
Figure 41: FHOD1 enhanced PM blebbing was not related to apoptosis. 
(A-C) FHOD1 and ROCK1 co-expressing cells were not apoptotic. (A) HeLa cells were transiently co-transfected 
with plasmids encoding FHOD1 and ROCK1. Following growth for 24 h they were treated for 3 h either with 
solvent or TNFα/Chx (50 µg/ml and 5 µg/ml) for induction of apoptosis, fixed, stained for the transiently expressed 
proteins, F-actin and chromatin (Hoechst 33268) and analyzed by confocal microscopy. FHOD1 and ROCK1  
co-expressing cells are highlighted (*), scale bars = 10 µm. (B) HeLa cells were similarly treated as described in A, 
but were stained for externalized phosphatidyl serine (PS) by Alexa Fluor-568 labeled Annexin V first, than fixed, 
stained for the transiently expressed proteins and F-actin and finally analyzed by fluorescence microscopy. FHOD1 
and ROCK1 co-expressing cells are highlighted (*), scale bars = 10 µm. (C) Percentage of blebbing and PS positive 
HeLa cells treated and handled as described in B (arithmetic means of at least three independent experiments + SD 
with > 100/condition). (D) PM blebbing induced by FHOD1 and ROCK1 was not reduced by inhibition of 
apoptosis. HeLa cells were transiently co-transfected with plasmids encoding FHOD1 and ROCK1. Following 
growth in the presence of zVAD-fmk (100 µM) cells were fixed, stained for the transiently expressed proteins and 
F-actin and were analyzed by fluorescence microscopy. Depicted is the percentage of blebbing cells (arithmetic 
means of three independent experiments + SD with > 100/condition). 
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Although induction of apoptosis with TNFα (50 µg/ml) and Cycloheximide (Chx, 5 µg/ml for  
3 h) was still possible in ROCK1/FHOD1 expressing HeLa cells, they showed no increased 
apoptotic behavior without apoptosis induction like the SH4-domain expressing cells (fig. 41A-C 
and data not shown). Furthermore, treatment of these cells with the apoptosis inhibitory drug 
zVAD-fmk (100 µM for 24h) did not reduce the amount of PM blebbing cells (fig. 41D).  
Thus, FHOD1 increased ROCK1s capability to induce non apoptotic PM blebbing suggesting 
positive contribution of FHOD1. Therefore, FHOD1s F-actin nucleation ability was required as 
well as parts of its Rac1 binding region. These results supported the hypothesis of interplay 
between ROCK1 and FHOD1 (Gasteier et al., 2003). 
8.2.3 Regulation of FHOD1/ROCK1 PM Blebbing Depends on Rho Signaling 
To obtain a more detailed picture of the signaling pathway that controls FHOD1/ROCK1 
stimulated PM blebbing, the activity requirements of different Rho-GTPases were analyzed 
analogous to SH4-domain induced PM-blebbing (see chapter 8.1.6). Therefore FHOD1 was  
co-expressed in combination with ROCK1 and a GFP fusion protein of either dominant negative 
Rac1 (Rac1-N17) or Cdc42 (Cdc42-N17) or the Clostridium botulinum TAT-C3 transferase for 
inactivation of the Rho-pathway, respectively.  
Figure 42: Rho activity was 
required for FHOD1 enhanced 
PM blebbing. 
(A) HeLa cells were co-transfected 
with expression plasmids of ROCK1 
and FHOD1 together with 
expression plasmids of either GFP 
or dominant negative forms of 
GTPases (Rac1-N17, Cdc42-N17) 
fused to GFP or GFP tagged  
TAT-C3 transferase from 
Clostridium botulinum for inhibition 
of Rho activity. After 24 h cells 
were fixed, stained for transiently 
expressed proteins and F-actin and 
analyzed for PM blebbing by 
confocal microscopy. Triple 
transfected cells are highlighted (*), 
scale bars = 10 µm. (B) Percentages 
of blebbing HeLa cells treated and 
processed as described in A (black 
bars: ROCK1; dark grey bars: 
ROCK1 and FHOD1; light grey 
bars: FHOD1; white bars: empty 
vector; (arithmetic means of at least 
three independent experiments + SD 
with > 100/condition). 
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Comparable to SH4-domain induced PM blebs, only inhibition of Rho activity significantly 
decreased the amount of blebbing HeLa cells to background levels obtained in parallel with GFP. 
In fact, neither expression of ROCK1 alone nor together with FHOD1 induced PM blebbing  
(fig. 42). Inhibition of Rac1 or Cdc42 drastically increased the amounts of blebbing cells even in 
cells expressing vector only (fig. 42). This might be due to a regulatory crosstalk between the 
single Rho-GTPases, as it was suggested for several physiological situations (Burridge and 
Wennerberg, 2004). These results were also in line with previously described findings in Rac1 
deficient cells, which start blebbing in certain situations (Imamura et al., 1999, Vidali et al., 
2006).  
In order to gain further insight into the signaling events during FHOD1 enhancement of PM 
blebbing, several downstream steps of the Rho activation cascade were investigated by specific 
inhibition. Similar to SH4-domain expressing cells the generation of new PM blebs was studied 
in HeLa cells following pretreatment with the ROCK inhibitor Y27632 (90 µM or 10 µM, 2 h, 
see chapter 8.1.7). As it was observed for SH4-domain induced PM blebbing, its addition 
potently abolished PM blebbing in HeLa cells expressing solely ROCK1 or in combination with 
FHOD1 (fig. 43Acd/B and data not shown).  
 
Figure 43: Activity of Rho-ROCK pathway proteins and activity of Src kinases were required but not 
microtubule integrity for FHOD1 mediated increase of PM blebbing. 
(A) HeLa cells were transfected with plasmids encoding ROCK1 and FHOD1 as indicated, pretreated with 90 µM 
Y-27632 for 2 h to remove already formed PM blebs, washed and incubated in the presence of the denoted drugs for 
additional 3 h (90 µM Y-27632; 2 µM Cytochalasin D; 25 µM Latrunculin B; 100 µM Blebbistatin; 384 µM 
Nocodazole; 50 µM PP1). Finally, cells were fixed, stained for the transiently expressed proteins and F-actin and 
analyzed for PM blebbing by confocal microscopy. Transfected cells are highlighted (*), scale bars = 10 µm.  
(B) Percentages of blebbing HeLa cells treated and handled as described in A (black bars: ROCK1; dark grey bars: 
ROCK1 and FHOD1; arithmetic means of at least three independent experiments + SD with > 100/condition). 
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These results were in line with the necessity of Rho and ROCK activity for induction of F-actin 
cables by FHOD1-ΔC (Gasteier et al., 2003, Westendorf, 2001). To examine the role of the 
cytoskeleton, cells were treated either with F-actin (2 µM Cytochalasin D or 25 µM  
Latrunculin B) or microtubule (384 µM Nocodazole) disrupting drugs. As a result both, ROCK1 
and ROCK1/FHOD1 induced PM blebs required microfilament integrity (fig. 43Ae-h/B), but in 
contrast to SH4-domain induced PM blebs, they were independent of microtubule disassembly 
(fig. 43Ak-l/B). Second, the need for myosin mediated contractility was determined. As 
mentioned before, ROCK proteins activate myosins by phosphorylation. To test the requirement 
of myosin activity, the myosin II motor protein was specifically inhibited by treatment of the 
cells with 100 µM Blebbistatin (BS). In presence of this drug, the number of blebbing cells 
expressing ROCK1 was decreased from 58 % to 16 %, but in combination with FHOD1 the level 
of blebbing cells remained at 40 % in comparison to 93 % (fig. 43Ai-j/B). However, in both 
cases the amount of blebbing cells was reduced (ROCK1: 3.8 fold; ROCK1/FHOD1: 2.2 fold). 
As it was described in the previous chapters, SH4-domain induced PM blebbing required the 
activity of endogenous Src kinases (see chapter 8.1.9). To check whether this held true for 
ROCK1 mediated PM blebbing as well, transfected cells were treated with the Src kinase 
inhibitor PP1 (50 µM). This drug had almost no effect on ROCK1 blebs (1.2 fold reduction), but 
reduced the amount of PM blebbing cells transfected with ROCK1/FHOD1 to the amount of 
blebbing cells achieved by ROCK1 only (1.5 fold reduction, fig. 43Aa/m-n/B). 
Collectively, these results showed that enhancement of ROCK1 mediated PM blebbing by 
FHOD1 required the activity of the Rho-ROCK pathway and the integrity of the microfilament 
system. This was in line with the characteristics of SH4-domain induced PM blebs described 
above (chapter 8.1.6). In contrast, ROCK1 induced and FHOD1 enhanced PM blebbing did not 
depend on microtubule supply. However, the FHOD1 mediated increase in PM blebbing 
required Src kinase activity similar to SH4 blebs (chapter 8.1.9). The basal level of ROCK1 
induced PM blebbing was independent of Src kinase activity. 
8.2.4 Activation of ROCK1 and the Role of Src 
As it was shown in the previous chapters the Rac1 binding protein FHOD1 specifically 
interacted with ROCK1 (fig. 37 and 38) and positively affected ROCK1 induced non-apoptotic 
PM blebbing (fig. 39 and 41). This effect depended on the Rho pathway as well as on ROCK 
activity (fig. 42 and 43) and was affected by inhibition of the ROCK substrate myosin II as well 
as of Src kinase activity. Therefore, the intracellular localization of endogenous c-Src was 
determined in HeLa cells by confocal microscopy (fig. 44). A specific stain revealed that 
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endogenous c-Src was located at the basis as well as in the outer rim of the blebs. Activated pc-
Src (Y418) localized in the lumen of ROCK1 induced blebs. In contrast but similar to N18-Yes-
GFP induced blebs (see chapter 8.1.9), ROCK1/FHOD1 blebs were enriched in pc-Src (Y418) 
(fig. 44A/B). Nevertheless, these experiments have been performed only once and need future 
examination. Thereafter, the cellular distribution of MLC as marker for ROCK activity was 
explored. MLC and its activated and phosphorylated form pMLC (S19) specifically localized at 
the basis of PM blebs (fig. 44C/D).  
 
Figure 44: c-Src MLC localized in PM blebs. 
(A-B) Activated pc-Src (Y418) but not total Src was enriched in PM blebs. HeLa cells were co-transfected with 
FHOD1 and ROCK1. After 24 h cells were stained for the transiently expressed proteins as well as for F-actin and 
endogenous (A) c-Src or activated (B) pc-Src (Y418), respectively. Depicted are confocal micrographs in which 
transfected cells are highlighted (*), scale bars = 10 µm. (C-D) MLC as well as activated pMLC (S19) localize in PM 
blebs. HeLa cells were co-transfected with FHOD1 and ROCK1. After 24 h cells were stained for the transiently 
expressed proteins as well as for F-actin and endogenous (C) MLC or activated (D) pMLC (S19), respectively. 
Depicted are confocal micrographs in which transfected cells are highlighted (*), scale bars = 10 µm.  
The obtained results were comparable to SH4-domain induced PM blebs and confirmed that 
ROCK activity is essential. To test whether ROCK1 activity was induced by interaction with 
FHOD1, two strategies were pursued: The first approach based on the observation that during 
apoptosis ROCK1 is C-terminally cleaved at residue 1113 by caspase-3 and thus constitutively 
activated leading to bleb formation (Coleman et al., 2001, Sebbagh et al., 2005). To investigate 
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this possibility, cell lysates of transiently transfected HeLa cells were probed in a Western blot 
analysis for the two derivates of ROCK1 fused to a Myc tag. While induction of apoptosis with 
TNFα/Chx (50 µg/ml and 5 µg/ml for 3 h) clearly increased the amount of the cleaved and 
therefore smaller form, the cleavage was completely blocked by addition of 100 µM caspase 
inhibitor zVAD-fmk directly after transfection (fig. 45A, lanes 1, 3 and 4). However,  
co-expression of FHOD1 did not alter ROCK1 cleavage per se or following induction of 
apoptosis, respectively. It also did not interfere with the block of ROCK1 cleavage that was 
mediated by zVAD-fmk (fig. 45A, lanes 6, 8 and 9).  
 
Figure 45: FHOD1 did not alter overall activation levels of ROCK1. 
(A) FHOD1 did not activate ROCK1 by C-terminal truncation. HeLa cells transiently expressing either HA tagged 
FHOD1 or N-terminally Myc tagged ROCK1 alone or in combination either in the presence of zVAD-fmk  
(100 µM) or treated with TNFα/Chx (50 µg/ml and 5 µg/ml) for 3 h, respectively, were harvested and lysed. Equal 
amounts of total protein were separated by SDS-PAGE, subjected to Western blotting and probed with an antibody 
against Myc for expression levels and protein cleavage, against HA for expression levels or against 14-3-3 as 
loading control. The cleaved and therefore constitutively active form of ROCK1 is reduced in size and separates 
from the uncleaved protein during SDS-PAGE. (B) FHOD1 did not increase ROCK1-activity. In vitro kinase assay 
(IVKA) of immunoprecipitated Myc tagged ROCK1 transiently expressed alone or in combination with HA-tag 
fused FHOD1. 3 h before harvest, cells were either treated with solvent or TNFα/Chx (50 µg/ml and 5 µg/ml) to 
induce apoptosis as a positive control. Kinase reaction was started by addition of the immunoprecipitates to kinase 
activation buffer containing 4 µCi/30 µl [32P]-γATP and 1 µg/30 µl myelin basic protein (MBP) as a substrate 
together with either solvent or Y-27632 (900 µM). After 30 min at 30°C, the kinase reaction was stopped by 
addition of 6 x SDS sample buffer, proteins were separated by SDS-PAGE and transferred to a nitrocellulose 
membrane that was exposed to a photosensitive film for 24 h. Depicted are the input levels of Myc-ROCK1 and the 
signals obtained from the radioactively labeled MBP and radioactively labeled uncleaved Myc-ROCK1. 
The second employed strategy was a direct visualization of ROCK1-activity by an in vitro kinase 
assay (IVKA). Immunoprecipitated Myc-ROCK1 proteins from HeLa cell lysate were added to 
the kinase reaction containing [32P]-ATP and myelin basic protein (MBP) as a substrate. As 
judged by a photosensitive film, MBP was specifically phosphorylated in the presence of  
Myc-ROCK1 as well as the kinase itself presumably by autophosphorylation but not in its 
absence (fig. 45B, lanes 1 and 2). Addition of the ROCK inhibitor Y-27632 (900 µM) to the 
reaction completely abolished kinase activity (fig. 45B, lane 5). However, the kinase activity was 
neither increased after induction of apoptosis by TNFα and Chx nor by co-expression of  
HA-FHOD1, respectively (fig. 45B, lanes 3 and 4). Nevertheless, these experiments bore some 
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intrinsic errors complicating interpretation: First, neither the immunoprecipitated Myc-ROCK1 
nor the HA-FHOD1 could be probed by antibodies in the depicted experiment. Second, MBP is 
not a substrate specific for ROCK1 only and finally, the amounts of Y-27632 used were about  
90 fold in excess to the specific concentration of 10 µM (Davies et al., 2000). 
Together, an enrichment of Src kinase activity was found in blebs generated by ROCK1 and 
FHOD1 as it was shown for SH4-domain induced blebs. Similarly, active MLC and therefore 
ROCK1 activity specifically localized at these blebs, but an activation of bulk levels of ROCK1 
was not observed, which was also in line with the findings for SH4-doamins. 
8.2.5 FHOD1 is not Required for PM Blebbing Induced by ROCK1, Rac1 and 
Apoptosis 
Co-expression of FHOD1 increased the amount of ROCK1 induced PM blebbing in a way that 
required the activity of the Rho-ROCK cascade. As a Drf, FHOD1 is thought to have the 
potential for cytoskeletal rearrangements. Since the integrity of the microfilament system is 
required for formation of PM blebs, FHOD1 could be a central player in the development of PM 
blebbing. To investigate this hypothesis, the requirement of endogenous FHOD1 for several 
kinds of PM blebbing was investigated. Therefore, a specific RNAi mediated knockdown for 
FHOD1 was established. Depending on the cell line, cells were transfected with different 
methods but always twice (day 1 and day 3) with one of two different RNA-oligonucleotides 
directed against target sequences located in the N-terminus of FHOD1 or with unrelated control-
oligonucleotides, respectively (for detailed information please refer to material and methods). 
The efficiencies of FHOD1 downregulation varied from 50-80 % after 4-5 d incubation as 
judged by western-blot analysis with an FHOD1 specific antibody (Gasteier et al., 2005) and a 
following evaluation by BIO RAD "Quantity One" or LI-COR "Odyssey" software. First, the 
role of FHOD1 was analyzed for PM blebbing in apoptotic cells. Treatment of HeLa cells with 
TNFα/Chx (50 µg/ml and 5 µg/ml) for 3 h potently induced apoptosis and PM blebbing (fig. 41 
and fig. 45). However, this held also true in FHOD1 reduced cells (fig. 46).  
Figure 46: Reduction of FHOD1 had no influence on apoptotic PM blebbing. 
Following RNAi treatment with either control no-target siRNA oligonucleotides or 
FHOD1 specific siRNA oligonucleotides (knockdown efficiency see insert), HeLa cells 
were treated with TNFα/Chx (50 µg/ml and 5 µg/ml) for 3 h to induce apoptosis, stained 
for externalized phosphatidyl serine (PS) with Alexa Fluor-568 labeled Annexin V, fixed, 
additionally stained for F-actin and chromatin and analyzed by fluorescence microscopy. 
Depicted are the percentages of blebbing and PS positive cells (arithmetic means of two 
independent experiments + SD with > 100/condition).  
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In line with the fact that ROCK1/FHOD1 blebs are not apoptotic, FHOD1 had no detectable 
influence on apoptotic PM blebbing. 
A second approach addressed PM blebbing that was directly induced by ROCK1 expression. 
HeLa cells treated with siRNA oligonucleotides were transfected with expression plasmids 
encoding ROCK1. After fixation and stain the cells were analyzed for PM blebbing. FHOD1 
knockdown in this case showed no decrease (fig. 47Acd/B). However, ROCK1 (75 %) as well as 
vector (29 %) transfected cells revealed an unusual high bleb affinity (fig. 47B and data not 
shown), which might be due to the demanding transfection protocol or to a possible upregulation 
of other Drfs like FHOD2 to compensate for the lack of FHOD1 (see Material and Methods). 
 
Figure 47: PM blebbing induced by ROCK1 or Rac1 was not influenced by RNAi mediated knockdown of 
FHOD1. 
(A) Reduced levels of FHOD1 did not change cellular appearance of ROCK or Rac1 expressing cells. After a 
second RNAi treatment (knockdown efficiencies are depicted in insert of C), HeLa cells were either transfected with 
vector (a-b), plasmids encoding Myc-tagged ROCK1-wt (c-d) or constitutively active mutants of Rac1  
(Rac1-L61: e-f; Rac1-L61A37: g-h; Rac1-L61C40: i-j). After 24 h, cells were fixed, stained for the transiently 
expressed proteins and F-actin and analyzed by confocal microscopy. Transfected cells are highlighted (*), scale 
bars = 10 µm. (B) Reduction of FHOD1 had no influence on ROCK1 induced PM blebbing. HeLa cells depicted in 
A transiently expressing ROCK1-wt were evaluated for PM blebbing. Depicted are the percentages of blebbing cells 
(arithmetic means of three independent experiments + SD with > 100/condition). (C) Reduction of FHOD1 had no 
influence on Rac1 induced PM blebbing. HeLa cells depicted in A transiently expressing either vector, Rac1-L61, 
Rac1-L61A37 or Rac1-L61C40 were evaluated for PM blebbing. Depicted are the percentages of blebbing cells 
(arithmetic means of three independent experiments + SD with > 100/condition).  
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As mentioned before, the FHOD1 protein binds to the Rho-GTPase Rac1 (Gasteier et al., 2003, 
Westendorf, 2001). Interestingly, expression of a constitutively active form of Rac1 with two 
residue exchanges (Rac1-L61A37: Gln61 to leucine and Phe37 to alanine) had been described to 
induce PM blebbing (> 50 % after 7 h) in NIH3T3 cells. Two other Rac1 variants (Rac1-L61 and 
Rac1-L61C40: Gln61 to leucine and Tyr40 to cysteine) failed to induce PM blebbing (Schwartz 
et al., 1998). To test the influence of FHOD1 on formation of these blebs, Myc fusion proteins of 
the Rac1 mutants were expressed in HeLa cells for 24 h and assayed for PM blebbing by 
confocal microscopy (fig. 47Ae-j/C). In line with the published data, Rac1-L61A37 induced PM 
blebbing in approx. 73 % of the transiently transfected cells whereas Rac1-L61 and the vector 
control did not. Rac1-L61C40, however, also slightly induced PM blebbing (32 %). 
Nevertheless, RNAi mediated reduction of FHOD1 had no quantifiable effect on PM blebbing, 
neither in Rac1-L61A37 nor in Rac1-L61C40 expressing cells (fig. 47Ag-j/C). These results 
were in agreement with the findings described in the previous chapters that FHOD1 mediated 
enhancement of ROCK1 induced PM blebbing did not required Rac1 activity (chapter 8.2.3). 
In summary, PM blebbing induced by Rac1, ROCK1 or apoptosis was not affected by reduction 
of intracellular FHOD1 levels. Therefore, FHOD1 might be relevant in conjugation with ROCK1 
after specific triggering. 
8.2.6 FHOD1 Contributes to SH4 Mediated PM Blebbing 
As described in the first part of this work, PM blebbing was also inducible by expression of 
SH4-domains (chapter 8.1). Although these blebs required the integrity of microtubules, they 
also showed remarkable similarities to FHOD1 enhanced ROCK1 blebs concerning size and 
number, their non apoptotic nature as well as their dependency on the Rho-ROCK pathway, on 
localization and activity of Src kinases and the integrity of the microfilament system in general. 
This suggested a possible role of the FHOD1 protein in SH4 mediated PM blebbing. To test this 
hypothesis, RNAi mediated knockdown of FHOD1 was performed in CHO cells stably 
expressing N18-HASPB-GFP. Indeed, compared to cells treated with control oligonucleotide, 
PM blebbing was reduced up to twofold (p = 0.0004) in FHOD1 knockdown cells (fig. 48). Of 
note, this reduction occurred although FHOD1 expression levels were only moderately 
diminished. Interestingly, a further decrease of FHOD1 levels caused no additional reduction of 
PM blebbing (data not shown) indicating that FHOD1 may represent one of several factors that 
synergistically mediate SH4-domain induced PM blebbing. 
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Figure 48: FHOD1 was involved in HASPB-SH4-domain induced PM blebbing. 
(A-C) Reduction of FHOD1 resulted in decrease of HASPB-SH4-domain induced PM blebbing. (A) Following 
RNAi treatment (knockdown efficiency shown in B), N18-HASPB-GFP expression was induced for 24 h by 
addition of 1000 µg/ml dox in CHO cells. They were fixed and stained for F-actin to evaluate blebbing efficiency. 
Shown are confocal micrographs of control and FHOD1 knockdown cells. Scale bars = 10 µm. (B) Knockdown 
efficiency for CHO cells treated with either control no-target siRNA oligonucleotides or FHOD1 specific siRNA 
oligonucleotides. (C) Quantification of the blebbing efficiency of cells depicted in A. N18-HASPB-GFP expressing 
cells treated as described in A were evaluated for F-actin positive PM blebs by fluorescence microscopy. Values 
represent the arithmetic means of at least six independent experiments + SD in which over 100 cells were counted 
per condition. As calculated by Student's t-test values are statistical different (p = 0.0004).  
The involvement of other Drfs like the Dia proteins or FHOD2 and the confirmation of FHOD1s 
role in SH4-domain PM blebbing is part of current investigations. Since SH4-domain mediated 
PM blebbing also correlated with enhanced invasiveness in 3D matrices, FHOD1s contribution 
to this is of special interest as well and has to be further investigated. Nevertheless, besides its 
contribution to PM blebbing, there might be additional functions of FHOD1 which were 
addressed in the following chapter.  
8.3 The Role of FHOD1 in Intracellular Organization 
8.3.1 Characterization of Cells Reduced in FHOD1 
Drfs play a critical role in cytoskeletal reorganization. By nucleation of F-actin they control 
various cellular functions such as establishment of cell shape, cytokinesis or cell motility (Faix 
and Grosse, 2006, Wallar and Alberts, 2003). Although a common feature of Drfs is their highly 
conserved FH1- and FH2-domain which are required for interactions with cellular ligands, their 
individual function is thought to be unique. FHOD1s physiological functions remain elusive, 
although there have been many attempts for characterization. Besides its contribution to  
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PM blebbing as described in the previous chapters, it was shown that expression of FHOD1-ΔC 
leads to F-actin polymerization and formation of thick F-actin cables decorated by the Drf 
(Gasteier et al., 2003, Koka et al., 2003). Furthermore, it coordinates F-actin filaments and 
microtubules to induce cell elongation (Gasteier et al., 2005), an effect that was assigned to its 
ability to stimulate cell migration in an integrin-independent manner (Koka et al., 2003). 
However, all these functions have been deduced from over-expression experiments and might 
not display its natural physiological function. For more reliable characterization studies of 
FHOD1 that circumvent these limitations, a siRNA mediated knockdown of FHOD1 was 
employed as described in chapter 8.2.5. For a first approximation, the impact of an FHOD1 
knockdown on general cellular functions linked to the cytoskeleton was investigated. Since the 
cytoskeleton determines the cellular shape, the impact on of cell size was addressed. HeLa cells 
were seeded on coverslips for two days, fixed and stained for F-actin. Following fluorescence 
microscopy, the size of individual cells was manually measured with "ImageJ" software  
(fig. 49A/B). Compared to cells treated with control siRNA, only a slight reduction in cell size 
was observed. Nevertheless, the two populations could statistically be separated by  
Student's t-test (p < 0.001). Next, the F-actin content was analyzed: Confocal micrographs of 
Phalloidin-TRITC stained adherent HeLa cells showed no obvious differences in F-actin levels 
(fig. 49A/C1-2). Similar results were obtained by FACS analysis. RNAi treated HeLa cells 
grown for 24 h on culture dishes at approx. 75 % confluency were fixed, stained for F-actin with 
Alexa-Fluor-660 labeled Phalloidin and measured for F-actin content. In these experiments a 
slight but significant (p = 0.01, Student's t-test) decrease in F-actin levels could be detected in 
FHOD1 knockdown cells (fig. 49A/C3-4). These results demonstrated only a minor contribution 
of FHOD1 to overall F-actin levels. Third, the impact of FHOD1 reduction in cell proliferation 
was analyzed. Former studies showed no influence of FHOD1 over-expression in cytokinesis 
(Gasteier et al., 2005). In line with these results, a reduction of FHOD1 levels had no effect on 
proliferation of HeLa cells within 24 h (p = 0.2, Student's t-test) as it was measured by an 
incorporated thymidine analog (BrdU) in newly generated DNA (fig. 49A/D2).  
In 2003, Koka and coworkers could show that over-expression of FHOD1 enhanced cell 
migration in an integrin- and cell-surface adhesion-independent manner (Koka et al., 2003). 
Consequently, the adhesion capacity of siRNA treated HeLa cells to surfaces was determined. 
The amount of cells that were attached to different surfaces like uncoated wells or fibronectin, 
collagen or poly-L-lysine coated cell culture dishes, respectively, was quantified. In line with 
these studies no differences could be detected (fig. 49A/D1 and data not shown). 
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Figure 49: RNAi mediated knockdown of FHOD1 had minimal effects on cell size, F-actin levels, cell-surface 
adhesion and proliferation. 
(A) Levels of endogenous FHOD1 were reduced by a specific RNAi mediated knockdown. HeLa cells were 
transfected either with unrelated control siRNA oligonucleotides or FHOD1 specific siRNA oligonucleotides on  
day 1 and on day 3 as described in material and methods and harvested on day 5. Equal amounts of total protein 
were separated by SDS-PAGE, subjected to Western blotting and probed with a specific antibody against FHOD1 
(Gasteier et al., 2005) for knockdown efficiencies or against α-tubulin serving as loading control. (B) FHOD1 
reduction had minimal influence on cell size. RNAi treated HeLa cells with a knockdown efficiency as depicted in 
A were seeded on glass coverslips for 2 days. Cells were fixed, stained for F-actin and individual cell sizes were 
manually analyzed by perimeter measurement with "ImageJ" software (arithmetic means of three independent 
experiments + SD with > 100/condition; p < 0.001, Student's t-test). (C) FHOD1 reduction had minimal influence 
on F-actin levels. RNAi treated HeLa cells with a knockdown efficiency as depicted in A were grown on coverslips, 
fixed, stained for F-actin and subjected to confocal microscopy (1+2). In parallel, cells grown for 24 h on a culture 
dish by a confluency of approx. 75 % were detached by trypsin/EDTA, fixed, stained for F-actin with  
Alexa-Fluor-660 labeled Phalloidin and analyzed by FACS. Shown are the geo-mean values of gated cells (3) and 
arithmetic means (4) of three independent experiments + SD (p = 0.01, Student's t-test). Scale bars = 10 µm  
(D) FHOD1 reduction had minimal influence on cell-surface adhesion and proliferation. RNAi treated HeLa cells 
with a knockdown efficiency as depicted in A were seeded as triplicates in 96 well plates for 2 h. For evaluation of 
adhesion efficiencies, relative numbers of fixed cells were measured after chromatin stain (Hoechst 33268) with a 
fluorimeter (356 nm/458 nm) and normalized to a standard curve. Depicted are the percentages of the measured 
signals relative to control cells (1). For determination of proliferation rates, after adhesion newly generated DNA 
was labeled by addition of BrdU reagent for 24 h. Cells were fixed and analyzed by ELISA. Depicted are the 
percentages of the measured signals normalized to adhesion rates and relative to control cells (2) (arithmetic means 
of three independent experiments + SD with > 100/condition; Student's t-test: adhesion p = 0.7; proliferation  
p = 0.2).  
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Figure 50: Reduction of endogenous FHOD1 had no effect on chemotaxis and motility on planar surfaces. 
(A) FHOD1 reduction had no influence on chemotaxis. NIH3T3 cells were transfected either with unrelated control 
siRNA oligonucleotides or FHOD1 specific siRNA oligonucleotides (knockdown efficiency is depicted in insert). 
Serum starved cells were seeded onto a transwell insert grid (pore size 8 µm) for 1 h and were exposed to a gradient 
of FCS (0.5-0.5 % or 0.5-10 %) for 8 h. They were fixed and stained for F-actin and chromatin and amounts of 
migrated and not migrated cells were counted. Depicted are the relative amounts of migrated cells. Values are the 
arithmetic means of five microscopy fields + SD. (B-E) FHOD1 reduction has no influence on motility on planar 
surfaces. Cells were transfected either with unrelated control siRNA oligonucleotides or FHOD1 specific siRNA 
oligonucleotides (knockdown efficiency is depicted in insert). (B) Representative images of wound healing assays 
performed with NIH3T3 cells. Confluent cell layers were wounded and monitored by microscopy over time  
(24 h, 1 picture/30 min). Scale bars = 100 µm. (C-E) Quantification of wound closure time. Wound sizes of cell 
layers as described in B were measured by "ImageJ" software for (C) NIH3T3 cells, (D) HeLa cells and (E) MEFs. 
Values are the arithmetic means of at least three wounds + SD. 
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Additionally, cell migration in 2D was measured by two distinct methods: In a chemotaxis assay, 
the capacity of serum starved NIH3T3 cells was measured to migrate along a gradient of FCS 
(0.5-10 %). Therefore, siRNA treated cells were seeded at the bottom of a transwell insert and 
were monitored for 8-24 h. The relative amount of migrated cells was quantified after fixation 
and stain for chromatin and F-actin. In contrast to the results that had been described for over-
expressed FHOD1 (Koka et al., 2003), knockdown of FHOD1 did not yield significant 
difference in chemotaxis (fig. 50A and data not shown). Similar results were obtained in wound 
healing assays performed as described earlier for SH4-domain expressing cells (see  
chapter 8.1.11). Neither a reduction of FHOD1 in NIH3T3 nor in HeLa cells or MEFs revealed a 
detectable defect in motility on planar surfaces (fig. 50B-D).  
In summary, reduction of FHOD1 had no pronounced effect on cell size, F-actin content, cell 
proliferation, cell-surface adhesion, chemotaxis or cell migration. However, it cannot be 
excluded that other Drfs compensate for FHOD1s reduction. Furthermore, residual amounts of 
FHOD1 in knockdown cells might have been sufficient to facilitate the investigated functions. 
8.3.2 Interference of FHOD1 with Rho-GTPases 
The activity of Drfs is at least partially regulated by Rho-GTPases. Their interaction is mediated 
by the mostly N-terminally located GTPase binding domain (GBD) of Drfs (Faix and Grosse, 
2006, Wallar and Alberts, 2003). FHOD1 was shown to specifically interact with Rac1, but not 
with RhoA or Cdc42, and colocalizes with co-expressed constitutively active Rac1 at the PM of 
lamellipodia (Gasteier et al., 2003, Westendorf, 2001), but it has not been verified whether 
FHOD1 is a Rac1 effector. Interestingly, the already mentioned stress fiber formation by active 
FHOD1-ΔC depends on the activity of Rho and its effector kinase ROCK (Gasteier et al., 2003). 
Thus, RNAi mediated knockdown of FHOD1 was used to investigate a specific function of 
FHOD1 as Rho-GTPase effector in actin remodeling. HeLa cells treated with FHOD1 specific 
siRNA for efficient knockdown were transfected with expression plasmids of constitutively 
active Myc-tagged mutants of Rho-GTPases. Following fixation and staining, the cells were 
analyzed by confocal microscopy for the formation of F-actin phenotypes that are typically 
induced by Rho-GTPases (Allen et al., 1997). Quantification of at least 100 cells per experiment 
revealed neither a difference in development of stress fibers initiated by Rho-V14 or its effector 
ROCK1-Δ3 nor in formation of lamellipodia or filopodia induced by Rac1-L61 or Cdc42-L61, 
respectively (fig. 51A-F). If anything, the latter one was slightly increased. 
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Figure 51: FHOD1 reduction has no influence on GTPase mediated cytoskeletal rearrangements. 
(A) After RNAi treatment, HeLa cells were transfected with expression plasmids for the indicated constitutively 
active Rho-GTPases fused to GFP or GFP alone. Following 24 h of incubation the cells were fixed and stained for 
F-actin. Scale bars = 10 µm. (B) Knockdown efficiency for HeLa cells treated twice with either control no-target 
siRNA oligonucleotides or FHOD1 specific siRNA oligonucleotides. (C-E) HeLa cells as depicted in A were 
microscopically quantified for a specific phenotype: (C) Evaluation of RhoA-V14 expressing cells (see also Ac-d) 
for formation of F-actin fibers. (D) Evaluation of ROCK1-Δ3 expressing cells (see also Ae-f) for formation of  
F-actin fibers. (E) Evaluation of Rac1-L61 expressing cells (see also Ag-h) for lamellipodia formation. (F) 
Evaluation of Cdc42-L61 expressing cells (see also i-j) for filopodia formation. RNAi control values are set to  
100 % (arithmetic means of three independent experiments + SD with > 100/condition).  
Via increase of actin treadmilling, Rho-GTPases also regulate transcription from the SRE (Hill et 
al., 1995). The SRE is a common regulatory element of many promotors of genes whose 
transcription is linked to growth factor or mitogen stimulation (Treisman, 1992). To investigate 
the influence of FHOD1 in Rho-GTPase mediated SRE activation, FHOD1 reduced NIH3T3 
cells were co-transfected with expression plasmids of constitutively active Myc tagged GTPases 
in combination with a SRE reporter construct fused to luciferase (fig. 52). For evaluation, the 
fluorescently detected substrate turnover was normalized to the values obtained for FHOD1-ΔC 
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which have been shown to induce SRE activation as well (Gasteier et al., 2003, Westendorf, 
2001). No differences between control and FHOD1 knockdown cells were observed for any 
GTPase or for ROCK1-Δ3 (fig. 52). 
 
Figure 52: FHOD1 reduction had no influence on GTPase mediated SRE activation. 
After second RNAi treatment with either control no-target siRNA oligonucleotides or FHOD1 specific siRNA 
oligonucleotides (knockdown efficiency see insert), NIH3T3 cells were co-transfected with SRE reporter constructs 
and an expression plasmid encoding the indicated protein in triplicate experiments. After 24 h serum starvation cells 
were harvested and SRE activity luminiscently detected with a luminometer. Depicted are the fold activities 
normalized to the control FHOD1-ΔC signal (set to 100 % in each experiment) and relative to vector control. Values 
are the arithmetic means of three independent experiments + S.E.M. 
In summary, FHOD1 was not limiting for Rho-GTPase or ROCK1 mediated F-actin remodeling 
or SRE activation. These results were in contrast to described associations of FHOD1 with Rac1 
and Rho pathways. However, they also did not disprove this theory due to possible residual 
amounts of FHOD1 after siRNA treatment. 
8.3.3 Endogenous FHOD1 is Localized at to Golgi Structures 
Since studies of general and specific cytoskeletal phenotypes revealed no obvious contribution of 
the FHOD1 protein, another approach to investigate its intracellular distribution was chosen. As 
already mentioned, exogenous FHOD1 localizes at the PM of lamellipodia if co-expressed with 
the constitutively active form of the Rho-GTPase Rac1. Additionally, the constitutively active 
form FHOD1-ΔC decorates F-actin bundles, but FHOD1 alone shows an unspecific 
cytoplasmatic distribution (Gasteier et al., 2003, Westendorf, 2001). To investigate the intrinsic 
localization of FHOD1, the endogenous protein was detected with a specific polyclonal antibody 
directed against two FHOD1 peptide sequences in its N-terminal part (Gasteier et al., 2005). This 
revealed a certain perinuclear localization of FHOD1 in NIH3T3 cells that was not detectable by 
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usage of peptide saturated antibodies or the secondary antibody alone, respectively (fig. 53A and 
data not shown). However, these studies were only successful in rodent cell lines as mouse 
NIH3T3, hamster CHO or rat Rat2 cells, but not in human cell lines like HeLa, Huh-7 or Jurkat 
T-cells (fig. 53A/B and data not shown). In contrast, immuno-electron micrographs as described 
later were obtained from HeLa cells, only, but not from rodent cells (fig. 53C and data not 
shown).  
 
Figure 53: Endogenous FHOD1 was found in perinuclear regions and localized at Golgi structures. 
(A) Endogenous FHOD1 specifically localized in a perinuclear region. NIH3T3 cells grown on a coverslip were 
fixed and stained with (a) an antibody against FHOD1 (Gasteier et al., 2005) together with a fluorescently labeled 
secondary antibody. For specificity control cells were stained with (b) FHOD1 antibody saturated with its target 
peptides or (c) fluorescently labeled secondary antibody alone. Scale bars = 10 µm. (B) Endogenous FHOD1 is 
associated with Golgi proteins. Confocal micrographs of NIH3T3 cells grown on glass coverslips. They were fixed 
and stained for endogenous FHOD1 in combination with the indicated Golgi proteins. Squares in the "merge" panel 
indicate the zoomed regions depicted in the right panel. Scale bars = 10 µm. 
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The reason for this discrepancy is unclear. Possibly due to distinct posttranslational 
modifications such as species or cell type specific phosphorylations or variable complexation 
with other proteins the accessibility of the epitopes for the antibody was altered differently. 
Anyway, detection of endogenous FHOD1 in western blot analysis has been shown to be species 
independent (Gasteier et al., 2005) which was also proven in this work (fig. 50). In order to 
further define these perinuclear structures, co-localization studies with endogenous marker 
proteins were performed. As a result, FHOD1 localized in close proximity to Golgi marker 
proteins like TGN-46, coatomer or P115/TAP, but not with other vesicular markers like EEA1, 
LAMP1 or TfR (fig. 53B and data not shown). Endogenous FHOD1 localized very pronounced 
in between vesicles that were positive for P115/TAP, a protein that is involved in fusion of  
ER-derived COP-II vesicles and their binding to Golgi membranes (Allan et al., 2000, Alvarez et 
al., 2001). To get further insight into this distribution, immuno-electron microscopy of negative 
stained HeLa cells was performed by S. Welsch (group of G. Griffiths, EMBL, Heidelberg) (fig. 
54A):  
 
Figure 54: Endogenous FHOD1 localized at Golgi structures and PM ruffles. 
(A) Electron micrographs of HeLa cells stained for endogenous FHOD1 (10 nm gold) showed (a) Golgi related 
localization and (b) localization in ruffles at the PM. Scale bars = 100 nm (B) For specificity control cells were 
stained with antibody against endogenous FHOD1 untreated or treated with its target peptide for compensation. 
Values are the relative amounts of gold particles counted for each compound and are the arithmetic means of three 
independent labeling experiments + SD in which 100-200 particles were counted per grid (2 grids/experiment). 
Compensation values are set to 100 % . (kindly provided by S. Welsch from the group of G. Griffiths, EMBL, 
Heidelberg). 
Although the overall antibody affinity to the used samples in general was very low and, as 
judged by peptide compensation studies, the unspecific background relatively high (early or late 
endosomes, nucleus, mitochondria or other cellular components: fig. 54B), the signals for some 
cellular compartments were specific: Endogenous FHOD1 mainly localized at the lateral sites or 
in between some Golgi stacks and was also associated to PM ruffles (fig. 54C). 
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Assuming a specific role for FHOD1 in Golgi organization, variations in FHOD1 levels should 
possibly change the appearance of Golgi stacks. However, neither transiently expressed  
HA-FHOD1-wt for 24 h nor its active mutant HA-FHOD1-ΔC that potently induced F-actin 
cable formation changed the distribution of the Golgi marker p115/TAP (fig. 55).  
Figure 55: Protein level variations of FHOD1 had no influence on Golgi organization. 
(A) Over-expression of FHOD1 did not alter Golgi organization. Confocal micrographs of NIH3T3 cells that were 
transfected either with HA tagged FHOD1 or its constitutively active form FHOD1-ΔC. Cells were fixed and stained 
for the expressed proteins as well as for endogenous P115/TAP as a Golgi marker. (B-C) Knockdown efficiencies 
for NIH3T3 cells (B) or HeLa cells (C) treated either with unrelated control siRNA oligonucleotides or FHOD1 
specific siRNA oligonucleotides. (D) Reduced FHOD1 expression had no influence on Golgi organization and 
perinuclear FHOD1 stain. Confocal micrographs of RNAi treated NIH3T3 cells (knockdown efficiency see B) 
grown on a coverslip. Cells were fixed and stained for endogenous FHOD1 and for endogenous p115/TAP as a 
Golgi marker. (E) RNAi mediated FHOD1 reduction decreased signals in immuno-electron micrographs. Hela cells 
were subjected to FHOD1 knockdown as described in C, stained for endogenous FHOD1 and the number of gold 
particles was counted on electron micrographs. Data are exclusive mitochondrial signals. Values are the relative 
amounts of gold paritcles/µm2 that were counted on randomly taken images (100/condition) where RNAi control 
values were set to 100 % (kindly provided by S. Welsch: E). 
Similar results were obtained by siRNA mediated reduction of FHOD1 in NIH3T3 cells. 
Although the overall amounts of endogenous FHOD1 were drastically reduced in a western blot 
analysis, the signal intensity of the perinuclear stain was not obviously decreased (fig. 55D). This 
might indicate that a Golgi associated population of FHOD1 is more stable than the diffusely 
distributed cytoplasmic protein and was not affected by four days siRNA treatment. However, a 
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specific reduction could be observed in FHOD1 knockdown cells during immuno-electron 
microscopy: upon exclusion of signals obtained for mitochondria that usually show a high 
background level (S. Welsch, personal communication), quantification of gold particles/µm2 cell 
area in FHOD1 stained cells revealed a fourfold reduction of the overall cellular signal (inclusive 
mitochondria: 1.7 fold reduction) but without any apparent morphological changes (fig. 55E and 
data not shown). 
Since a strong association of endogenous FHOD1 with the Golgi apparatus could be 
demonstrated its functional relevance was investigated in the following. The Golgi complex 
consists of vesicles and cisternae that are thought to be organized by microtubules and F-actin 
dynamics (Egea et al., 2006, Vaughan, 2005). To investigate FHOD1s role in these organization 
processes, disassembly and reassembly of Golgi structures was analyzed. Therefore the Arf GEF 
inhibitor Brefeldin A (BFA) was employed. This drug specifically and reversibly blocks 
translocation of proteins from the endoplasmic reticulum to the Golgi apparatus without 
affecting endocytosis or lysosome function and furthermore causes disassembly of the Golgi 
apparatus (Dinter and Berger, 1998, Jackson and Casanova, 2000). Treatment of NIH3T3 cells 
with 5 µg/ml BFA potently disrupted the Golgi apparatus as shown in fig. 56 for the coatomer 
protein. After 10 min the perinuclear coatomer distribution completely dissolved and the protein 
strongly localized at distal areas of the cell. Interestingly, endogenous FHOD1 was still in close 
proximity to the coatomer protein (fig. 56, 10 min BFA, left insert), whereas most of the signal 
in the perinuclear region had disappeared (fig. 56, 10 min BFA, right insert). After 30 min of 
treatment the distribution of coatomer as well as of endogenous FHOD1 was observed to be 
more homogenously dispersed over the whole cell, although some distal accumulations were still 
detectable (fig. 56, 30 min BFA, insert). After removal of BFA from the cells the typical stack 
like structure of the Golgi reappeared within 1 h (fig. 56, 1h wash out). Of note, during 
microscopical observation of the Golgi redistribution the impression evolved that in some cells 
parts of the coatomer pool still distributed over the whole cell area, but the accumulation of 
endogenous FHOD1 seemed to proceed somehow faster (data not shown). Nevertheless, this 
effect was not quantified and requires further investigation. Moreover, siRNA mediated 
knockdown did not alter the reappearance of the Golgi after BFA treatment (data not shown). 
Thus, FHOD1 played no role in steady state organization and reorganization of the Golgi after 
disruption.  
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Figure 56: Brefeldin A (BFA) mediated disruption of the Golgi apparatus also disrupts perinuclear FHOD1 
distribution. 
Confocal micrographs of NIH3T3 cells that were treated with 5 µg/ml BFA for up to 30 min (b-c) or additionally 
with medium without BFA for 1 h (d). Cells were fixed and stained for endogenous FHOD1 and coatomer as Golgi 
marker. Squares indicate the zoomed regions depicted in the images. Scale bars = 10 µm. 
Since FHOD1 had no obvious effect in Golgi organization its contribution to vesicular transport 
was analyzed next. The Golgi apparatus of eukaryotic cells is the central organelle of the 
classical ER/Golgi dependent secretory pathway. Herein, vesicular transport is directed from the 
ER via the Golgi to the cell surface. Lumenal proteins are finally released into the extracellular 
space by fusion of Golgi-derived secretory vesicles with the PM (Mogelsvang and Howell, 2006, 
Nickel, 2003). The secretory capacity of this pathway can easily be quantified by tracking of 
cargo proteins such as the temperature sensitive vesicular stomatitis virus (VSV)  
ts-045-G glycoprotein fused to CFP. At the non-permissive temperature of 39.5°C the cargo 
marker accumulates in the ER due to a reversible folding defect. When shifted to the permissive 
temperature of 31°C, correctly folded ts-045-G is rapidly transported from the ER through the 
Golgi apparatus to the cell surface, where its appearance can be monitored using an antibody 
against the lumenal domain of the glycoprotein (Pepperkok et al., 1993). However, in a 
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fluorescence microscopy based analysis of ts-045-G-CFP transformed HeLa cells (adenovirus, 
MOI of 10; performed with the help of J. Simpson from the group of R. Pepperkok, EMBL, 
Heidelberg), the relative amounts of externalized ts-045-G (ratio antibody signal/CFP signal) 
were similar in control and FHOD1 knockdown cells over the monitored period of 90 min  
(fig. 57). 
Figure 57: FHOD1 knockdown had no 
influence on Golgi mediated transport 
of VSV-G cargo proteins. 
Following RNAi treatment with either 
control no-target siRNA oligonucleotides 
or FHOD1 specific siRNA 
oligonucleotides (knockdown efficiency 
see insert), HeLa cells were infected with 
adenoviruses (MOI of 10, 17 h) carrying 
genetic information for a CFP fused 
temperature sensitive mutant of the 
vesicle stomatitis virus (VSV) G-protein 
(ts-045-G-CFP). Cells were grown at 
39.5°C for accumulation of the protein in 
the ER and were shifted for up to 90 min 
to 31°C allowing Golgi mediated VSV-G 
transport. After fixation, surface bound 
VSV-G was stained. Cells were evaluated 
by fluorescence microscopy. Signal 
intensities (mean grey values) of total and 
externalized VSV-G were measured with 
"ImageJ" software. Depicted are the ratios 
of external signal to total signal, relative 
to RNAi control at 90 min. Values are the 
arithmetic means of at least 100 cells per 
condition and time point + SD, with the 
help of J. Simpson). 
In summary, endogenous FHOD1 was specifically found in perinuclear regions and closely 
localized nearby several Golgi marker proteins. Although variations of FHOD1 levels did not 
change the typical Golgi stack like structure, it is potently reorganized in these structures after 
removal of Golgi disrupting drugs. This indicated that FHOD1 might be a protein located at the 
Golgi periphery or the Golgi matrix. Since reduction of FHOD1 production had no detectable 
influence on ts-045-G cargo protein secretion or Golgi organization, its physiological role in 
processes other than PM blebbing remains unclear. 
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9 DISCUSSION 
PM blebbing describes a dynamic process at cellular surfaces that occurs under various 
circumstances, including apoptosis, secretion, virus entry and cell motility. It is thought to be 
mediated by common mechanisms. This work deals with the induction and regulation of PM 
blebbing by factors that have not been linked to this process before: PM blebbing was 
specifically induced by SH4-domains of various proteins. Formation of these blebs was related 
to the local activity of regulatory proteins like ROCK and Src kinases. In knockdown 
experiments, an additional factor, the Drf FHOD1 could be identified as a functional player in 
this process of PM dynamization. Expression of FHOD1 in combination with its binding partner 
ROCK1 also induced PM blebbing very similar to SH4-domains, again in a Src dependent 
manner. These results suggest a functional interplay of these factors. 
In the following, the individual regulation, activities and mechanistical functions of these 
proteins in PM blebbing and related phenotypes like cell motility will be discussed on the basis 
of experimental results that have been obtained during this work. 
9.1 The Induction and Regulation of PM Blebbing 
9.1.1 Induction of PM Blebbing by SH4-Domains 
The biological function of SH4-domains is described by their capacity to target proteins like 
proto-oncogenic Src kinases to cellular membranes where these subsequently perform many of 
their specific activities (Resh, 1999). A surprising and unexpected result of this work revealed 
that expression of SH4-domains from different proteins potently induced highly dynamic PM 
blebbing on cellular surfaces describing a phenomenon that has not been linked to these 
membrane anchoring domains before. In general, PM blebbing is not fully understood, but has 
been connected to a variety of physiological conditions such as apoptosis (Mills et al., 1999, 
Zhang et al., 1998), vesicle shedding during secretion (MacKenzie et al., 2001, Mehul and 
Hughes, 1997), cytokinesis (Boss, 1955, Laster and Mackenzie, 1996) and cell migration (Sahai 
and Marshall, 2003, Trinkaus, 1973). 
In order to evaluate SH4-domain induced PM blebbing, as a first approach the characteristics of 
PM blebs and blebbing cells were analyzed. CHO cells expressing SH4-domains were constantly 
blebbing over an extended period without any detectable vesicular shedding. Although the SH4-
domain of HASPB has been reported to be released into the medium (Stegmayer et al., 2005), a 
bleb related secretion was not observed (C. Stegmayer, personal communication). Vesicular 
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shedding from blebbing cells has been reported for galactins and ATP-induced secretion of  
IL-1β MacKenzie et al., 2001, Mehul and Hughes, 1997), even though it was suggested that  
IL-1β secretion is uncoupled of PM blebbing (Verhoef et al., 2003). Release of cellular 
compartments occurs in the late phases of apoptosis as well. In this case, these apoptotic bodies 
bud from the cell leading to its disruption (Mills et al., 1999, Zhang et al., 1998). During this 
work, pronounced cell fractionation has not been observed for SH4-domain expressing cells. 
Furthermore, these cells were negative for TUNEL reaction, PS externalization or chromatin 
condensation. Together, this clearly indicated that SH4-domain expressing cells were not in an 
apoptotic stage (Huerta et al., 2007) and inhibition of caspase dependent apoptosis did not 
influence blebbing. 
Interestingly, a prerequisite for bleb induction by SH4-domains was their presence at the PM, 
since PM blebbing was absent upon expression of myristoylation or palmitoylation defective 
mutants of the HASPB- or Yes-SH4-domains. Consistently, the number of blebs per cell was 
related to SH4-domain expression levels indicating that high amounts of SH4-domains are 
required for induction of PM blebbing. A comparison of amino acid sequences from various 
SH4-domains, however, did not yield a common consensus sequence providing hints for 
specificity. Since the PM is the site for a variety of signaling events that require a definite 
interplay and localization of distinct determinants, these results might indicate that SH4-domain 
induced PM blebbing was caused by artificial effects due to their abundant presence at the PM. 
In this scenario, SH4-domains would alter the organization of the PM thereby disturbing 
subsequent signaling events required for its maintenance. Indeed, it has been shown that the 
myristoylated protein MARCKS which localizes at the PM upon activation of a myristoyl-
electrostatic switch, is also capable of PM blebbing induction if a palmitoylated mutant is 
expressed in fibroblasts (Myat et al., 1997). Nevertheless, as shown in this work the mode of 
acetylation does not determine blebbing activity, since non palmitoylated SH4-domains like the 
one of c-Src potently induced PM blebbing as well. Furthermore, endogenous c-Src was still 
found at the PM of Yes-SH4-domain expressing cells. Thus, the binding sites for this protein at 
the PM were not saturated by the presence of SH4-domains indicating that the PM is at least not 
overloaded with SH4-domains and a more specific process is involved. 
Together, SH4-domain induced PM blebbing was not related to secretion or apoptotic behavior. 
An artificial effect caused by the abundant presence of SH4-domains at the PM is unlikely as 
well, but cannot be excluded at the moment. To address this issue, a PM targeted SH4-domain 
lacking the capacity for PM blebbing induction will have to be identified in future experiments. 
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9.1.2 Identification of Central Factors in PM Blebbing 
A further microscopical analysis of SH4-domain induced PM blebbing revealed a well organized 
process that can be subdivided into three distinct phases: A fast bleb expansion, in which a newly 
formed bleb inflates very rapidly, always followed by an extended retention phase characterized 
by a stable distance of the distal bleb membrane relative to the PM. Finally, the blebs are 
retrieved to PM levels in a slow process termed retraction phase. Together with the observed 
bleb size and morphology, these characteristics were very similar to PM blebs described for  
M2 melanoma cells (Charras et al., 2005, Cunningham, 1995). Detailed investigations of these 
constantly blebbing cells had contributed to the model of poroelastic bleb formation: Herein it is 
thought that local contractility of the cortical actin meshwork which is tethered to the PM, causes 
a local hydrostatic pressure of the cytoplasm in this particular area. In combination with a 
destabilization of the cortical actin the cytosol squeezes out, resulting in detachment of the PM 
and thereby in bleb expansion (Charras et al., 2005). Subsequently, this enlargement is stopped 
by de novo polymerization of F-actin generating a new actin cortex that stabilizes the bleb 
membrane. The bleb is finally retracted in an active process based on acto-myosin contractility 
(Charras et al., 2006, Cunningham, 1995, Paluch et al., 2005, Wyckoff et al., 2006).  
Consistent with this model, SH4-domain mediated formation of PM blebs required acto-myosin 
contractility: Disruption of the microfilament system potently blocked PM blebbing which 
indicated that its integrity as well as active actin turnover were important prerequisites. Similar 
results have been obtained by bulk inhibition of myosin II mediated contractility or its activating 
kinase ROCK. In fact, ROCK proteins, being effectors of the Rho-GTPase Rho, are key 
regulators of contractility and play a central role during apoptotic PM blebbing (Coleman et al., 
2001, Riento and Ridley, 2003, Sebbagh et al., 2005, Sebbagh et al., 2001). In line with this, 
SH4-domain mediated PM blebbing was specifically regulated by the activity of Rho and not by 
other Rho-GTPases such as Rac or Cdc42, although all of them were found at the outer rim of a 
bleb membrane. Since PM localization of the SH4-domain was not impaired by inhibition of 
GTPase activity, Rho regulation of PM blebbing is likely to occur downstream of SH4-domain 
PM targeting and indicates that bleb induction is triggered by the presence of SH4-domains at 
the site of action. Whether Rho-GTPase activity can be found at the site of PM blebbing in 
particular and if it is deregulated in SH4-domain expressing cells will have to be addressed in 
future experiments. 
Nevertheless, a local activity of its effector ROCK was discovered at the bleb basis and inside 
the bleb lumen as demonstrated by specific staining of endogenous phosphorylated ROCK 
substrate MLC. Since no general MLC activation was detected upon SH4-domain expression by 
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Western blot analysis, the acto-myosin contractility is limited to local areas only. This is 
consistent with the model of poroelastic bleb formation, in which a delimited contraction of the 
cortical actin meshwork leads to PM blebbing as it occurs in M2 cells. Due to their FLNa 
deficiency, M2 cells possess a reduced integrity of the cortical actin meshwork triggering PM 
blebbing (Charras et al., 2006, Cunningham, 1995, Stossel et al., 2001). However, expression of 
SH4-domains had no obvious effects on overall FLNa expression levels or its serine 
phosphorylation, suggesting that SH4-domains either induce PM blebbing by a distinct trigger or 
cause only local variations of FLNa. Whether this is the case could not be demonstrated by 
immuno-fluorescence with the used antibodies. 
Another group of factors contributing to SH4-domain PM blebbing was identified in this study: 
Src kinases had not been linked to any kind of PM blebbing before. Inhibition of overall Src 
kinase activity potently reduced PM blebbing. Additionally, the Yes-SH4-domain failed to 
induce PM blebbing in fibroblasts depleted of the Src kinases c-Src, Yes and Fyn (SYF -/-), but 
succeeded in c-Src reconstituted cells (SYF + c-Src) again in a manner that required Src activity. 
These experiments clearly suggest that presence as well as activity of Src kinases is necessary for 
PM blebbing, which is highly interesting since they itself are attached to the PM by SH4-
domains (Resh, 1999). In line with this, endogenous c-Src was found at the PM and at the 
membrane of SH4-domain induced PM blebs. Thereby, its general distribution did not change 
upon expression of SH4-domains. In contrast to this, tyrosine phosphorylated and active c-Src 
accumulated in the bleb lumen similar to phosphorylated MLC. Since a change in bulk levels of 
active c-Src upon expression of SH4-domains was not detected, a local activation or most likely 
a specific recruitment of active c-Src can be suggested. This implies a novel biological function 
for SH4-domains that has not been described yet. 
In addition to ROCK and Src kinases, the Drf FHOD1 was found to play a role in PM blebbing 
as well: Co-expression of FHOD1 and ROCK1, but not of FHOD1 alone resulted in an apoptosis 
independent increase of ROCK1 mediated PM blebbing. Drfs are F-actin organizing proteins 
which have the ability to nucleate F-actin polymerization. Consistently, FHOD1/ROCK1 blebs 
were filled with F-actin, whereas co-expression of ROCK1 with FHOD1 variants lacking their 
capacity for G-actin recruitment or F-actin nucleation (ΔFH1, ΔFH2; (Gasteier et al., 2003) 
failed to increase PM blebbing. Interestingly, most of the parameters characterizing 
FHOD1/ROCK1 blebs are highly similar to SH4-domain induced blebs concerning bleb number 
and size, dependency on F-actin integrity, myosin II contractility, Rho and ROCK activity as 
well as localization of ROCK activity at the site of PM blebbing. Furthermore, the contribution 
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of FHOD1 to the formation of FHOD1/ROCK induced PM blebs was sensitive to inhibition of 
Src kinase activity, which was also enriched in the bleb lumen.  
In line with this, knockdown experiments of FHOD1 showed that SH4-domain induced PM 
blebbing was not simply depended on Src kinase or ROCK activity, but also involved the 
presence of FHOD1. Moderate reduction of endogenous FHOD1 levels decreased the amount of 
PM blebbing cells indicating a functional role for the Drf. Interestingly, this effect was not 
enhanced by a more efficient knockdown of FHOD1 suggesting that the Drf is not absolutely 
essential for PM blebbing. Thus, it might act in combination with other factors that do not 
require FHOD1. For example other Drfs such as mDia1, mDia2 or FHOD2 might compensate 
FHOD1 reduction simply by their presence or by an upregulation of their expression. This has 
not been tested yet, but would explain the slight increase in PM blebbing of ROCK1 expressing 
FHOD1 knockdown HeLa cells. Furthermore, FHOD1 might be of minor importance in 
endothelial cells such as CHO or HeLa cells. Although FHOD1 is ubiquitously expressed to 
some levels in human tissues, it had been predominantly detected in spleen cells, suggesting a 
tissue specific physiological role for the formin (Westendorf et al., 1999). In fact, two recent 
studies in mDia1 knockout mice have clearly demonstrated that various physiological processes 
are affected in T-cells only, but not in closely related B lymphocytes which are additionally 
enriched in mDia2 that presumably adopts functions of mDia1 (Eisenmann et al., 2007, Sakata et 
al., 2007). This also means that the key player for maintenance of the cortical actin in HeLa cells 
and possibly in CHO cells might be another Drf. Indeed, mDia1 is required for PM blebbing 
related invasion of MDA-MB-435 breast cancer cells (Kitzing et al., 2007). Furthermore, a role 
for mDia2 in PM blebbing had been suggested as well, even though knockdown of the Drf had 
not been sufficient to induce PM blebbing per se (Eisenmann et al., 2007). Consistently, potent 
reduction of endogenous FHOD1 which localized in the cortical actin of PM ruffles neither 
induced PM blebbing nor had a negative effect on PM blebbing of ROCK1 or Rac-L61A37 
expressing or apoptotic HeLa cells, respectively. This might indicate that specific Drfs are 
employed trigger dependently to mediate PM blebbing and are redundant in other blebbing 
situations. Thus, FHOD1 may represent one of several factors that synergistically mediate PM 
blebbing possibly cell type and trigger dependent. 
In summary, the three cellular determinants ROCK1, FHOD1 and c-Src were identified as 
potential regulatory proteins being involved in PM blebbing which is related to their presence at 
the blebbing site. While c-Src and ROCK1 are most likely recruited in their active forms, 
FHOD1 that to not induce PM blebbing when it is solely expressed may be activated during this 
process as discussed in the following chapter. 
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9.1.3 Synergistic Interplay Between ROCK1, FHOD1 and c-Src in PM Blebbing 
Although the Drf FHOD1 had been shown to interact with the Rho-GTPase Rac1 but not with 
RhoA (Westendorf, 2001), expression of a constitutively active variant lacking its C-terminal 
DAD results in formation of F-actin stress fibers and cables which are decorated with the Drf 
(Gasteier et al., 2003). This phenotype is dependent on the Rho-ROCK pathway but does not 
require Rac1 activity, suggesting a functional interaction between FHOD1 and ROCK. Indeed, 
Yeast two hybrid and Co-IP experiments revealed a physiological interaction of FHOD1 and 
ROCK1, but not ROCK2. The interacting regions could be roughly mapped to amino acid 
residues 368-727 in ROCK1 and 612-806 in FHOD1. In ROCK proteins this region is thought to 
be required for protein-protein interactions since it is part of a general coiled-coil structure 
(Nakagawa et al., 1996). The coiled-coil regions of ROCK proteins share 55 % identity in their 
amino acid sequences and are proposed to interact with α-helical structures of further proteins 
(Liao et al., 2007, Riento and Ridley, 2003). Such a 3-helix-bundle has been found at the  
C-terminal end of the FHOD1 region that binds to ROCK1 (Madrid et al., 2005). The 3-helix-
bundle is integrated into a predicted knob domain which provides structure and formation of the 
FH2-hemidimer in combination with the lasso region of a second FH2-monomer (Xu et al., 
2004). This predicted FHOD1 lasso-linker region is also part of the ROCK1 binding region. 
Since lasso-linker and knob without its 3-helix-bundle are mainly constructed of non-helical 
regions, only the 3-helix-bundle provides the required structure for an interaction. This 
interaction might be involved in a ROCK1 mediated activation of the autoinhibited FHOD1, a 
process that is not fully understood, yet. Drfs are thought to be regulated by the activity of Rho 
GTPases and additional factors (Faix and Grosse, 2006). Thus, ROCK1 may represent one of 
these factors for regulation of FHOD1. Therefore, the 3-helix-bundle in non-activated FHOD1 
has to be accessible to ROCK1, which is very likely since an interaction was detected with full-
length FHOD1 as well. 
This interaction, however, might be dependent on the presence of further cellular proteins as 
well. In vitro experiments demonstrated that FHOD1 co-precipitated with ROCK1 in the 
presence of active Src only, but not in PP2 treated cells (R. Madrid, personal communication). 
Consistently, SRE-activity mediated by constitutively active FHOD1-ΔC requires Src kinase 
activity (Koka et al., 2005). This is in line with the findings obtained in this work revealing that 
Src kinases are involved in FHOD1/ROCK1 mediated PM blebbing. Thus, a functional and 
physical interaction of these proteins might be suggested, although a direct c-Src binding to 
FHOD1 or ROCK1 was not investigated so far and will be addressed in future experiments. 
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Nevertheless, other Drfs like mDia1 and mDia2 directly interact with the c-Src SH3-domain 
presumably via proline rich regions of their FH1-domain suggesting this possibility for FHOD1 
as well (Tominaga et al., 2000, Yamana et al., 2006). 
Together, a hypothetical ternary regulatory complex of ROCK1, FHOD1 and c-Src is a likely 
option and might be constantly or transiently formed during induction and maintenance of PM 
blebbing. Whether for its assembly FHOD1 binds to c-Src first, followed by a subsequent 
recruitment of ROCK1 or a complex formation of FHOD1 and ROCK1 is required as the 
initially step, is not clear. Since over-expressed FHOD1 alone did not induce PM blebbing and 
predominately showed a cytoplasmic location, the latter possibility is more likely. In fact, 
activation of ROCK1 by additional factors seems to be a prerequisite for PM blebbing. During 
apoptosis, ROCK1 is C-terminally cleaved by caspase-3 and therefore constitutively activated 
(Coleman et al., 2001, Sebbagh et al., 2001). Furthermore, ROCK1/FHOD1 as well as SH4-
domain induced PM blebbing were dependent on Rho activity which directly activates ROCK1. 
This had been shown for other PM blebbing cells as well (Charras et al., 2006, Gadea et al., 
2007, Riento and Ridley, 2003, Sahai and Marshall, 2003). Interestingly, in p53 deficient MEF 
cells (p53 -/- MEF) Rho is activated and recruited to the PM of blebbing cells (Gadea et al., 
2007). Since Rho also localizes at the PM of SH4-domain induced blebbing cells a direct 
contribution to the complex formation is possible. Thus, active ROCK1 may be the seed which 
subsequently bind to FHOD1 mediated by additional factors like c-Src. One of these factors 
might be the Rho-GTPase Rac1 as well, which could be found at the membrane of SH4-domain 
blebbing cells. FHOD1 co-localizes with co-expressed constitutively active Rac1-L61 at the 
cortical actin (Gasteier et al., 2003) and interacts with Rac1-GTP as well as with its diphosphate 
variant in vitro (Westendorf, 2001). This suggests a contribution of the physical presence of 
Rac1 independent of its activity state to FHOD1 regulation. In fact, this would explain why 
dominant negative Rac1-N17 had no effect on PM blebbing. Interestingly, ROCK1/FHOD1 PM 
blebbing was supported by parts of the upstream region adjacent to the FH1-domain  
(FHOD1-Δ4). This region participates in FHOD1s interaction with Rac1 (Gasteier et al., 2003, 
Westendorf, 2001). In contrast to Rac1, proteins like DIP/WISH can bridge the interaction of 
Drfs and Src kinases. They interact directly and functionally with c-Src (Meng et al., 2004) as 
well as with Drfs such as mDia1, mDia2 and most importantly with FHOD1 (Eisenmann et al., 
2007, Satoh and Tominaga, 2001, Westendorf and Koka, 2004). Thereby, the N-terminal  
SH3-domain of DIP/WISH binds to the FH1-domain and N-terminal region of FHOD1. 
Interestingly, DIP/WISH proteins also regulate ROCK activity in a Src dependent manner by 
phosphorylation of p190RhoGAP facilitating hydrolysis of Rho-GTP to Rho-GDP, and further 
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Rho regulating proteins such as MEK and RhoGDI (DerMardirossian et al., 2006, Meng et al., 
2004, Pawlak and Helfman, 2002). 
Together, a combinatory binding of active ROCK1 together with Rac1, c-Src and DIP/WISH 
might synergistically regulate the activity of FHOD1 presumably by conformational changes and 
thereby interferes with its intramolecular autoinhibition. Since c-Src and ROCK1 are kinases, 
phosphorylation of FHOD1 might contribute to this regulation. Indeed, FHOD1 had been shown 
to be a target of GMP-dependent protein kinase 1 (PGK1), a serine/threonine kinase that 
phosphorylates the C-terminal DAD at amino acid residue Ser1131 in vascular smooth muscle 
cells (Wang et al., 2004). Phosphorylation of the DAD might impair its binding to the  
N-terminal end to release FHOD1 autoinhibition. So far, such a mechanism has not been 
described for other formins, even though it had been postulated (Wallar and Alberts, 2003). 
According to the consensus sequences for ROCK phosphorylation (R/K-X-S/T or  
R/K-X-X-S/T), a prediction of FHOD1 phosphorylation sites resulted in about 15 serine and  
11 threonine residues which are distributed across the whole protein (NetPhos 2.0: 
http://www.cbs.dtu.dk/services/NetPhos (Blom et al., 1999). Interestingly, Ser1131, Ser1137 and 
Thr1141 are located in the basic cluster of the DAD, whereas Ser138, Ser357, Ser358, Ser364 
and Ser367 lay within the predicted DAD-interacting FH3-domain (Schonichen et al., 2006) that 
basically consists of a cluster of armadillo repeats (A. Schulte, submitted). Consistently, a 
phosphorylation at these sites might release FHOD1s autoinhibition or contribute to a 
stabilization of the open conformation. In fact, Ser367 had been found to be phosphorylated in 
HeLa cells (Beausoleil et al., 2004). In addition to the amino acid residues located in the 
armadillo repeat, Thr42 represents a potential target for ROCK1 phosphorylation and Tyr99 is 
predicted to be phosphorylated by c-Src (NetPhos 2.0: http://www.cbs.dtu.dk/services/NetPhosK 
(Blom et al., 2004). These amino acid residues are located in a novel GTPase-domain that has 
been identified at the very N-terminus of FHOD1 (amino acid residues 1-135) and is placed 
upstream of the armadillo repeat within the FH3-domain (A. Schulte, submitted). This GTPase-
domain is unique to Drfs, although a similar N-terminal domain lacking the very first 70 amino 
acid residues has been described for mDia1 as well (Nezami et al., 2006, Rose et al., 2005). The 
FHOD1 N-terminal domain displays an ubiquitin-superfold which is thought to bind to the Ras 
family of GTPases. Functional studies with various GTPases which are supposed to interact with 
this domain are currently under investigation and may reveal a new regulatory pathway for 
FHOD1, which might be regulated by ROCK1 or c-Src mediated phosphorylation. 
Interestingly, PM blebbing induced by SH4-domains or FHOD1/ROCK1 is inhibited upon  
co-expression of the HIV-1 Nef protein (B. Stolp, unpublished data). In infected cells this viral 
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pathogenicity factor shows a variety of functions that are related to downmodulation of cell-
surface receptors such as CD4, MHC-I, CXCR4 and CCR5 (Garcia and Miller, 1991, Michel et 
al., 2005, Schwartz et al., 1996, Venzke et al., 2006) as well as to F-actin organization (Fackler 
et al., 1999). In fact, the HIV-1 Nef protein had been shown to interact in vitro with the DAD of 
FHOD1 in Yeast two hybrid (S. Benichou, Institut Cochin, Paris, unpublished data) and GST-
pulldown experiments (J. Gasteier, unpublished data). Additionally to inhibition of PM blebbing, 
a significant amount of co-expressed SH4-domains and HIV-1 Nef highly co-localized in a not 
yet identified perinuclear region. Similar results had been described in T-cells in which HIV-1 
Nef caused the relocalization of the Src kinase Lck from the immunological synapse to an 
intracellular compound, thereby altering signaling events at the site of cell-cell contact and 
inhibiting cytoskeletal rearrangements (Haller et al., 2006, Thoulouze et al., 2006 and C. Haller, 
unpublished data). Of note, the inhibitory effect on PM blebbing was not detected by  
co-expression of SH4-domains in combination with HIV-1 Nef mutants lacking either their PM 
targeting signal (Nef-G2A, non-myristoylated) or their P-X-X-P motif (Nef-AxxA) which is 
required for binding to SH3-domains such as of Src kinases. Together, HIV-1 Nef has the 
capacity to interfere with processes that involve the postulated c-Src-FHOD1-ROCK1 complex 
at the PM and may thus serve as a tool to identify the associated blebbing machinery. 
Additionally to its function in complex assembly and regulation, c-Src might be involved in PM 
targeting of the complex. Src kinases preferentially localize via their SH4-domain in lipid-
ordered areas of the PM termed lipid-rafts (Resh, 1999). These microdomains are hallmarked by 
a higher packing of the saturated hydrocarbon chains (Rajendran and Simons, 2005) and are 
proposed to be very dynamic and float freely within the disordered bilayer. They are thought to 
represent a site for enhanced cell signaling. According to a current model, lipid-rafts are formed 
and stabilized by the presence of PM associated peripheric proteins such as glycolphosphatidyl-
inositol (GPI)-anchored proteins, cholesterol-binding proteins like caveolin or double acetylated 
proteins like Src kinases (Hancock, 2006, Simons and Toomre, 2000). This indicates that the 
expressed SH4-domains preferentially localize at these lipid-ordered areas and might contribute 
to local clustering and enrichment of lipid-rafts. As a result, Src kinases and therewith the 
postulated c-Src-FHOD1-ROCK1 complex might then be recruited and concentrated at such 
sites leading to an increased net activity and thus bleb formation. Consistently, lipid-rafts are 
enriched in arachidonic acid (Pike et al., 2002), which regulate ROCK activity by direct 
interaction with its PH-domain and would therefore contribute to PM blebbing (Riento and 
Ridley, 2003). 
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In addition to their intrinsic dynamics, PMs are in continuous turnover. For fibroblasts with a 
surface area of about 3600 µm2, a PM endocytosis rate of 1-3 µm2/s was measured suggesting a 
very rapid process (Sheetz et al., 2006). Interestingly, cultivation of SH4-domain expressing 
cells at 20°C markedly reduced PM blebbing (S. Tournaviti, personal communication) indicating 
that an active vesicular transport providing the PM with cellular determinants is necessary. In 
fact, at least the HASPB-SH4-domain binds to vesicles in anterograde or retrograde transport 
which mostly occurs along microtubule tracks (Musch, 2004, Nickel, 2005). Since the 
components of the c-Src-FHOD1-ROCK1 complex might be transported to the PM in a similar 
way possibly following recruitment by SH4-domains, a destruction of microtubules would 
abolish SH4-domain mediated PM blebbing which was indeed demonstrated in this study. 
However, PM blebbing induced by co-expression of FHOD1 and ROCK1 was independent of 
microtubule integrity. This may be due to their abundant presence in the cytoplasm that does not 
require an active PM directed transport. Nevertheless, this model provides a simple mechanism 
of how SH4-domains recruit cellular components to the PM. 
Finally, the enrichment of SH4-domains at the PM might have further effects on its molecular 
composition which may contribute to induction of PM blebbing. In in vitro experiments it had 
been shown that alterations in the lipid composition directly influence the curvature of a 
monolayer membrane (Bacia et al., 2005). In SH4-domain expressing cells, this alteration may 
either be caused by the high proportion of integrated myristoyl and palmitoyl hydrocarbon chains 
itself or due to a selective recruitment of certain lipid species, but would have to be restricted to 
only one leaflet of the PM bilayer (Zimmerberg and Kozlov, 2006). However, SH4-domains 
were not enriched in PM blebs. An asymmetric distribution of the SH4-domains is also unlikely, 
since the SH4-domain of HASPB is present at both sides of the PM bilayer (Denny et al., 2000). 
Nevertheless, further experiments addressing the lipid and the protein composition of the bleb 
membrane are required to determine the direct contribution of the PM consistence in PM 
blebbing and to visualize a possible clustering of the lipid-ordered areas. 
Although there is no final prove for the formation of a ternary complex, the assimilation of the 
three central factors c-Src, FHOD1 and ROCK1 to form a functional PM blebbing machinery 
which is regulated by additional triggers appears likely based on obtained results. 
9.1.4 A Hypothetical Model for SH4-Domain Induced PM Blebbing 
Assuming formation of a ternary regulatory complex of ROCK1, FHOD1 and c-Src, the 
following hypothetical model on SH4-domain induced PM blebbing is proposed. Consistent with 
the poroelastic model of PM blebbing, the elements of this complex may orchestrate various 
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steps of this dynamic process. At the onset of bleb formation, the complex is formed and 
recruited by SH4-domains to the PM (fig. 58A). There, ROCK1 contributes in combination with 
c-Src to the regulation of FHOD1 (fig. 58B). Active FHOD1 catalyzes de novo polymerization 
of F-actin filaments thereby disturbing the organization of the cortical F-actin meshwork 
resulting in pore formation. This would be a simple explanation for FHOD1s effect in PM 
blebbing upon co-expression with ROCK1, since a further activation of ROCK1 by FHOD1 was 
not detected in IVKAs or Western blot analysis. 
 
Figure 58: Hypothetical model of the machinery orchestrating dynamic SH4-domain induced PM blebbing. 
(A) Recruitment and activation phase: Driven by SH4-domains as a specific trigger, a ternary complex consisting of 
the Drf FHOD1, the Ser/Thr kinase ROCK1 and the Tyr kinase c-Src is formed in the presence of active Rho and is 
in parallel recruited to lipid ordered regions at the PM. Adaptor proteins such as DIP/WISH may contribute to this 
complex since they bind to both Src kinases and FHOD1 and may be required for an intrinsic regulation of the 
complex. Furthermore, the Rho GTPase Rac1 interacts irrespectively of its activation state with FHOD1 and may 
help to release its intramolecular binding. Further, yet unidentified GTPases might be involved in this process as 
well. (B) Expansion phase: Activity of the ternary c-Src-FHOD1-ROCK1 complex at the PM results in F-actin 
polymerization and myosin II dependent contraction. Upon this activity and in line with the model of poroelastic 
bleb formation, the integrity of the cortical F-actin meshwork is disrupted and local hydrostatic pressure is affected 
to the cytoplasm resulting in its flow towards the PM. Combined with a c-Src-FHOD1-ROCK1 complex mediated 
regulation of tethering factors like ERM-proteins a PM bleb is formed. (C) Retention and retraction phase: Activity 
of the ternary c-Src-FHOD1-ROCK1 complex also facilitates generation of a new cortical F-actin meshwork which 
is linked to the bleb membrane by recruited tethering proteins and thereby stabilizes the newly formed bleb. 
Subsequently, ROCK1 activity mediates myosin II dependent contraction of the new filaments which results in bleb 
retraction. Additional, so far unidentified factors (XY) may be required for further regulation of the complex 
activity. 
However, pore formation might include additional factors as well. At least for the Src kinase Lck 
a phosphorylation mediated regulation of FLNa has been shown and FLNa deficiency triggers 
PM blebbing in M2 cells (Cunningham, 1995, Goldmann, 2002, Pal Sharma and Goldmann, 
2004). Since only serine phosphorylation was tested in this study, effects of SH4-domain 
expression on tyrosine phosphorylation by Src kinases cannot be excluded. Thus, this regulated 
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process would generate a situation very similar to that in M2 cells. Mediated by ROCK1 activity, 
contraction of the actin cortex by phosphorylation of myosin II is initiated and forces a 
cytoplasmic flow toward the PM where a bleb is formed. This process might be supported by a 
local variation of PM tethering to the cortical actin again by the activity of c-Src and ROCK1. 
Indeed, it has been shown, that both kinases phosphorylate members of the family of ERM 
proteins (Bretscher et al., 2002, Elliott et al., 2004, Riento and Ridley, 2003, Srivastava et al., 
2005). However, since phosphorylation of ERM proteins was linked to their activation only, a 
contribution in bleb stabilization during retention phase is more likely (fig. 58C). In fact, ezrin 
had been shown to play a role in regeneration of the cortical actin meshwork during retention 
and retraction phase of blebs generated in M2 cells (Charras et al., 2006). There it facilitates the 
connection of newly formed F-actin fibers to the bleb membrane. Thus, actin polymerization 
activity is required in these phases of PM blebbing (Charras et al., 2006, Paluch et al., 2005) and 
could be catalyzed by FHOD1. In this way, a new scaffold is organized which is subsequently 
retracted by ROCK1 mediated contractility through phosphorylation of MLC. 
In summary, the postulated ternary complex of c-Src, ROCK1 and FHOD1 may constitute a 
basic component of a prevalent blebbing machinery. However, depending on the trigger and the 
cellular environment, its elements might be replaceable with ROCK2, other Drfs or Src kinases. 
Nevertheless, the described hypothetical model of PM blebbing can be used as a working 
hypothesis for future studies. Whether this machinery represents a general mechanism for PM 
blebbing will have to be addressed in future experiments. 
9.2 Functional Relevance 
9.2.1 Functions of SH4-Domain Induced PM Blebbing 
Physiological PM blebbing occurring on animal cells is usually linked to certain situations in 
which specific signals presumably trigger a common machinery. Tumor cells show no PM 
blebbing when cultured on planar surfaces, but activate blebbing motility in 3D environments 
consisting of ECM determinants (Sahai and Marshall, 2003, Wolf et al., 2003). During this 
amoeboid or rounded mode of motility, blebs are formed in the direction of movement and are 
thought to provide the basic structure that enables the cell to squeeze through the matrix pores 
(Sahai, 2005, Yamazaki et al., 2005). Interestingly, upon expression of SH4-domains but not of 
GFP alone, CHO cells were able to invade into such 3D environments in which they showed PM 
blebbing as well. In fact, the invasiveness closely matched that of MDA-MB-435 human breast 
carcinoma cells that were used as a control. Furthermore, this motility seems to be related to the 
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capability of SH4-domains to induce PM blebbing, since expression of the myristoylation mutant 
of the HASPB-SH4-domain did not mediate invasiveness. This implies that SH4-domain 
induced PM blebbing in 2D represents the constitutive activation of a cellular pathway which is 
required for 3D motility of tumor cells. Interestingly, the palmitoylation deficient mutant of the 
HASPB-SH4-domain, that failed to induce PM blebbing in 2D, still slightly enhanced 
invasiveness of CHO cells. Thus, SH4-domains may have additional effects on cell signaling 
events that are independent of PM blebbing but influence 3D motility. Since the  
N18-Δpal-HASPB-GFP is enriched at intracellular membranes that are most likely Golgi 
associated vesicles (Denny et al., 2000, Stegmayer et al., 2005), SH4-domains may contribute to 
events that are required for directed cell motility such as cell polarization (Nabi, 1999, Nobes 
and Hall, 1999). To obtain a further insight into this phenomenon, additional SH4-domains will 
have to be investigated for induction of invasiveness by an approach allowing analysis of single 
cell behavior during migration. Of note, Src kinase activity which is required for the formation of 
SH4-domain induced blebs contributes to the mesenchymal or elongated mode of motility that 
depends on the formation of invadopodia or podosomes which are distinct from PM blebs 
(Linder and Aepfelbacher, 2003). This type of 3D invasion is based on secretion of 
metalloproteases that disrupt the ECM in order to form a passage for the cell (Sahai, 2005, 
Yamaguchi and Condeelis, 2007). Whether SH4-domain mediated invasiveness depends on Src 
activity has to be analyzed in future experiments as well. However, first experiments 
demonstrated that SH4-domain mediated 3D motility was dependent on ROCK activity which is 
not required for the mesenchymal but necessary for the amoeboid mode (Sahai and Marshall, 
2003, Wyckoff et al., 2006).  
Motility in 3D environments is usually investigated in combination with a gradient of FCS to 
provide a directional movement (Hooper et al., 2006), which was applied in this study as well. 
This implicates that chemotactic factors bind to specific receptors at cellular surfaces or have to 
be internalized into the cell in order to induce an internal signaling asymmetry that leads to 
cytoskeletal rearrangements and polarization of the cell (Yamazaki et al., 2005). Since PM 
blebbing had been observed during the entry process of Vaccinia viruses (A. Helenius and  
J. Mercer: 58. Mosbacher Kolloquium 2007) a possible role of SH4-domain induced PM 
blebbing in internalization of extracellular fluid was investigated. Indeed, SH4-domain 
expressing cells showed an increased ability for non-specific fluid-phase uptake of dextran from 
the extracellular space. This additional internalization was insensitive to EIPA, an inhibitory 
drug mainly interfering with macropinocytosis but also with other endocytotic pathways 
(Norbury, 2006). Although a contribution of clathrin mediated uptake of dextran was considered 
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as well, SH4-domain expression did not influence the internalization of transferrin. Further 
experiments with specific inhibitory drugs are required to address this issue. Additionally, other 
endocytotic mechanisms principally facilitate fluid-phase uptake, especially over a long time 
range. Interestingly both caveolae and lipid-raft mediated endocytosis depend on lipid-ordered 
areas where SH4-domains are predominantly localized (Johannes and Lamaze, 2002, Resh, 
1999). Assuming an influence of abundant SH4-domains on the characteristics of such 
microdomains as discussed above, these internalization pathways are indeed possible candidates 
to facilitate SH4-domain mediated fluid-phase uptake. These possibilities will have to be 
addressed in future experiments. Nevertheless, this uptake does not seem to be solely dependent 
on PM blebbing induction since the myristoylation and palmitoylation defective mutants of the 
HASPB-SH4-domain were able to induce this uptake as well, though with reduced efficiency. 
This again indicates possible additional effects of SH4-domains in cellular signaling as it was 
suggested for 3D motility. Thus it is not clear whether mediation of fluid-phase uptake of 
chemotactic factors can account for increased motility in 3D. However, in a 2D wounding assay 
where cellular motility is triggered by chemotactic orientation in combination with a unilateral 
loss of cell-cell contact-inhibition (Nobes and Hall, 1999), expression of SH4-domains had no 
detectable influence on cell migration. 
In summary, it was shown that SH4-domains are the triggers for induction of 2D PM blebbing, 
3D invasion and fluid-phase uptake. Although 2D PM blebbing is highly dependent on their PM 
localization, additional signaling events may be involved in 3D invasion and fluid-phase uptake, 
mediated by the presence of SH4-domains e.g. on internal membranes. Whether these signaling 
events are interconnected and require the activity of the postulated c-Src-FHOD1-ROCK1 
ternary complex will have to be addressed in future experiments. Nevertheless, all these results 
claim novel functions for SH4-domains that had not been described before and exceed their 
function as simple membrane anchors. 
9.2.2 The Role of FHOD1 in Intracellular Organization 
Another aim of this study was the investigation of endogenous FHOD1. In over-expression 
experiments, FHOD1 exclusively shows a diffuse cytoplasmic distribution. To investigate 
cellular functions and localization of the endogenous protein, a polyclonal rabbit antibody 
directed against two peptides in the N-terminus of the protein has been generated (Gasteier et al., 
2005). Interestingly, in immuno-fluorescence experiments, a specific signal in perinuclear 
regions was obtained with this antibody. This could be confirmed by immuno-electron 
microscopy, in which it was shown that the protein mainly localized at the lateral sites but not in 
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the lumen of Golgi vesicles as well as in close proximity to PM ruffles. The specificity of the 
antibody was verified in both methods via blocking experiments with the target peptides. 
However, examination of immuno-fluorescence experiments was possible in rodent cell lines 
only, whereas electron-microscopy yielded specific signals in human HeLa cells. Detection of 
FHOD1 by Western blotting was possible with lysates from cells of both phylae. The reasons for 
this discrepancy are unclear but might be due to a different accessibility of the protein. For 
Western blotting, the proteins are initially denaturated during SDS-PAGE for a homologous 
separation. They are thought to be partially refolded after transfer to the nitrocellulose membrane 
due to a change of buffer conditions. Thereby, initially hidden epitopes might be exposed under 
these circumstances. This is supported by destruction of intracellular protein complexes and 
removal of posttranslational modifications, which might be specific for diverse cell types and 
phylae. However, the signals confirm a role for FHOD1 at the PM in which it is involved in PM 
blebbing as shown in this study. Furthermore, these findings were in line with FRET 
experiments with co-expressed FHOD1 and constitutively active Rac1-L61 (A. Alberts, 
unpublished data). In these experiments a specific FRET signal distribution was found that 
indicated a localization of FHOD1 in similar perinuclear regions as well as in membrane ruffle 
like structures. Of note, a comparable distribution of over-expressed FHOD1 in lamellipodia 
upon co-expression with constitutively active Rac1-L61 had been shown as well (Gasteier et al., 
2003). Furthermore, FHOD1 has been demonstrated to co-localize with the multifunctional cell 
surface protein CD21 at the PM following binding to EBV (Gill et al., 2004). In fact, in the same 
study the authors have also described that over-expressed FHOD1 fused to GFP can be found in 
a perinuclear region of some cells per se, which is in contrast to other studies (Gasteier et al., 
2003, Koka et al., 2003, Takeya and Sumimoto, 2003) and the results obtained in this work. 
Finally and most interestingly, FHOD1 had been shown to be phosphorylated by PGK1 at the 
DAD and to co-localize with the kinase at perinuclear regions of vascular smooth muscle cells 
(Wang et al., 2004). However, this localization was not observed by co-expression of FHOD1 in 
combination with ROCK1 or with the constitutively active ROCK1-Δ3, even though endogenous 
ROCK1 has been shown to localize at Golgi stacks (Percival et al., 2004, Riento et al., 2003). 
Unfortunately, staining of endogenous ROCK1 in order to investigate the co-localization with 
FHOD1 at the Golgi failed with the employed antibodies. 
Interestingly, the microfilament system is required to determine Golgi shape and regulate vesicle 
transport (DePina and Langford, 1999). Thus, a role for FHOD1 in combination with its binding 
partner ROCK1 in Golgi specific F-actin organization could be envisioned. For identification of 
relevant Golgi compartments, immuno-fluorescence studies with marker proteins were 
Discussion 
 
   
 
130
performed: Endogenous FHOD1 localized distinct to endosome marker proteins (EEA1, 
LAMP1, TfR), but in close proximity to the cis- and trans-Golgi proteins TGN-46 or coatomer 
and most pronounced in between p115/TAP positive vesicles. This protein is involved in fusion 
of ER-derived COP-II vesicles and their binding to Golgi membranes (Allan et al., 2000). 
However, neither over-expression nor knockdown of FHOD1 altered the appearance of these 
vesicles. Of note, the FHOD1 specific perinuclear stain was not altered as expected from reduced 
protein amounts detectable in a Western blot analysis. The reason for this observation is unclear, 
but Golgi associated FHOD1 might comprise of subpopulations with evaluated half life as 
compared to cytosolic protein pools. Increased incubation times in knockdown experiments 
might then be necessary to remove these proteins as well. Indeed, in HeLa cells in which the 
knockdown efficiency had been improved, the specific signal was clearly diminished in immuno-
electron microscopy, however, without any apparent effect on Golgi organization. Nevertheless, 
this might be due to sufficient residual amounts of FHOD1 or substitutive effects of other Drfs as 
already discussed in the previous chapters. Even so, after BFA mediated disruption of the Golgi, 
distinct amounts of FHOD1 were still associated with the coatomer protein at distal regions of 
the cell. Both proteins were similarly redistributed to a stack like structure upon wash out of the 
inhibitory drug. By microscopical observation the impression was obtained that FHOD1 
assembled faster to the perinuclear region, but this has yet to be quantified. However, 
knockdown of FHOD1 had no effect on reorganization of the Golgi (data not shown). Similarly, 
a cargo transport assay with VSV-G protein did not show any defect in Golgi dependent 
secretion. 
Since FHOD1 was not involved in the functionality of the Golgi, further Golgi related functions 
were analyzed by an FHOD1 specific knockdown: During mitosis, the Golgi disperses in the 
cytoplasm and reorganizes following completed cytokinesis (Colanzi and Corda, 2007). 
However, FHOD1 had no detectable influence on the proliferation rate. Furthermore, in various 
cells, a polarization of the Golgi and the MTOC towards the direction of movement is required 
for cell migration (Nabi, 1999). Reduction of FHOD1 neither affected these active processes 
(data not shown) nor impaired cell migration in wound healing assays or chemotaxis along a 
gradient of FCS, which stays in conflict with published data obtained with over-expressed 
FHOD1 (Koka et al., 2003). Next, knockdown of FHOD1 did not affect cell adhesion to various 
surfaces, nor had a detectable influence on F-actin content or cell size. Consistently, reduction of 
FHOD1 levels had no detectable effects on Rho, Rac1 or Cdc42 mediated microfilament 
reorganization or SRE activation. 
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In summary, endogenous FHOD1 localized at Golgi structures which was in line with several 
studies. The role of the protein at this cellular compartment remains elusive although a 
contribution to Golgi organization cannot be ruled out by the knockdown experiments. Since all 
these experiments have been performed in HeLa cells or fibroblasts, future experiments should 
include cells of spleen origin. Therefore, a more advanced screen than the published one 
(Westendorf et al., 1999) should be performed that distinguishes between different cell types as 
it has been evaluated in other studies for mDia proteins (Eisenmann et al., 2007, Sakata et al., 
2007). Since FHOD1 is involved in SH4-domain mediated PM-blebbing and SH4-domains such 
as that of HASPB are palmitoylated in association to the Golgi apparatus, FHOD1 might have 
the capacity to affect transport and posttranslational modifications of these proteins. Whether this 
link can be deduced will have to be addressed in future studies. 
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10 OUTLOOK 
In this study, SH4-domains have been identified as a new trigger for cell invasion, fluid-phase 
uptake and PM blebbing. Following detailed analysis of intrinsic signaling pathways required for 
PM blebbing, a novel mechanism is proposed which includes Src kinases as novel key players, 
ROCK proteins and the Drf FHOD1 as actin remodeling and regulatory components. 
Furthermore, this study adds new knowledge to the activation of FHOD1 and provides a first 
view on cellular localization and function of the endogenous FHOD1 protein. However, various 
additional experiments will be necessary to answer open questions and to complete the 
hypothetical model of a synergistic interplay between Src kinases, ROCK proteins and FHOD1: 
 
1. What are the physiological roles and specificities of SH4-domain induced PM blebbing, 
cell invasion and fluid-phase uptake and is there evidence for the influence of lipid-
ordered microdomains on these functions? The most important issue will be the 
identification of a PM targeted SH4-domain, that fails to induce PM blebbing. To 
investigate the physiological relevance, Src kinases that are linked to this artificial SH4-
domain have to be constructed followed by a detailed study evaluating a variety of 
endogenous functions e.g. by transient expression in SYF -/- cells. Additionally, a 
detailed analysis of the lipid and protein composition of bleb membranes is required as 
well as an artificial change of this composition and its influence on the described 
phenotypes. 
 
2. Is there a biochemical and functional proof for the here postulated ternary complex of  
c-Src, FHOD1 and ROCK1 and does it have a physiological relevance? Detailed 
interaction studies and systematic modifications of the interaction partners should be 
addressed in the background of PM blebbing, cell invasion and fluid-phase uptake. First 
approaches include the investigation of the influence of inhibitory drugs that target Src 
kinase and ROCK activity.  
 
3. Is FHOD1 the only Drf that is involved in SH4-mediated PM blebbing, fluid-phase 
uptake and cell invasion and other forms of PM blebbing or are further Drfs involved as 
well? Therefore, a detailed analysis of the protein and expression levels of FHOD1 
knockdown cells as well as knockdown of further Drfs like Dia1, Dia2, Dia3, FHOD2, 
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FRL and others, singularly or in combination with each other is necessary. In line with 
this, the knockdown efficiency of FHOD1 will have to be further improved, e.g. by 
further methods based on shRNA. The final goal must be a rescue of obtained phenotypes 
with expression of RNAi insensitive constructs.  
 
4. What is the exact mechanism for regulation of the Drf FHOD1? To answer this question, 
functional interaction partners with the N-terminal GTPase domain are under current 
investigation. Furthermore, the role of ROCK1 will have to be examined, particularly by 
a more detailed mapping of the regions necessary for interaction. In line with this, the 
role of Src kinases for this interaction and other proteins like DIP/WISH must be 
addressed as well.   
 
5. What is the functional relevance of FHOD1 localization at Golgi structures and is there 
a link to other functions like PM blebbing? Localization studies of endogenous FHOD1 
in SH4-domain expressing cells and cells that are treated with inhibitory drugs against 
Src kinases or ROCK will be necessary to address this question. Since Drfs are postulated 
to function in specific tissues, a detailed analysis of FHOD1 expression patterns in 
several cells especially in those derived from spleen is required to narrow down FHOD1s 
functions. 
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